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Introduction 
Two of the 21
st
 century most promising technologies are biotechnology and 
nanotechnology. This science of nanoscale structures deals with the creation, 
investigation and utilization of systems that are 1000 times smaller than the 
components currently used in the field of microelectronics. Convergence of 
these two technologies results in growth of nanobiotechnology. This 
interdisciplinary combination can create many innovative tools. The 
biomedical applications of nanotechnology are the direct products of such 
convergence. 
Indeed, due to their unique size-dependent properties, nanomaterials have the 
potential to revolutionize the detection, diagnosis, and treatment of diseases by 
offering superior capabilities compared to conventionally used materials. 
Today nanomaterials have been designed for a variety of biomedical and 
biotechnological applications, including biosensors, enzyme encapsulation; 
neuronal nanotechnology, on the other hand, is based on the introduction of 
novel nanomaterials which can result in revolutionary new structures and 
devices using extremely biologically sophisticated tools to precisely position 
molecules. Nanotechnology in biomedical sciences presents many 
revolutionary opportunities in the fight against all kinds of cancer, cardiac and 
neurodegenerative disorders, infection and other diseases. Utility of 
nanotechnology to biomedical sciences imply creation of materials and devices 
designed to interact with the body at sub-cellular scales with a high degree of 
specificity. This could be potentially translated into targeted cellular and tissue-
specific clinical applications aimed at maximal therapeutic effects with very 
limited adverse-effects. 
Nanoparticles are part of the family of devices nanotechnology had given birth 
to. By their size and morphologic properties they encounter a large panel of 
different applications, biomedical applications are part of this panel. These 
specific nanoparticles can cover different functions from diagnosis to direct 
treatment; more specifically they can be used as carriers for specific delivery of 
drugs or as vector for specific therapies. In a first chapter different kind of 
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nanoparticles will be described in a first time, and the related therapy they 
apply to will be explained in a second time. 
In order to be used for this specific kind of application, the nanoparticles 
should comply with a certain number of requirements and specifications. To 
this end, not only the materials used for their preparation, but also the method 
employed should satisfy such requirements. In a second chapter, the 
requirements will be listed and their implications will be explained, and in the 
third chapter specific preparation methods meeting these criteria will be 
described. 
A lot of research is currently being conducted on this specific topic, for this 
reason it is a challenge to constantly find new methods of preparation and new 
materials meeting all the previously described requirements and in the same 
time bringing and improvement in the potential treatments. 
In the fourth chapter will be described the materials and methods I used to 
prepare devices and take up that challenge. 
Firstly, a new fast and convenient method is reported for preparing magnetic 
nanoparticles with a Fe3O4 core and a Poly(ethylene glycol)-diacrylate shell in 
water. A reduction coprecipitation method was used to obtain Fe3O4 in aqueous 
solution whereas the PEGDA coating was obtain via photochemical reaction at 
room temperature in an initiator free aqueous system. The fact that this method 
is solvent free and initiator free makes it ideal for biomedical applications. 
Secondly, magnetite nanoparticles were coated following a previous surface 
functionalization. The Fe3O4 nanoparticles were obtained as before and further 
stabilized with citric acid. Afterwards nanoparticles surface was modified by a 
silanization reaction with vinyltrimethoxysilane involving magnetite hydroxyl 
groups. Vinyl functionalized nanoparticles were coated with poly (ethylene-
glycol) (PEG) using PEG dithiol (PEG-SH) under UV irradiation. Thiol-ene is 
a free-radical reaction that proceeds by a step-growth mechanism, involving 
two main steps, a free-radical addition followed by a chain transfer reaction; 
this reaction is well known for occurring in absence of any radical 
photoinitiator making it ideal for eventual biomedical applications. 
Thirdly, the use of ―click‖ reactions for preparing magnetic NPs with Fe3O4 
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core and different biocompatible polymeric shells is reported. Magnetite 
nanoparticles were obtained following the same procedure that in the first two 
studies. As a next step, magnetic nanoparticles surface was modified by a 
silanization reaction with (3-bromopropyl)trimethoxysilane in order to 
introduce bromine groups on the particles surface. Afterwards the bromine 
groups were converted to azide groups by the reaction with sodium azide in 
order to obtain azide groups to take part to click reaction with alkyne 
functionalized polymers. For this reason, acetylene functionalized 
poly(ethylene glycol) (a-PEG) and poly(ε-caprolactone) (a-PCL) were 
synthesized and grafted onto the surface of azide functionalized nanoparticles 
via ―click‖ reaction to obtain monodisperse magnetic nanoparticles. The 
peculiar characteristics of this method make it ideal for biomedical 
applications.  
Fourthly, a new, fast and convenient method for preparing gold nanoparticles 
with a poly(ethylene glycol)-diacrylate (PEGDA) shell in water is reported. 
Polyethyleneglycol (PEG) was used as hydrophilic monomer in emulsifier-free 
emulsion polymerization to form polymeric nanoparticles by the UV-induced 
process. At the same time, gold was generated as the core of the PEG 
nanospheres by the reduction of HAuCl4 activated through the radical 
photogenerated from 2-hydroxy-2-methyl-1-phenyl-1-propanone. This one-
step procedure is very easy to implement and fast. Moreover, the fact that this 
method is performed in water makes it ideal for biomedical applications. 
Fifthly, hollow gold nanoparticles were prepared and coated with Poly(ethylene 
glycol) methyl ether thiol. In a first time, cobalt nanoparticles were prepared by 
reduction of cobalt salts and in a second time gold salts were reduced on the 
surface of cobalt nanoparticles forming a gold shell while consuming the 
cobalt, leaving at the end of the reaction a hollow gold nanoparticles. 
Successively these devices were coated with the polymer taking advantage of 
the natural affinity between thiol groups and gold. 
Sixthly, gold nanoshell were prepared and coated with Poly(ethylene glycol) 
methyl ether thiol. Gold nanoshells are constituted by a silica core and a gold 
shell. Silica nanoparticles were obtained by the well-known Stöber method, 
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then gold seeds (3 nm diameter) were grafted on the surface of these silica 
nanoparticles and successively grown by gold salts addition until obtaining a 
continuous and homogeneous gold shell. In the end these devices were coated 
with the polymer taking advantage of the natural affinity between thiol groups 
and gold. 
The fifth and sixth chapters describe the characterization of these devices 
correlated to their potential applications. 
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1. Nanoparticles for biomedical applications 
Most treatments distribute to the whole body, which gives rise to general 
toxicity and poor patient acceptance. Since transporting across the membrane is 
one of the key obstacles therapeutic treatments must overcome to effectively 
function in the cell, potential treatments should be designed taking into account 
these specific membrane-transport properties [1]. This aim can be reached by 
using vectors. However, although a variety of treatments have been designed as 
vectors with their own advantages and limitations, scientists are still learning to 
optimize delivery to enhance the bioavailability of the treatment toward 
diseased cells, promoting the required response while minimizing side-effects. 
Therefore, in the field of targeted therapies the way to develop treatment 
vectors able to target defined cells by means of specific recognition 
mechanisms, and to overcome biological barriers, has become a common goal 
to reach.  
 1.1  Different nano-vectors 
Nanovectors are multifunctional organic and inorganic nanoparticles, 
nanowires, or nanotubes. In the laboratory setting, nanovectors can improve 
both the targeted delivery of anticancer drugs and the targeted localized killing 
of cancerous cells [2]. Moreover nanovectors have the potential to be a generic 
platform for different types of cancer treatments localized on a unique device. 
Last but not least, in near future nanovectors could also give rise to 
nanosurgical tools for surgical treatments of cancer. The main characteristics of 
the vectors are biocompatibility and biodegradability so as to be easily 
eliminated afterwards and avoid any toxic accumulation. 
 1.1.1  Nanocarriers 
Therapeutic efficacy of a drug is linked to its pharmaco-kinetic behavior. The 
drug should reach quickly and in sufficient quantity its target and remain active 
on the same site long enough to complete its therapeutic action. Furthermore, 
the drug should be able to avoid accumulating in healthy tissues and organs in 
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order not to cause toxic effects. In this way it would be possible to decrease 
side effects as well as drug concentration. On the contrary, very often, the drug 
distribution in the body is not the one expected: drug quantity is too low on the 
target site and too high in healthy tissues causing damages. Different strategies 
have been studied in order to increase the drug concentration on the target site 
avoiding contact with healthy tissues. One of these strategies consists in linking 
the drug to a vector. The drug is encapsulated in this vector, which is able to 
transport it to the target and release it in a controlled way. Nanoparticles are 
one of the many vectors that can be used to this aim and have been widely 
studied lately. 
Nanoparticles are colloidal systems, generally constituted from polymer, 
preferentially biodegradable, from natural or synthetic origins. They can be 
matricials (nanospheres) or empty (nanocapsule) as can be seen in Figure 1.1.  
In the first case the drug can be molecularly dispersed inside the polymeric 
matrix and then be released either by osmotic diffusion from inside the 
nanoparticles to the outside, or by biodegradation of the device inside the 
organism.  
Nanocapsules, on the other hands, are constituted from a generally liquid core 
and a thin polymeric shell. 
Compared to other colloidal systems, such as liposomes, nanoparticles are 
characterized by a higher stability in biological fluids. This behavior can be 
explained by their polymeric structure which is a lot more stable than the 
lipidic bilayer of the liposomes. Moreover, nanoparticles constitute a very 
versatile colloidal system; as a matter of fact a wide range of biocompatible 
polymers is available allowing to choose the most suitable system for the 
 
Figure 1.1: schematic representation of a nanosphere 
(A), and a nanocapsule (B) 
 
 
1-Nanoparticles for biomedical applications 
________________________________________________________ 
7 
 
controlled release of the encapsulated drug, adjusting the vector degradation. 
Furthermore, the surface of nanoparticles-based vectors designed for drug 
delivery can be decorated with various targeting agents or biological materials, 
such as antibodies, imaging agents or reporter molecules which can be used to 
target a specific receptor in malignant cells, image these cells and trace the 
device during the treatment. 
Depending on the materials of preparation, nanoparticles have been 
synthesized most frequently by three methods: dispersion of preformed 
polymers, polymerization of monomers and ionic gelation or coacervation of 
hydrophilic polymers [3]. The application of nanoparticulate delivery systems 
should applied to sites as varied as brain cells or epithelial cells and includes 
not only drug delivery, but also delivery of peptides, proteins or whole genes. 
The potential applications of colloidal drug carriers by the intravenous route 
can be summarized as concentrating drugs in accessible sites, rerouting drugs 
away from sites of toxicity and increasing the circulation time of labile or 
rapidly eliminates drugs (e.g. peptides and proteins). 
Liposomes or nanoparticles can be used to concentrate antibiotics at the site of 
infection for direct treatment of bacterial and parasitic infections, particularly 
when the microorganism is within the lysosomes [4]. For example, 
nanoparticles containing ampicillin were more effective than the free drug 
against both Salmonella tymphimurium and Listeria monocytogenes. Co-
localization of the particles and bacteria was seen in Salmonella infected 
macrophages in vitro [4]. 
Colloidal carriers can also be used to divert drugs from sites of toxicity after 
intravenous administration. For example, the anticancer drug doxorubicin 
(adriamycin) is active against a wide spectrum of tumors, but provokes dose-
limiting cardiotoxicity. Encapsulation within liposomes or nanoparticles 
reduces this toxicity, by reducing the amount of drug which reaches the 
myocardium [5][6]. 
A corollary is that concentrations of doxorubicin in the liver increase 
considerably. In one study in mice, this was not associated with any overall 
toxicity [6]. However, another group reported a temporary depletion of Kupffer 
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cells and hence the ability to clear bacteria, in rats, which was less marked 
when long-circulating liposomes were used [7]. A systematic study using 
unloaded nanoparticles confirmed a reversible decline in the phagocytic 
capacity of the liver after prolonging dosing, as well as a slight inflammatory 
response [8]. Thus, altered distribution may generate new types of toxicity and 
this must be borne in mind when developing carrier systems. 
In recent years, gene therapy is also opening up a possibility for treating some 
incurable diseases. Broadly defining, gene therapy is the insertion of genes into 
specific cells and/or tissues to treat a defect, as example a hereditary disease in 
which a deleterious mutant allele is replaced with a functional one. Although 
the technology is still in its beginning, it has been used with some success [9] 
and has the potential to change medical science dramatically in the future.  
 1.1.2  Magnetic nanoparticles 
Lately, magnetic nanoparticles (MNPs) have attracted attention because of their 
potential application not only in drug delivery and magnetic resonance imaging 
(MRI) but also in magnetic hyperthermia. MNPs for such biomedical 
application should be hydrophilic and biocompatible [10]. To that end, variety 
of inorganic nanoparticles such as magnetic nanoparticles, metal nanoparticles 
and metal oxide nanoparticles have gained increasing interest in the field of 
material sciences because of their specific optical, electronic and magnetic 
properties [11]. Among these particles, iron oxide nanoparticles such as 
magnetite, or its oxidized form maghemite, are the most biocompatible agents. 
These particles are typically coated with a biocompatible polymer to prevent 
their aggregation and biodegradation for in vivo applications [12]. 
Magnetite (Fe3O4) is a common magnetite oxide that has a cubic inverse spinel 
structure [13][10]. The most common method to prepare magnetite 
nanoparticles consists in mixing solutions of FeCl3 and FeCl2, followed by 
precipitation of magnetite by addition of a base [14]. Fe3O4 nanoparticles may 
then be superficially oxidized to the more stable maghemite (γ-Fe2O3) by 
addition of ferric nitrate to the colloidal suspension [15]. Size, shape and 
composition of iron oxide nanoparticles depend on the operating conditions 
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(pH, nature of the base, Fe
2+
 and Fe
3+
 ratio…). The content of magnetite and 
maghemite in these nanoparticles can be estimated by techniques such as 
Mössbauer spectroscopy [16] and X-ray diffraction [17]. Moreover, it is 
possible to deduce the magnetite/maghemite ratio in the solid phase of 
ferrofluids from Raman spectra [18] by using the ratio of their respective 
characteristic vibrational bands (671 cm
-1
/ 721 cm
-1
). It has also been observed 
that exposure to oxygen and elevated temperatures favored the formation of 
undesirable species like antiferromagnetic hematite. Usually, the iron oxide 
nanocrystals are nearly spherical and their size is most often described in the 
literature to be 6-12 nm. 
The iron oxide nanoparticles can be dispersed in suitable solvents to form 
homogeneous suspensions called ferrofluids or magnetic fluids. They present a 
very interesting amphoteric character (Figure 1.2) due to the presence of 
hydroxyl groups at their surface [15]. Because the stability of an aqueous 
ferrofluid is mainly due to electrostatic repulsion between charged particles, 
they flocculate around the point of zero charge (PZC, established around pH 7). 
Typically, the iron oxide nanoparticles are used as cationic ferrofluids, which 
means that the particle surface is positively charged and accompanied by 
anionic counterions (usually nitrates). A PZC close to physiological pH should 
not necessarily be considered an inconvenient as the particles still have to be 
coated before injection. Thus, the iron oxide nanoparticle is just a precursor, 
and its surface properties need only to be compatible with coating and eventual 
drug loading. 
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Figure 1.2: Diagram of surface properties of iron oxide nanoparticles. Insert: surface 
silanization 
 
As the nanoparticles have large surface area/volume ratios, they tend to adsorb 
plasma proteins and agglomerate in vivo. As a result, without coating the ferrite 
nanoparticles are rapidly cleared by macrophages in the reticulo-endothelial 
system. 
For this reason, usually, the iron oxide nanoparticles constitute the core of the 
final forms of therapeutic nanovectors. From a physiochemical point of view, 
the main objective is the preparation of magnetic nanoparticles consists in a 
strict control of particle size and colloid stability/dispersibility under 
physiological conditions. These properties can be modulated by coating the 
particles in 2 different ways: either the iron oxide nanoparticles are physically 
incorporated in a polymer matrix or their surface is functionalized with 
polymer molecules (see Figure 1.3). 
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Figure 1.3: Schematic representation of the coating of iron oxide nanoparticles with 
polymers via encapsulation (a) or via surface treatment (b). In this latter case, a polymer 
layer may form around individual iron oxide particles or around aggregates. 
 
After coating, the particles size is increased, but it still should remain in the 
sub-micron range. In this case, they will not block vessels and capillaries and 
thus avoid embolization [19]. Moreover, size and surface of resulting particles 
are determinant with respect to pharmacokinetics in vivo, where major 
limitations are quick blood clearance and non-specific uptake by macrophages. 
To maximize circulation times and targeting ability, the optimal size should be 
less than 100 nm in diameter and the surface should be hydrophilic [20][21]. 
Ideally, these properties should render the particles ―furtive‖, which means that 
they are not cleared by the reticulo-endothelial system.  
As we noted above, one possibility of coating is to encapsulate the magnetic 
particles in a solid polymer matrix. Alternatively, the hydroxyl groups at the 
surface of iron oxide nanoparticles can be used to directly anchor active 
molecules or polymers. To enrich the choice of possible reactions, one can use 
silane (Figure 1.2 insert) as coupling intermediated: silanes form Fe-O-Si 
bonds with the particle surface and offer on their opposite end functional 
groups (amines, thiols) that can interact with therapeutical agents, biologically 
relevant ligands and polymers [22]. 
To increase both the stability and furtivity (or stealthiness) of magnetic 
suspensions, iron oxide nanoparticles are often coated with hydrophilic 
polymers adsorbed or chemically attached to their surface. Polyethylene glycol 
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(PEG) seems to be one of the most appropriate ones because of its unique 
properties such as hydrophilicity, flexibility, nontoxicity, and non 
immunogenicity. 
As a matter of fact, data from physico-chemical characterization indicate that 
coating with PEG efficiently reduces nanoparticles agglomeration [23]. A first 
study to demonstrate that polyethylene oxide exhibits low protein adsorption 
was performed by Jeon and Andrade [24]. Consecutively to this study, many 
authors tried to link such polymers to the surface of different kinds of 
nanoparticles with the hope to decrease their uptake by the mononuclear 
phagocyte system [25]. Zhang et al [26] immobilized silane modified PEG on 
the surface of magnetite nanoparticles. A rather similar approach was proposed 
for coating magnetic nanoparticles with PEG by Butterwoth et al [27].  
Using fluorimetry, confocal fluorescence microscopy and inductively coupled 
plasma emission spectroscopy (ICP), Zhang et al [26] measured the uptake of 
their magnetic nanoformulations in breast cancer cells (BT20 cells) and in 
mouse macrophage cells (RAW 264.7). The results of this study suggest that 
PEG coating of iron oxide nanoparticles limits protein adsorption on their 
surface and avoids their recognition by macrophages. Furthermore, PEG-
modified surfaces facilitated incorporation of nanoparticles by cancer cells, 
probably due to high affinity of the polymer to cellular membranes. 
The main difficulty with using PEG for the formulation of nanovectors is that, 
except for the terminal (hydroxyl) group, this long-chain polymer lacks 
functional groups useful to attach therapeutic agents and/or specific ligands. 
Zhang circumvented this difficulty by introducing PEG modified with a 
trifluoroethylester-silane terminus [28]. This modification allowed them to bind 
folic acid ligand to PEG-treated magnetic nanoparticles. Since folate receptors 
are overexpressed on membrane of many cancer cells, the folic acid ligand 
should provide better access of nanovectors to tumor. Rupta et. al also studied 
iron oxide nanoparticles modified with PEG and found them to be internalized 
within lysosomes of fibroblasts [29]. In a different way, Acar covered iron 
oxide nanoparticles with PEGylated polymers [30]. In that case the coating 
consisted of two layers, the inner layer composed by an ionic surfactant such as 
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10-undecenoic acid, and an outer layer made of PEG modified by etherification 
with the same surfactant. These particles were synthesized according to various 
modes of preparation and present really interesting sizes for a possible 
administration in vivo. 
As an alternative to PEG, natural polymers such as dextran, chitosan or starch 
can be attached to the surface of iron oxide nanoparticles in order to minimize 
the adsorption of proteins and to protect them for macrophages [23]. Dextran is 
a polymer of anhydroglucose having mainly alpha-D(1-6) linkages with side 
chains attached to the 3-positions of the backbone glucose units. Thirty years 
ago, Molday and Mackenzie prepared iron oxide nanoparticles modified with 
dextran [31]. They mixed a solution of ferrous chloride and ferric chloride with 
dextran under alkaline conditions. Similar preparations, where dextran was 
physically adsorbed, were then studied by various authors [32][33]. Recently, 
Xu et al [34] contributed to optimize the protocol by their study of various 
operating conditions. The authors reported that reaction time and size of the 
polymer are the main parameters essential for the quality of preparations. The 
high biological tolerance [35] of these modified particles has been 
demonstrated and justified their extensive use as contrast agents for magnetic-
resonance imaging (MRI). 
The main interest of these nanoparticles is based on their superparamagnetic 
behavior: superparamagnetic iron oxide nanoparticles (SPION) are small 
synthetic γ-Fe2O3 or Fe3O4 particles with a core size of < 10 nm and an organic 
or inorganic coating. If the crystal size is small enough the thermal energy kT 
(where k is Boltzmann‘s constant and T is the absolute temperature) may be 
sufficient to cause fluctuations of the magnetization direction. The term 
―superparamagnetism‖ is used to infer an analogy between the behavior of the 
small magnetic moment of a single paramagnetic atom and that of the much 
larger magnetic moment of a nanosized magnetic particle which arises from the 
coupling of many atomic spins. After eliminating the magnetic field, the 
particles no longer show magnetic interactions; a feature that is important for 
their usability for medical application, the particles are well dispersed in a 
liquid, normally in water, or form composites with organic or inorganic 
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matrices, the so-called beads. Superparamagnetic magnetization is, compared 
to normal paramagnetic materials, much higher and can reach nearly the 
magnetization saturation of ferromagnetic iron oxide. This behavior allows the 
tracking of such particles in a magnetic field gradient without losing the 
advantage of a stable colloidal suspension. Additionally, applying an 
alternating magnetic field, heating of the particles can be observed based on the 
Néel relaxation mechanism. In the Néel mechanism, the magnetic moment of 
the nanoparticle, originally locked along the crystal easy axis rotates away 
from that axis toward the external field. The Néel mechanism is analogous to 
the hysteresis loss in multi-domain magnetic particles whereby there is an 
―internal friction‖ due to the movement of the magnetic moment in an external 
field that results in heat generation [36][37]. 
 1.1.3  Gold nanoparticles 
Gold nanoparticles (AuNPs) possess many unique features and have been 
investigated in a variety of imaging related areas, such as computed 
tomography (CT), photoacoustics and surface-enhanced Raman spectroscopy 
(SERS). AuNPs have been brought to the forefront of cancer research in recent 
years because of their easy synthesis and surface modification, strongly 
enhanced and tunable optical properties, as well as excellent biocompatibility. 
High quality, high yield and size controllable colloidal gold can be quickly 
prepared by the well-known citrate reduction method [38][39][40]. Synthesis 
of AuNPs has been well established, and those in the forms of spheres 
[41][42][43], cubes [44], rods [45][46], cages [47] and wires [48] can now be 
acquired with accurate quality control and in large quantity. Such morphology 
control is important as it greatly influences the physical properties of the 
products and in turn affects their role as imaging probes. For instance, 10 nm 
spherical AuNPs have characteristic surface plasmonic absorption at around 
520 nm. Increasing the particle size leads to some, but not dramatic, red-shift 
of the particle absorption spectrum; the maximum absorption of 48.3 and 99.4 
nm AuNPs is at 533 nm and 575 nm, respectively [49]. Changing the 
nanoparticle shape to rod-like, on the other hand, can push the absorption to the 
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NIR region (650–900 nm), which suggests their role as probes in photoacoustic 
imaging or mediators in photothermal therapeutics [50]. The AuNPs of 
different shapes and structure [51] including gold nanorods [52][53][54] 
(Figure 1.4) silica/gold nanoshells [55] (Figure 1.5 A) and hollow Au NPs [56] 
(Figure 1.5 B) all show largely red-shifted properties, boosting their values in 
photothermal cancer therapy [57][58][59]. The strongly enhanced radiative 
properties such as absorption, scattering and plasmonic field for surface 
enhanced Raman of adjacent molecules make them extremely useful as well 
for molecular cancer imaging [60][61] (Figure 1.4). 
 
Figure 1.4: Tunable optical properties of gold nanorods by changing the aspect ratios. 
Gold nanorods of different aspect ratios exhibit different dimensions as seen by TEM (A), 
in different color (B) and different SPR wavelength (C) [62][63] 
 
AuNPs have interested scientist for decades largely due to the ability of optical 
tuning by synthetic controlling of the particle shape, composition and structure. 
As predicted by Gan theory in 1915 [64], when the shape of AuNPs change 
from spheres to rods (Figure 1.4 A), the SPR band is split into two bands: a 
strong band in NIR region corresponding to electron oscillations along the long 
axis, referred to as longitudinal band, and a weak band in the visible region at a 
wavelength similar to that of gold nanospheres, referred to as transverse bands. 
While the transverse band is insensitive to the size changes, the longitudinal 
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band is red shifted largely from the visible to near-infrared region with 
increasing aspect ratios (Length/Width), causing the color changes from blue to 
red (Figure 1.4 B and C). Currently, the aspect ratio can be precisely controlled 
by changing the experimental parameters such as the catalyst of silver ions in 
the seed-mediated growth method developed by Murphy and El- Sayed groups 
[65][66]. The nanorods are formed by asymmetric growth of small gold 
spheres in the presence of shape-forming surfactants, weak reducing agents and 
the catalysts [67]. 
Besides the shape factor for optical tuning into NIR region, structure variation 
results in similar phenomenon. Two examples are the gold nanoshells (Figure 
1.5 A) and nanocages (Figure 1.5 B). Au nanocages are a type of hollow and 
porous gold nanostructures which are formed by a galvanic replacement 
reaction between silver nanocubes and auric acid in aqueous solution [68]. 
Simultaneous deposition of gold atoms and depletion of silver atoms results in 
Au nanoshells which then anneal to generate smooth hollow and porous 
structures. General size of the nanocages is around 50 nm edge width with few 
nanometers walls and holes for SPR wavelength around 800 nm [69]. By 
controlling the amount of auric acid solution, the SPR of gold nanocages could 
be tuned to NIR region with specified wavelength. The total light extinction of 
Au nanocages with SPR around 800 nm is dominated by absorption, which 
makes them suitable for photothermal therapy [70].  
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Figure 1.5: TEM images (a), absorption spectra (b), and physical appearance (c) of the 
tunable optical properties of gold nanoshells(A) by changing the shell thickness  [71] and 
gold nanocages (B) by changing the auric acid in the synthetic procedure [72] 
 
The bioapplications of AuNPs in life sciences can be classified into four areas: 
sensing, labeling, delivery, and heating.  
AuNPs can be used as sensors. Their optical properties can change upon 
binding to certain molecules, allowing the detection and quantification of 
analytes. The absorption spectra of AuNPs change drastically when several 
particles come close to each other. In the business of colloids aggregation is 
actually rather annoying but it can be exploited for very sensitive DNA 
detection, even of a single-base mismatch.  
Secondly, certain properties of the particles are exploited to generate contrast 
to use as labeling. For example in transmission electron microscopy, the strong 
electron absorbing properties of gold nanoparticles make them suitable as a 
stain for samples with poor contrast, such as tissue samples. Their small size 
and the possibility of functionalizing the particles, for instance with antibodies 
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(immunostaining), mean that they also provide extremely high spatial 
resolution and specificity in many labeling applications. Similarly, the 
particles' optical properties - strong absorption, scattering and especially 
plasmon resonance – make them of value for a large variety of light-based 
techniques including combined schemes such as photothermal or photoacoustic 
imaging. In addition, gold nanoparticles can be radioactively-labeled by 
neutron activation, which allows for very sensitive detection, and used as an x-
ray contrast agent.  
Thirdly, AuNPs can serve as carriers for drug and gene delivery. Biologically 
active molecules adsorbed on the particle surfaces can be guided inside cells 
and released. DNA delivery, for instance, is the basis for gene therapy.  
Finally, their strong light absorbing properties makes AuNPs suitable as heat-
mediating objects; the absorbed light energy is dissipated into the particles' 
surroundings, generating an elevated temperature in their vicinity. This effect 
can be used to open polymer microcapsules, for example, for drug delivery 
purposes. Moreover, appropriately functionalized nanoparticles can bind 
specifically to certain cells, and find a use in cancer targeting and hyperthermal 
therapy by heating the particle-loaded tissue in order to destruct the malignant 
cells. 
 1.1.4  Hollow gold nanoparticles 
Recently, a new class of molecular-specific photothermal coupling agents 
based on hollow gold nanoparticles (HGNs) has been developed [73][74]. The 
synthesis process of such nanostructures is based on templating using cobalt 
(Co) nanoparticles as initial seeds via a galvanic reaction with Au
3+
 ions. On 
the basis of theoretical calculation, a large diameter and thinner shells result in 
redder SPR peaks. Moreover, the SPR bandwidth depends sensitively in the 
uniformity of the shell diameter and thickness, and poorer uniformity results in 
broader spectral width, thus the combination of shell diameter and thickness 
determines the peak position of the SPR absorption [75]. Therefore, one can 
control the shell diameter and thickness to manipulate the color of the HGNs at 
will for different applications. In addition to the strong, narrow, and tunable 
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NIR absorption desired for PTA, the HGNs have small size (30-50 nm) and 
spherical shape, and both are highly desired for delivery and membrane 
penetration [76]. These HGNs have been successfully utilized in both in vitro 
and in vivo PTA of carcinoma and melanoma cancer cells [77][78]. In the 
carcinoma PTA study, HGNs were covalently attached to a monoclonal 
antibody directed at the epidermal growth factor receptor (EGFR) 
overexpressed in carcinoma cancer cells [77].  
In the melanoma PTA study, the HGNs were stabilized with a PEG coating and 
attached with a melanocyte stimulating hormone (MSH) analogue, [Nle4,D-
Phe7]a-MSH (NDP-MSH), which is a potent agonist of melanocortin type-1 
receptor (MC1R) overexpressed in melanoma [78]. The intracellular uptake of 
the NDP-MSH conjugated PEGylated HGNs (MSH-PEG-HGNs) and the 
distribution of h-arrestin were examined in murine B16/F10 melanoma cells. 
The biodistribution of NDP-MSH-PEG-HGNs was assessed at 4h post 
intravenous injection in tumor beating nude mice. The final results showed that 
the HGNs were specifically taken up by melanoma cells, which initiated the 
recruitment of h-arrestins, the adapters to link the activated G-protein-coupled 
receptors to clathrin, indicating the involvement of receptor-mediated 
endocytosis [78]. This resulted in enhanced extravasation of the NDP-MSH-
PEG-HGNs from tumor blood vessels and their dispersion into a tumor matrix 
compared with non-specific PEGylated HGNs. Successful selective 
photothermal ablation of B16/F10 melanoma with targeted HGNs was 
confirmed by histologic and positron emission tomography.  
Both in vitro and in vivo studies have shown that the HGNs are ideally suited 
for PTA applications because of their unique combination of spherical shape, 
small size (average outer diameter of 30-50 nm) as well as narrow, tunable, and 
strong absorption in the NIR region. Using a small molecular weight peptide as 
a targeting ligand and attaching it at the end of PEG chains, receptor-mediated 
active targeting of melanoma and efficient PTA with photothermal coupling 
agents in vivo have been shown, for the first time. Direct comparison with solid 
gold nanoparticles shows that the HGNs are, at least, eight times more 
effective, mainly due to much stronger NIR absorption and more effective 
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photothermal conversion. Both size and shape have been recognized to be 
critical in determining cell uptake of nanostructures [78]. 
 1.1.5  Gold nanoshell 
Metallic nanoshells are a new class of subwavelength optical components with 
geometrically tunable plasmon resonances, allowing materials to be 
specifically designed to match the wavelength required for a particular 
application. A metallic nanoshell is composed of a spherical dielectric core 
surrounded by a concentric metallic thin shell. By varying the core and shell 
dimensions, the nanoshell plasmon resonances can be fine-tuned all the way 
across the visible and infrared spectral regions. In 1998, Naomi Halas and 
coworkers at Rice University demonstrated that the nanoshell geometry could 
be experimentally realized by growing a thin layer of Au onto a spherical silica 
nanoparticle through seed-mediated electroless pasting [79]. This synthetic 
method allows independent control over the core and the shell radii. The as-
fabricated nanoshells exhibit LSPRs that can be tuned from the visible all the 
way into mid-infra-red. 
Because nanoshells are spherically symmetric, their resonances can be 
analytically described by Mie theory. In 1951, Aden and Kerker [80] first 
proposed the model for simulating the scattering of electromagnetic waves 
from a composite spherical particle consisting of a metallic shell and a 
dielectric core based on the Mie Scattering theory. Neeves and Birnboim [81] 
proposed in 1989 that such a core-shell geometry could give rise to Localized 
Surface Plasmon Resonance (LSPR) modes with their wavelengths tunable 
over a broad range of the electromagnetic spectrum. 
The geometry dependent nanoshell plasmon resonances result from the 
interaction between the essentially fixed frequency plasmon response of a 
sphere and that of a cavity (see Figure 1.6 A). The sphere and cavity plasmons 
are electromagnetic excitations at the outer and inner interfaces of the metal 
shell, respectively. Because of the finite thickness of the shell layer, the sphere 
and cavity plasmons interact with each other and hybridize in a way analogous 
to the hybridization between atomic orbitals. As illustrated in Figure 1.6 A, this 
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interaction results in the splitting of the plasmon resonance into 2 new 
resonances, the lower energy symmetric or ―bonding‖ plasmon (ω-) and the 
higher energy antisymmetric or ―anti-bonding‖ plamon (ω+). The strength of 
the interaction between the sphere and cavity plasmons is controlled by the 
thickness of the metal shell layer (Figure 1.6 B). 
 
Figure 1.6: (A) Energy level diagram depicting plasmon hybridization in metal nanoshells 
resulting from interacting sphere and cavity plasmons. the 2 hybridized plasmon modes 
are an anti-symmetric or "anti-bonding" plasmon (ω+) and a symmetric or "bonding" 
plasmon resonance (ω-). (B) Energy diagram illustrating the dependence of nanoshell 
plasmon energies on the strength of the interaction between the sphere and the cavity 
plasmons, determined by the thickness of the metallic shell. 
 
For example, this picture provides a simple and intuitive explanation for why 
the energy of the optically active plasmon resonance shifts to lower energies 
with decreasing shell thickness: the decreased shell thickness leads to a 
stronger coupling between the sphere and cavity plasmons, increasing the 
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splitting between the bonding and anti-bonding hybridized plasmons. This 
result is in quantitative agreement with Mie scattering theory which offers no 
such physical picture for this effect [82] [83]. In the case of metallic gold 
coating a dielectric core, such as silica, nanoshells resonate at specific 
wavelength of light ranging from 500 nm to 2µm, depending on their core/shell 
thickness ratio. Indeed, gold shell of 10 encasing a 110 nm silica core resonate 
in the NIR spectrum (± 800 nm); these wavelengths exhibit minimal optical 
absorption by, and consequently optimum penetration through, overlying 
tissues, with minimal attendant thermal injury. In the context of specifically 
absorbing energy in the NIR spectrum, these nanoshells are extremely efficient 
converting optical energy into heat [84]. 
 1.2  Different therapies 
 1.2.1  Drug delivery 
Many of the pharmacological properties of conventional (―free‖) drugs can be 
improved through the use of drug delivery systems, which include particulate 
carriers and their associated therapeutics. Drug delivery systems are designed 
to alter the pharmacokinetics and biodistribution of their associated drugs or to 
function as drug reservoirs (i.e., as sustained release systems), or both. Figure 
1.7 gives example of problems exhibited by free drugs that can be ameliorated 
by drug delivery systems [85] . 
 
Figure 1.7: Non-ideal properties of drugs and their therapeutic implications 
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 One solution, to improve drug efficiency, is to covalently link it to a polymer 
such as poly (ethylene glycol) (PEG). This strategy is used to increase the 
lifetime of proteins such as interferons, in this way they can stay in the 
bloodstream up to one week [86][87]. Another method consists in chemically 
linking the drug and a polymer soluble in water, non-immunogenic and 
biocompatible that can be degraded and eliminated by the body. When the 
system reaches the target (for example the ill cell), the specific links are 
destroyed and the drug is released. The drug biodistribution is modified by the 
dimension of the vector. The administration of antitumoral drugs is based on 
this principle: having a low molecular weight, these drugs can easily and 
quickly cross cellular membranes when administrated intravenously. 
Colloidal systems tend to be quickly eliminated from the bloodstream and to 
accumulate in the reticuloendothelial system (RES) (liver, spleen, lungs and 
bone marrow). This phenomenon is called passive targeting. In other words, 
these systems accumulate in the liver because they are captured by the Kupffer 
cells while endothelial cells as well as parenchyma cells demonstrate a reduced 
uptake. The organs of the RES are responsible for this elimination; as a matter 
of fact their cells show a phagocytic activity and present, on their surface, 
specific receptors for plasmatic proteins which are able to fix themselves on the 
surface of colloidal systems in the bloodstream. This process is called 
opsonization and the proteins, opsonins.  After interacting with macrophages 
receptors, the vectors are internalized via endocytosis and end up in lysosomes 
in which they will be degraded by lysosomal enzymes [88]. The preferential 
uptake of the vectors by the liver and the spleen can be used as passive 
targeting either for curing tumors located in these specific organs or 
intracellular infections regarding macrophages. In this case the vectors are 
called first generation vectors. One characteristic of these vectors is their 
specific accumulation in the liver; however this can represent an obstacle for 
reaching the target site. Therefore, the aim of the second generation vectors is 
to remain longer in the vascular system (without accumulating in the liver as 
the first generation vector). Analyzing the vectors uptake it has been 
demonstrated that the captation process depends substantially on the 
1-Nanoparticles for biomedical applications 
________________________________________________________ 
24 
 
nanoparticles superficial properties and diameter [89]. Liposomes and 
nanoparticles with a diameter lower than 80 nm are captured by the liver, when 
the diameter is higher than 400 nm the vectors are captured by the spleen and, 
finally when the diameter is in between the vectors are captured by the liver 
and the spleen in an increasing proportion depending on their diameter [90]. 
The captation by the RES organs is highly modified by the vectors surface 
properties for example it increases with the hydrophobic behavior of the 
vectors. Therefore, to avoid this issue, surfaces are often modified by coating 
with macromolecules and hydrophilic polymers. In this way it is possible to 
create a hydrophilic layer on the surface which inhibit the adsorption of the 
opsonins by hydrophobic interaction and steric repulsion [91] [92][93].  
There are a variety of nanoparticles systems currently being explored for 
cancer therapeutics [94]. The material properties of each nanoparticle system 
have been developed to enhance delivery to the tumor. For example, 
hydrophilic surfaces can be used to provide the nanoparticles with stealth 
properties for longer circulation times and positively charged surfaces can 
enhance endocytosis. The types of nanoparticles currently used in research for 
cancer therapeutic applications include dendrimers [95], liposomes [96], 
polymeric nanoparticles [97], micelles [98], protein nanoparticles [99], ceramic 
nanoparticles [100], viral nanoparticles [101], metallic nanoparticles [102], and 
carbon nanotubes [103]. Some of these systems are reported in Figure 1.8. 
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Figure 1.8: Examples of nanoparticulate systems for drug delivery 
 
Functionalization of nanoparticles to create a stealth surface from opsonization, 
the adherence of serum proteins to the nanoparticle surface, is necessary to 
increase circulation times through avoidance of removal by the 
reticuloendothelial systems (RES) [104][105]. Short circulation times decrease 
the efficiency of the delivery of the nanoparticles to the tumor site. 
Incorporation of a hydrophilic polymer, such as poly(ethylene glycol) (PEG), 
to the surface of the nanoparticles allows for a reduction in opsonization, which 
reduces removal by the RES [106][107]. 
Despite extensive research on nanoparticles systems for cancer therapeutics, 
there are only a few nanoparticles drug delivery systems approved by the U.S. 
Federal Drug Administration and European Medicines Agency to treat cancer. 
Specifically, the systems that have been approved include liposomal 
doxorubicin (Myocet
TM
, Elan Pharmaceuticals), PEGylated liposomal 
doxorubicin (Doxil
®
, Ortho Biotech, and Caelyx
®
, Schering Plough), 
PEGylated liposomal daunorubicin (DaunoXome
®
, Diatos), and the recently 
approved albumin-bound paclitaxel-loaded nanoparticles (Abraxane
®
, Abraxis 
Bioscience) [94].   
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 1.2.2  Hyperthermia 
Magnetic fluid hyperthermia (MFH), i.e. the heating of tissue [108] using 
magnetic nanoparticles (MNPs), is a promising tool in the therapy of various 
cancers because tumor cells are more sensitive to temperatures in the range of 
42-45°C than normal tissues cells [109]. As a matter of fact, there are several 
benefits to using hyperthermia, this process not only enhances the effectiveness 
of other cancer treatments, but it also kills tumor cells that are resistant to other 
forms of cancer treatment. 
Several methods of hyperthermia are employed in cancer therapy: whole body 
hyperthermia, radiofrequency hyperthermia, inductive hyperthermia using a 
microwave antenna, implantable needles, and nanosized magnetic 
nanoparticles [110]. 
At least four different mechanisms exist by which magnetic materials can 
generate heat in an alternating field [111]: 
 Generation of eddy currents in magnetic particles with size > 1 µm, 
 Hysteresis losses in magnetic particles > 1 µm and multidomain 
magnetic particles, 
 Relaxation losses in superparamagnetic single-domain magnetic 
particles, 
 Frictional losses in viscous suspension. 
Relaxation losses in single-domain magnetic nanoparticles fall into two modes: 
rotational (Brownian) mode and Néel mode. 
Majority of hyperthermia treatments don‘t achieve uniform heating of tumor 
region to the desired temperature without damaging normal tissue. Therefore, 
researchers have proposed intracellular hyperthermia by using nanosized 
magnetic particles [110]. MFH allows the heating to be restricted to the tumor 
area [112]. This method, which incorporates injecting the magnetic fluids 
directly into the tumor body, relies on the theory that any metallic objects when 
placed in an alternating magnetic field will have induced currents flowing 
within them [113]. As this occurs, the magnetic nanoparticles produce heat, as 
a product of resisting the current flow. With the application of an external 
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alternated magnetic field [114], the particles in turn heat the malignant cells 
when they come into contact, thus increasing the cells sensitivity to other 
treatments such as chemotherapy or radiation. 
It was discovered that magnetic nanoparticles concentrated by an external 
constant magnetic field in tumor vasculature may lead to embolic lesions and 
necrosis of a tumor body and further the heat produced for thermal activation 
of a drug enhances the effect of chemotherapy by local hyperthermic treatment 
of neoplastic cells [115]. 
Using magnetite particles, Ohno et al strategy was based on the heat radiation 
associated with the physical process of hysteresis loss of magnetic substance in 
the alternative magnetic field [116]. Instead, though, they made a thin stick-
type mingled with carboxymethylcellulose to obtain a higher heating effect 
[116]. The benefit of this product was that one could much more easily direct 
the magnetic nanoparticles to their desired location. What was found was that, 
by using carboxymethylcellulose, the particles did not invade the surrounding 
normal tissue. In addition, the tumor sized decreased, thus obtaining 
satisfactory results. 
The response of the tumor to hyperthermia depends on the size of the tumor, its 
composition, physical location within the host tissue, and its vascularization 
[117]. During hyperthermia, the tumor bed does not vasodilate therefore, blood 
flow can‘t increase and heat is retained in the tumor tissue at temperatures that 
would have caused normal capillary beds to vasodilate [117]. The growth of 
solid tumors is associated with the incorporation of fluid within the tumor mass 
as a result of nutrient deprivation, which can constitute up to 60% of the tumor 
volume. This fluid however, is void of oxygen and glucose, and may contain 
excessive amounts of carbon dioxide and lactic acid. Under conditions of 
extreme nutrient deprivation, cell death occurs rapidly at 37°C and even 
quicker at higher temperatures. An increase in the temperature of this fluid may 
lead to an increase in the hydrostatic pressure due to the increase in molecular 
motion [117]. 
Cell death occurs in two modes, apoptosis and necrosis, which are 
biochemically and morphologically different [118]. Apoptosis is a genetically 
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programmed and biochemically active mode of death in which the cell actively 
participates in its own elimination. It is required for cell life span and normal 
development [119]. Apoptosis aids in self-deletion of injured cells, terminal 
differentiation of epithelial cells, and organ and tissue shaping [118]. 
Abnormalities of this process are implicated on several human diseases, 
including cancer. This process can be recognized by cell shrinking, 
condensation of the chromatin, and eventually DNA fragmentation. In addition, 
actin is considered to play a role in several main morphological events of 
apoptosis, including formation of blebs, cell rounding, detachment, and final 
cell disintegration into apoptotic bodies [119]. Cells inducing apoptosis retain 
much of their membrane function and do not elicit an inflammatory response. 
This process can be triggered by radiation, tranduced signals, DNA damage, 
and hyperthermia. Furthermore, hyperthermia with a temperature range of 41- 
45 °C induces apoptosis to varying degrees in many cell lines. The mechanism 
behind hyperthermia-induced apoptosis, however, isn‘t well understood. Some 
postulate that the primary targets are heat liable and newly synthesized 
proteins. These denatured proteins and unfolded nascent peptides can be 
cytotoxic and lead to cell death as illustrated in Figure 1.9 [118].  
 
Figure 1.9: Illustration of the protein denaturation process by hyperthermia 
 
In addition, heat shock proteins act by preventing the aggregation of the 
denatured proteins through interactions with the ATP pathway. Targeted 
proteins must go through the ATP pathway before the can be recognized as 
substrate for proteolysis. Therefore when hyperthermia is induced on the cells, 
the proteins denature before the heat shock protein response can occur. It is 
logical to assume then, that by administering hyperthermia, the cell can 
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accumulate high dose of heat shock proteins. Some hypothesize that by 
inhibiting the synthesis of the heat shock proteins the cell is unable to build a 
pool of protective stress proteins and the cell loses its capability to survive 
[118]. 
Necrosis concerns cells subject to toxic attack [120]. In this case, metabolic 
functions stop, which therefore causes a lack of osmotic regulation, thereby 
inflicting cellular swelling. In addition, necrosis causes a sharp decline in ATP 
production, mitochondrial swelling, and eventually cytolysis and the release of 
pro-inflammatory agents as illustrated in Figure 1.10 [118]. 
 
Figure 1.10: illustration of the necrosis phenomenon caused by hyperthermia 
 
 Unlike apoptosis, these reactions occur as a natural result of loss of cell 
function. Although it has been widely accepted that hyperthermia always 
caused necrosis, it is now clear that it isn‘t the case [121]. Rather, hyperthermia 
induces apoptosis in neoplastic cells and tissues[122]. 
 1.2.3  Photothermal therapy 
Over the past decade, it has become increasingly apparent that by precisely 
controlling the dimensions of metallic nanostructures of certain specific shapes, 
one can control the wavelength at which they interact with the incident light in 
a highly precise manner [123][124][125][126][127]. The optical resonance 
frequency of metal is function of not only the type of metal, but also, especially 
on the nanometer scale, of the shape of the particle. For solid metallic 
nanospheres, the optical resonance is essentially an almost fixed frequency 
resonance. Solid Au nanoparticles which are ~ 30 nm in diameter are well 
known to absorb green light at ~ 520 nm, and give rise to a deep red color 
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when dispersed in colloidal solutions. Michael Faraday was the first person to 
observe this spectacular phenomenon around 1850. Actually, the optical 
resonant frequency of solid metallic nanoparticles varies only weakly with 
particle size, slightly shifting to longer wavelengths as the particles become 
larger. One nanoparticle geometry that gives rise to much broader optical 
tenability is that of metallic nanorods [128]. As the aspect ratio of the nanorods 
is tuned, the wavelength at which optical resonance of the structure occurs can 
be systematically tuned over a broad spectral range from visible to near 
infrared regions. Such optical tenability of metallic nanorods is evident based 
on the dramatic color change of the colloidal nanorods solutions as the aspect 
ratio varies. 
The fascinating optical resonant behaviors of metal nanoparticles are 
essentially determined by the collective oscillations of free electrons in the 
metals with respect to the positive ion background, known as plasmons.  The 
plasmon resonances can be optically excited when a photon is absorbed at a 
metal-dielectric interface and transfers energy into the collective electron 
oscillations, which are coupled in-phase with the incident light at a certain 
resonant frequency. In nanoparticles systems, the plasmon resonance 
frequencies are dependent on the size and shape of the metallic nanoparticles as 
the oscillations of free electrons are confined by the particle boundaries [125].  
Another type of surface plasmons is called localized surface plasmons (LSPs), 
which corresponds to collective excitations of free electrons confined to a finite 
volume. Under the irradiation of incident light, the free electrons in a metallic 
nanostructure are driven by the electric field to collectively oscillate at a 
resonant frequency relative to the lattice of positive ions [129]. At this resonant 
frequency, the incident light is absorbed by the nanostructure. Some of these 
photons will be released with the same frequency in all directions and this 
process is known as scattering. Meanwhile, some of these photons will be 
converted into phonons or vibrations of the lattice and this process is referred 
to as absorption [130]. 
For spherical Au and Ag particles of relatively small size (with dimensions 
much smaller than the wavelength of incident light, with diameters in the range 
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of 5-50 nm), only dipole plasmon resonance is involved. The colloidal 
suspensions of these small Au and Ag nanoparticles display a strong LSP peak 
around 520 nm and 400 nm, respectively. Strong optical scattering absorption 
of light by solid Au and Ag nanoparticles in visible spectral region due to 
localized surface plasmon resonance (LSPR) are a classical effect in which the 
light‘s electromagnetic field drives the collective oscillations of the free 
electrons into resonance. This effect was theoretically described by Mie in 
1908 by solving Maxwell‘s equations for a metal sphere surrounded by a 
dielectric medium using the dielectric function of the bulk metal [131]. 
It is very important to create highly tunable LSPRs of nanoparticles over a 
broader spectral region. Indeed, expanding the plasmonic tunability of metallic 
nanoparticles from the visible into the near infrared regions opens a whole set 
of new opportunities for spectroscopic sensing and biomedical applications. 
For example, metallic nanoparticles with plasmon resonances in the near 
infrared can be used for high-contrast bioimaging and photothermal cancer 
therapy [132][133]. It has been discovered that by changing nanospheres into 
either nanorods or nanoshells, one can tune the plasmon resonances of the 
nanoparticles from the visible region to the near infrared ―water window‖ 
where tissues and blood are transparent. These near infrared resonant 
nanoparticles can be properly functionalized with antibodies to target specific 
types of tumors. Because tissue is relatively transparent in the near infrared, the 
nanoparticles can be illuminated from outside the body to locally heat and thus, 
selectively destroy the tumors in vivo. 
As a matter of fact, local application of heat is a well-known concept in 
therapeutic medicine [134]; as such photothermal therapy based on metal 
nanomaterials has been actively explored for treating cancer with encouraging 
success [135]. Photothermal therapy relies on heat generated from light for 
destroying cancer cells, and it affords potential advantages of active targeting at 
specific cancer sites, low toxicity, minimal side effects and high efficacy [136]. 
In order to realize the full therapeutic potential of photothermal therapy it is 
essential to optimize its photothermal conversion efficiency, decreasing the 
energy dose of laser light and minimizing potential damage to surrounding 
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normal tissue; that is why ideal material for photothermal therapy should have 
strong and tunable SPR, especially in the Near Infra Red (NIR: 700 - 900 nm) 
thereby providing an opportunity for therapeutic effects in deep tissues while 
limiting the heat generated to the region of the target tissue. The process is 
illustrated Figure 1.11. 
 
Figure 1.11: Illustration of the photothermal therapy process 
 
In general, photothermal ablation (PTA) can operate in three basic modes, (i) 
light without sensitizers, (ii) light with molecular sensitizer for phothermal 
conversion [136], and (iii) light with metal nanostructure for photothermal 
conversion. Because of the high photothermal conversion efficiency of metal, 
the third approach is the most effective in terms of heat generation. However, 
PTA based on metal nanostructures does involve issues such as delivery to 
target cancer sites and potential toxicity and side effects. Using strategies such 
as antibody-antigen or ligand-receptor interaction, one can actively target and 
deliver the metal nanostructure to specific cancer tissues [137][138]. Metals 
such as gold and silver are considered as biocompatible and low in toxicity and 
thus exhibit good potential for PTA applications. 
For example, laser-induced local heating of cellular structures through PTA 
using either pulsed or continuous laser radiation and mediated by light-
absorbing nanoparticles and microparticles provides precisely localized 
damage limited to even single cells [139][140][141][142][143]. Accumulation 
of light-absorbing nanoparticles in relatively transparent cells can enhance their 
optical absorption up to several orders of magnitude. Thus, metal nanoparticles 
act as localized sources for photothermal generation to result in cell damage.  
The mechanism for heat-induced cell death in PTA is not yet well understood. 
Possible explanations include heat shock of proteins, inactivation of membrane 
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proteins and mitochondria, depolymerization of cytoskeleton filaments, 
membrane blebbing, and plasma membrane disruption due to a cavitation effect 
[144][145][146][147][148]. The cavitation effect was also suggested to be 
responsible of bubble formation [149][150][151]. One interesting related 
question is the local temperature on the metal nanostructure surface that is 
likely much higher than the average temperature of the surroundings. 
Molecules with temperature-dependent luminescence or Raman scattering 
based on the ratio of Stokes and anti-Stokes scattering may provide some 
possible means for determining the local temperature. The distance between the 
metal nanostructure and the cancer cell is expected to be an important 
parameter for PTA. Likewise, the location of the nanostructure in the cancer 
cell will also be crucial, for example, on the surface, in the membrane, or near 
the cell nuclei. 
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2. Nanoparticles properties for biomedical 
applications 
Nanoparticles (NPs) are attracting considerable interest as viable biomedical 
devices due to their unique physical and chemical properties. Biomedical 
applications of NPs include drug carriers, labeling and tracking agents, vectors 
for gene therapy, hyperthermia treatments, photothermal therapy, and magnetic 
resonance imaging (MRI) contrast agents. In order for the NPs to be useful in 
biomedicine, they must satisfy certain criteria. For in vitro applications such as 
fluorescent staining of proteins and TEM imaging, NPs must have minimal 
cytotoxicity. In vivo, NPs have to avoid non-specific interactions with plasma-
proteins (biocompatibility) and either evade (stealthiness) or allow  uptake by 
the reticuloendothelial system (RES) depending on the application, to reach 
their intended target efficiently (targeting). 
 2.1  Biocompatibility 
Biocompatibility is, by definition, a measurement of how compatible a device 
is with a biological system. The purpose of performing biocompatibility testing 
is to determine the fitness of a device for human use, and to see whether use of 
the device can have any potentially harmful physiological effects [1]. 
A biomaterial implanted into the body induces a foreign body reaction [2][3]. 
The degree of this reaction depends on the properties of the device, such as 
shape, size, surface chemistry and roughness, design, morphology and porosity, 
composition, sterility issue, contact duration, and degradation [2][4][5][6][7]. 
In the case of a coated device, following injection, a polymer-blood interface is 
immediately created and nonspecific absorption of blood and tissue fluid 
proteins onto the surface of the device is induced [8]. In fact, the extent of 
nonspecific protein absorption can be used to evaluate the degree of 
biocompatibility of the device. 
It is generally accepted that the term biocompatibility is defined not only by the 
lack of cytotoxicity of a biomaterial, but also by the biofunctionality of the 
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material, which enables it to support cell-biomaterial interactions according to 
the local and organ-specific situation where the biomaterial is applied [9]. 
Biocompatibility studies on a biomedical device for intravenous injection 
require complex experiments both  in vitro and  in vivo in order to test the local 
and systemic effects of the material on culture cells, tissue sections and the 
whole body. In vitro cell culture tests are often used to screen the 
biocompatibility of implantable devices. Such tests are sensitive, reliable, 
convenient and reproducible screening methods [16] [10][11]. Permanent cell 
lines are generally employed for such in vitro testing. For instance, a rat 
primary culture of osteoblasts is a well-established model used to investigate 
biocompatibility by evaluating cellular viability [12][13][14][15]. 
Nanoparticles for such medical applications are frequently given via 
intravenous administration, as with any foreign material, the body mounts a 
biological response to administered nanoparticles. This response is the result of 
a complex interplay of factors, not just the intrinsic characteristics of the 
nanoparticles. In particular, most materials, upon contact with biological 
matrices, are immediately coated by proteins, leading to a protein corona 
[17][18][19]. Protein coronas are complex and variable. The complete plasma 
proteome is expected to contain as many as 3700 proteins [20][21], of which 
approximately 50 have been identified in association with various 
nanoparticles [22][23][24][25]. 
Certain components of the nanoparticle corona, called opsonins, may enhance 
uptake of the coated material by cells of the reticuloendothelial system (RES) 
[26][27]. The presence of opsonins on the particle surface creates a ―molecular 
signature‖ which is recognized by immune cells and determines the route of 
particle internalization [28][29]. The route of internalization, then, may affect 
the eventual fate of the nanoparticle in the body (i.e. its rate of clearance from 
the bloodstream, volume of distribution, organ disposition, and route of 
clearance from the body) [30][31].  
The effect of this protein corona may have special significance for 
nanoparticles, due to the increased importance of surface effects for particles of 
this size. Several studies have shown that biological responses to nanoparticles 
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tend to scale with surface areas rather than mass [32][33][34][35][36]. As 
things become smaller, their surface areas shrink much more slowly than their 
volumes, causing nanoscale materials to have far greater surface-to-volume 
ratios than larger particles. A larger surface-to-volume ratio also implies more 
proteins will bind a nanoparticle (relative to its mass) than a particle of larger 
size. Even for larger particles, protein binding is established as one of the most 
important factors influencing biodistribution [37][38][39][40]. In current 
preclinical testing of pharmaceutical molecules, evaluation of plasma protein 
binding is recognized as an important element in an assessment of drug 
efficacy, safety and disposition [41][42]. It has been shown to be important for 
understanding pharmacokinetics and pharmacodynamics of the drug inside the 
body [41][43][44][45]. It is also used to extrapolate preclinical data to models 
that predicts potential drug efficacy and/or toxicity in humans [41]. For 
biomaterials used as medical implants, it has long been understood that the 
nature of the deposited protein layer onto these medical devices is responsible 
for the early immunological response in patients. In fact, even late stage 
biological responses are influenced and dictated by the surface composition of 
the material and how this surface interacts with surrounding tissue. 
Of course, other factors play a role in determining how nanoparticles distribute 
within the body. These include particle properties such as size, shape, surface 
charge (zeta potential), solubility, surface modifications (including targeting), 
and route of administration.   
Poly (ethylene glycol) (PEG) is a biocompatible linear synthetic polyether that 
can be prepared with a wide range of sizes and terminal function groups [46]. 
For decades variations of this polymer have been used clinically as excipients 
in FDA approved pharmaceutical formulations [47]. They are neutral, 
hydrophilic molecules in biological fluids, which help to improve the dispersity 
and blood circulation time of the devices they are bound to [48][49][50][51]. 
PEG-coated NPs are commonly regarded as stealth because they are not readily 
recognized by the RES [52]. This limit their use in imaging macrophages or 
other RES-related cells [53], but the same characteristic made them ideally 
suited for use in target specific cell labeling after modification targeting ligands 
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[54][55][56]. Among the polymeric nanoparticles for biomedical applications, 
biodegradable and biocompatible poly(D,L-lactic acid)/ poly(D,L-
lactic/glycolic acid) (PLA/PLGA)-based nanoparticles have been investigated 
as carriers for therapeutic bioactive molecules [57][58][59], since PLA/PLGA 
have been studied for many years and are approved by the US Food and Drug 
Administration for human therapy [60][61][62]. 
 2.2  Stealthiness 
Intrinsic to the body‘s defense system are a series of ―biological barriers‖ that 
serve to protect the body against foreign entities, including injected 
therapeutics and contrast agents, keeping them from reaching their intended 
destinations. These barriers can restrict NPs function by blocking their 
movement, causing physical changes to them, or by inducing a negative host 
response using biochemical signaling [63]. 
Upon intravascular injection, NPs immediately encounter blood, a high ionic 
strength, heterogeneous solution, that can induce NPs agglomeration, altering 
their properties and inducing particles sequestration. Additionally, NPs can, 
non-specifically, interact with plasma proteins (which can trigger the adaptive 
immune system), extracellular matrices, and non-targeted cell surfaces while in 
the blood stream. In each case, the NP is in danger of prematurely binding to or 
being taken by cells before reaching its target tissue. 
 In addition to coping with the vascular environment, NPs must overcome 
various anatomical size restrictions which limit their access to target tissue 
(e.g. extravasation of lymph-targeting NPs from the blood vessels). These size 
limitations are especially strict when targeting certain organs like the brain and 
kidney [64]. Biological barriers are not unique to extracellular spaces; in fact 
intracellular barriers are a critical reason why many drugs and drug delivery 
systems fail. Once a cell-specific NP has bound to the membrane of its target, it 
is typically taken up by the cell through receptor-mediated endocytosis, where 
it is trafficked intracellularly via endosomal compartments for processing and 
destruction through acidification of the endosome [65]. Most of these 
endosomes are then translocated into lysosomes where hydrolytic and 
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enzymatic reactions completely metabolize macromolecules. 
Moreover, NPs biodistribution appears to be significantly influenced by its 
physicochemical properties [66]. Hydrodynamic size, for instance, helps 
govern the NPs concentration profile in the blood vessel, as well as it affects 
the mechanism of NPs clearance, and dictates the permeability of NPs out of 
the vasculature [67]. For instance, in the case of NPs clearance, it has been 
reported that  small NPs (< 20 nm) are excreted through kidneys, while 
medium sized NPs (30-150 nm) have accumulated in the bone marrow, heart, 
kidney and stomach, and large NPs (150-300 nm) are found in the spleen and 
in the liver. While these size ranges provide general clearance mechanisms, 
other physical parameters simultaneously affect NPs mobility. 
As previously discussed, NPs size affects their ability to extravasate from the 
vasculature. While most endothelial barriers allow NPs < 150 nm in diameter 
to pass, more stringent barriers, such as the blood brain barrier (BBB) are far 
more restrictive. The BBB allows passive diffusion of only small (< 500 Da 
MW), neutrally charged lipid soluble molecules, prohibiting > 98% of all 
potential neurotherapeutics and contrast agent from passing through. 
NPs charge and hydrophobicity can affect their biodistribution as well, by 
limiting or enhancing their interactions with the adaptive immune system, 
plasma proteins, extracellular matrices and non-targeted cells [68]. Specifically, 
hydrophobic and charged NPs have short circulation times due to adsorption of 
plasma proteins (opsonization) which can lead to recognition by the 
reticuloendothelial system (RES), followed by removal from circulation [69]. 
Positively charged NPs can also bind with non-targeted cells (typically 
negatively charged) leading to non-specific internalization. In addition, 
hydrophobic groups on the surface can induce agglomeration of the NPs upon 
injection, leading to rapid removal by the RES. 
To limit NPs-host interactions, surface engineering has led to the development 
of stealth NPs. Surface modification with molecules like the hydrophilic PEG 
have been shown to reduce the potential for opsonization through steric 
repulsion, prolonging NPs circulation time [70]. PEG has been introduced at 
the surface in two ways, either by adsorption of surfactants [71] or by using 
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block or branched copolymers, usually with poly(lactide) (PLA) [72][73]. As 
far as the adsorption of hydrophilic surfactants onto the particle surface is 
concerned, Illum et al. [71] studied the use of surfactants with polyoxyethylene 
blocks, such as the poloxamer and poloxamine series, onto polystyrene latex 
surfaces. In particular, they found that coating with poloxamer 407 reduced 
uptake by Kuppfer cells but promoted uptake by the bone marrow [74]. 
Moghimi and co-workers [75] found that poloxamine 908 reduced liver uptake 
of polystyrene particles, which they interpreted as being due to reduced 
absorption of opsonins and increased adsorption of dysopsonins. This 
surfactant, even when not associated with particles, also activated phagocytic 
cells so that a second dose some days later was cleared rapidly by the liver. 
However, with the more hydrophilic biodegradable polymeric surfaces such as 
poly(lactide-co-glycolide) (PLGA), reversible adsorption was observed in vivo 
[76]. On the other hand, biodegradable nanospheres prepared from PLGA 
coated with PLA-PEG diblock copolymers showed a significant increase in 
blood circulation time and reduced liver uptake in a rat model, compared with 
naked PLGA nanoparticles [77]. Although interesting results have been 
obtained with adsorbed surfactants (e.g. concentration of phtalocyanines in 
tumors using nanocapsules coated with poloxamer 407 [78]), covalently linked 
copolymers would seem to be a better choice since they are less easily 
desorbed from the surface. 
The surface characteristics (length and density of PEG chains) of nanospheres 
prepared from PLA-PEG copolymers have been optimized to reduce their 
interactions with plasma proteins and to increase their circulating half-life 
[72][73]. The average distance between two terminally attached chains had to 
be 2,2 nm or less for protein repulsion [72] and although PEG of 5kDa was 
more effective than PEG of 2kDa, increasing the chain length further did not 
confer any additional advantage at optimal surface density. Lipophilic drugs, 
such as lidocaine and cyclosporine A, and proteins, have been encapsulated and 
are released in a controlled manner [79]. PEG chains have also been attached 
covalently to poly(alkylcyanoacrylate) polymers by two different chemical 
strategies, and both types of particle have shown long-circulating properties in 
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vivo [80]. This type of particle has been loaded with tamoxifen, with a view to 
its use in the treatment of hormone-dependent tumors [81]. 
 2.3  Targeting 
Passive targeting uses the predetermined physicochemical properties of given 
NPs to specifically migrate to a given tissue region. For example, targeting of 
solid tumors tissue can be achieved through passive mechanism called 
enhanced permeation and retention (EPR) [82]. This phenomenon is based on 
the principle that tumor cells, in an effort to grow rapidly, stimulate production 
of new blood vessels (the neovasculature) that are poorly organized and have 
leaky fenestrations. This enables extravasation of small macromolecules and 
NPs out of the vasculature, into the tumor tissue [83]. Due to inefficient 
lymphatic drainage, there is poor clearance of these agents, leading to their 
selective accumulation [84]. However, EPR is limited to specific metastatic 
solid tumors, and successful implementation depends on a number of factors 
including degree of capillary disorder, blood flow, and lymphatic drainage rate 
making effective management difficult.  
Because passive targeting is available for only certain in vivo applications and 
does not necessarily guarantee internalization of NPs by targeted cells, NPs can 
be additionally modified with targeting ligands to employ active cell targeting 
[85][86]. The devices can be decorated with targeting molecules, 
complementary to unique receptors on target cells, to actively target only 
diseased tissues; these targeting ligands can be small organic molecules 
[85][87][88], peptides [89][90][91][92], proteins [93], antibodies [94][95][96], 
and aptamers [97][98]. In addition to the type of ligand used, active targeting is 
affected by targeting molecules density and by the size and shape of the NPs. 
Recent studies indicated that the density and molecular organization of bounds 
ligands significantly influence NPs binding to target cells due to the 
multivalency phenomenon [90][99]. Multivalency is the enhanced binding 
avidity phenomenon observed when multiple ligands simultaneously bind with 
multiple receptors between two surfaces [100][101]. In addition, multivalency 
is also affected by NPs size [102]. In a notable study NPs of size ranging from 
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2 to 100 nm were decorated with targeting antibodies and evaluated for ability 
to bind and be internalized by targeted cells [102]. Through a series of 
experiments it was revealed that NPs smaller than 25 nm lack the ability to 
present multiple ligands to a cell unlike larger variants, limiting any potential 
multivalency binding effects. At the same time, larger NPs are not as readily 
endocytosed by cells, limiting their functionality for certain applications. 
Notably, NPs of 25-50 nm were revealed to be most suitable for multivalent 
binding and endocytosis. 
For the treatment of leukemia, effective targeting of sterically stabilized 
liposomes containing doxorubicin and bearing anti-CD19 to malignant B cells 
has been observed in vitro and in vivo in mice [103]. The same liposome 
system has also been used to target circulating myeloma cells, in order to 
prevent relapse after bone marrow transplant [104]. Another cell-surface 
receptor which has been targeted by such ―immunoliposomes‖ is the her2 
(ErbB2) antigen [105]. In this case, a phospholipid bearing a PEG chain 
terminated by an anti-her2 antibody fragment was inserted into preformed 
commercially available doxorubicin-loaded liposomes (Doxil
TM
). Binding to 
this receptor is followed by internalization and this way the drug 
concentrations can be dramatically increased in her2-overexpressing tumor 
cells. 
However, antibody-targeted systems do not always show an advantage over 
simple sterically stabilized liposomes in solid tumors, as observed by Allen and 
Moase [106] in a human ovarian tumor growing in nude mice, probably 
because the larger antibody-decorated particles diffuse less easily within the 
tumors, where the hydrostatic pressure is increased due to lack of lymphatic 
drainage [107]. Furthermore, such immunoliposomes can, in some cases, be 
opsonized and cleared rapidly from the circulation [108] and may even give 
rise to immunological and pseudoallergic reactions [109][110]. An approach 
which avoids coupling a large protein to the carrier surface is a two or three-
step procedure using bispecific antibodies, which combine two immunological 
recognition functions in the same molecules. The antibody can therefore act as 
a bridge between the target cell and a carrier bearing a low-molecular-weight 
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ligand. For example, in the protocol described by Cao and Suresh [111], a 
bispecific antibody was engineered to recognize a tumor-specific antigen and 
biotin. This was given intravenously and after allowing time for distribution, 
conventional, multilamellar liposomes bearing biotin were given. This was 
given intravenously and after allowing time for distribution, conventional, 
multilamellar liposomes bearing biotin were given. These bound excess 
antibody in the circulation and carried it to the liver, but could not reach 
antibody already bound to tumor cells. A few hours later, small liposomes 
bearing PEG chains and biotin were administered; these could circulate, 
extravasate and bind to the antibody present on the surface of the tumor cells. 
This approach can concentrate the carrier within the tumor, but will not 
necessarily promote internalization, since for the procedure to function, the 
bispecific antibody must remain at the cell surface. However, this may be 
sufficient in many cases, for example, if the carrier is loaded with a 
radioisotope to provide local irradiation. 
Another receptor which is overexpressed on many tumor cells is the folate 
receptor. Folic acid has some advantages over transferring or antibodies as a 
ligand for long-circulating carriers because it is a much smaller molecule 
which is unlikely to interact with opsonins and can be coupled easily to a PEG 
chain without loss of receptor-binding activity. This targeting strategy has been 
applied to long-circulating nanoparticles prepared from a cyanoacrylate-based 
polymer. Conjugation of folic acid to the distal end of the PEG chain does not 
affects its ability to bind to its receptor, as determined by surface plasmon 
resonance [111]. 
In addition to engineering NPs for tissue targeting, some researchers have used 
external magnetic systems to help direct magnetic NPs (MNPs) localization in 
a strategy called magnetic targeting [112][113]. This involves focusing high 
field, high gradient, or rare earth magnets on the target site, inducing 
accumulation of the higly magnetically susceptible MNPs. Recently this 
technique was successfully implemented in a clinical trial to deliver the 
chemotherapeutic, doxorubicin, to hepatocarcinoma cells [114]. While 
successful, the efficiency of magnetic targeting is limited to target tissue close 
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to the body‘s surface, due to loss of magnetic field strength further away from 
the magnetic source. 
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3. Nanoparticles preparation strategies for 
biomedical applications 
As explained previously nanoparticles for biomedical applications must be 
biocompatible and stealth, to this end so have to be reagents and solvents used 
during the preparation. Moreover, the synthesis byproducts must be limited and 
controlled, and the material obtained must be stable for a long time under 
peculiar conditions (pH, temperature, …). For these reasons only some 
preparation methods are compatible to this kind of application. 
 3.1  Photopolymerization 
Except for specific references, this chapter has been written according the 
following books:  
C.G Roffey, Photopolymerization of Surface Coatings, John Wiley & Sons, 
Chichester, 1982.  
J.P. Fouassier, J.F. Rakek, Radiation curing in Polymer Science and 
Technology, Elsevier London, 1993.  
S. P. Pappas, Radiation curing science and technology, Plenium Press, New 
York, 1992. 
S. Penczek, P. Kubisa, .Ring opening polymerization, P. J. Brunelle, Hanser, 
Munich 1993  
Photopolymerization is a technique that through the reaction of monomer or 
oligomer activated by a light induced initiation leads to the formation of 
polymer (if monomer or oligomers are monofunctional) or, usually, 3D cross-
linked polymers (starting from multifunctional monomers). The general idea 
beyond all the photopolymerization processes involves reaction and 
solidification of the liquid precursor into a stable polymeric structure with 
tailored physical, chemical and mechanical properties using light, usually in 
UV range but, in some case, also in the visible region. 
In a typical UV curing process multifunctional monomers, or oligomers, are 
converted into a cross-linked polymer by means of a chain reaction initiated by 
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reactive species (free radical or ions), which are generated by UV irradiation. 
Considering that a photochemical process (like photopolymerization) can occur 
only if the radiation absorbed by the medium induce a chemical reaction, and 
that most monomers are not able to produce initiating species when exposed to 
UV light, in order to activate the process it is necessary to introduce a 
photoinitiator in the initial photocurable mixture. The whole process is 
schematically reported in Figure 3.1. 
 
Figure 3.1: General representation of a photocuring process 
 
In general, a photocurable formulation contains: 
 Photoinitiator: the chemical species that, by absorbing the light, 
generate the reactive species. Generated species, depending on the 
functionalities of the monomer to cure, could be either radicals or 
cation or anion. 
 A reactive diluent to adjust the viscosity of the formulation for its 
application. Usually it is also involved into the polymerization 
mechanism. 
 Monomers or oligomers that usually possess multifunctionalities in 
order to generate a cross-linked network. Chemical structure of the 
backbone confers to the cured polymer the physical and mechanical 
properties. 
While the monomers have a predominant role on the physical-chemical 
properties of the cured material, photoinitiator rules on the curing rate and 
production. First of all, molecular absorption coefficient of the photoinitiator 
determines the amount of light absorbed, i.e. energy utilized in the reaction. 
Moreover if the efficiency of the photoinitiator is high, its concentration could 
3. Nanoparticles preparation strategies for biomedical applications 
________________________________________________________ 
61 
 
be reduced in the formulation reducing the price and, at the same time, 
reducing problems involved with high concentration of photoinitiator (e.g. 
yellowing of the cured polymers). 
There are two major classes of photocurable resins that differ for the 
polymerization mechanism: 
 Photoinitiated free radicals polymerization, for the polymerization of 
acrylate, methacrylates and unsaturated polyesters resins. 
 Photoinitiated cationic polymerization, for the epoxy, vinylethers and 
propenylethers resins. 
Radical photopolymerization is defined as a polymerization initiated by the 
light in which both initiating species and growing chain ends are radicals. With 
this process, as far as for the classical thermal activated, it‘s possible to obtain 
high molecular weight chains or crosslinked. First of all, it is important to point 
out that in all the photopolymerization mechanisms absorption of the incident 
light, by any photoactive component of the pristine mixture able to generate, in 
some way, an initiating species it‘s a determinant prerequisite. In radical 
photopolymerization, radiation energy could be directly absorbed by a 
photosensitive species that could undergo to homolitic break of the covalent 
bond and generate a radical which may initiate the photopolymerization. This 
compound could be a monomer but, in the greatest part of the cases, it‘s 
another molecule called photoinitiator. However in some case, the species that 
absorb the photons energy are not able to create a radical. These compounds, 
called sensitizers, transfer their electronic excitation to other reactive 
constituents in the curable mixture that are able to generate the radicals and so, 
under the right conditions, start the polymerization reaction. 
Free radical photopolymerization mechanism consists in four steps, as reported 
in Figure 3.2:  
 Photoinitiation. In this step the light is directly absorbed by the 
photoinitiator, or an excited sensitizer transfers its energy to another 
species. In both cases, with different mechanisms, creation of a radical 
that reacts with a monomeric unit occurs. 
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 Propagation. In this step a consecutive addition of monomer takes 
place. This reaction leads to the formation of the polymer backbone 
through the radical chain growth mechanism.  
 Chain transfer. Growing chains could terminate by a hydrogen 
abstraction that could occur in many ways (e.g. reactions with other 
monomers, other growing chains, photoinitiator). At the same time new 
radical are generated and they could start another chain addition. 
 Termination. The growing chains are terminated by disproportion or 
recombination with other growing chains or monomers or primary 
radicals produced in the photoinitiation step. 
 
Figure 3.2: Photoinitiated free radical polymerization mechanism. PI is the photoinitiator, 
R is the radicals generated and M the monomers. 
 
It is important to underline that light plays a role only in the first step of the 
photopolymerization, the photoinitiation, because light absorption is necessary 
in order to generate active species. All the other steps could occur even in the 
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dark because they are purely thermal controlled process (propagation and 
termination rate are both temperature dependent). 
Regarding the photoinitiators it is possible to divide them in two categories 
according with the pathway to generate the reactive species: 
 By photocleavage, if, once absorbed the light, the photoinitiator 
generates radicals by intramolecular scission (Norrish type I), Figure 
3.3. 
 By hydrogen abstraction, generating the radicals by abstraction of a 
hydrogen atom from a donor molecule (Norrish type II), Figure 3.3. 
 
 
Figure 3.3: Norrish I and Norrish II type mechanisms 
 
The most diffused Norrish I type photoinitiators are aromatic carbonyl 
compounds, e.g. benzoin ether derivates and benzileketals, that undergo to 
homolitic scission of the C-C bond after UV exposure, generating two radicals 
fragments(Figure 3.4). 
 
 
Figure 3.4: Radical formation in 2,2-Dimethoxy-2-phenylacetophenone 
 
Norrish II type photoinitiators includes aromatic ketons, e.g. benzophenone, 
thioxanthone and camphorquinone. Under UV light there isn‘t any cleavage of 
a covalent bond but an abstraction of a hydrogen atom from a H-donor 
molecule (usually H is abstracted from a monomer). In this way a ketyl radical 
and a donor radical are generated, according to Figure 3.5. 
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Figure 3.5: Radicals formation mechanism from benzophenone 
 
Light-induced free radical polymerization is the most used technique for 
industrial applications even because for the large source of monomer available 
and the possibility to have waterborne resins. In the market curing of coatings 
on wood, metal and paper, adhesives, printing inks and photoresists 
applications are practically based on photoinitiated radical polymerization. On 
the other side this method presents several drawbacks such as volatility of 
many photocurable compounds, unpleasant odor (most of all by acrylic and 
methacrylic resins), toxicity of unreacted groups and monomers, and large 
shrinkage. Moreover the process has the disadvantage that it must be carried 
out in inert atmosphere (e.g. nitrogen, argon, carbon dioxide or vacuum) 
because it suffers from oxygen inhibition. Free radicals generated by the 
photolysis of the initiator are rapidly scavenged by O2 molecules to yield 
peroxyl radicals [1]. These are not reactive towards the double bounds present 
in the photocurable compounds and can therefore not initiate the 
polymerization reaction. They usually abstract hydrogen atoms from the 
polymer backbone to generate hydroperoxides (See Figure 3.6). This 
modification of curing reaction also influences strongly the properties of the 
cured materials [2]. An additional amount of photoinitiator (and of UV energy) 
is therefore needed to consume the oxygen dissolved in the resin, reducing the 
rate of photopolymerization. 
 
Figure 3.6: Oxygen inhibition mechanisms in free radical photopolymerization 
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Initiation reaction is a multistep process that first involves the absorbing of the 
radiation and thus the excitation of the onium salts. The generated excited 
singlet state could than decays with both heterolytic and hemolytic cleavages. 
The resulting free radicals, cation and cationradical fragments are very reactive 
with monomers. Hence a Brønsted Acid is formed and, actually, this species 
initiates the polymerization reaction. The Brønsted acid could also be indicated 
as HMtXn were MtXn
-
 is the anionic part. It must have non-nucleophile 
behavior because otherwise any cationic species generated during the 
photolysis or during chain grow mechanism would give termination reaction by 
combination with this anion. According with their nucleophilicity, the most 
used counterions are PF6
-
, AsF6
-
, SbF6
-
 and BF4
-
. 
Of course the type of anion also determines the strength of the Brønsted acid 
produced in the photolysis reaction. The more stable are the anions the higher 
is the strength of the superacid generated. The order of reactivity is 
SbF6>AsF6>PF6>BF4. 
Epoxides and Vinyl ethers are the most employed cationic photocurable 
compounds. While the polymerization of Vinyl ethers occurs by addition of a 
carbocation on the double bound, epoxy polymerization occurs by ring opening 
polymerization. This mechanism involves opening and polymerizing cyclic 
functionalities and lead to the production of a linear polymer. Bifunctional or 
multifunctional monomers lead to the formation of 3D cross-linked network 
[3]. 
 3.2  Click chemistry 
―Click chemistry‖ is a relatively new approach of direct conjugation, 
developed by Sharpless et al almost a decade ago. Specifically ―click 
reactions‖ are fast, efficient, require mild reaction conditions (aqueous 
environment, relatively neutral pH), and create water-soluble and 
biocompatible linkages (electron configuration similar to amide bonds)[4]. 
Compared to other direct conjugation strategies, this method of attachment 
offers several unique features. 
The ‗‗Click chemistry‘‘ focuses on the extraordinary power of a very few 
3. Nanoparticles preparation strategies for biomedical applications 
________________________________________________________ 
66 
 
reactions which form desired bonds under diverse reaction conditions, with 
highly diverse building blocks, in high yields and with no byproducts [5]. 
Recent studies demonstrated that ―click‖ chemistry meets the criteria of being 
applicable under aqueous conditions, efficient, orthogonal to thiol and amine 
containing targeting motifs, and stable in the complex in vivo environments of 
the blood and tumor milieu [6]. 
 
 3.2.2  Thiol-ene addition 
Thiol-ene is a free-radical reaction that proceeds by a step-growth mechanism, 
involving two main steps, a free-radical addition followed by a chain transfer 
reaction [7][8]; this reaction is well known for occurring in absence of any 
radical photoinitiator [9].  
With this technique it is possible to form a three dimensional crosslinked 
polymer when either the thiol and the ene monomers has a functionality greater 
than two, whereas a linear polymer is produced upon reaction of difunctional 
thiol with difunctional ene. Therefore, to obtain highly uniform crosslinked 
networks, thiol-ene systems are based on a mixture of a poly-ene and 
multifunctional thiols that polymerize by a free radical reaction. Typical 
examples of a multifunctional thiol and a multifunctional ene are reported in 
Figure 3.7. 
 
Figure 3.7: Typical multifunctional thiol and ene. 
 
Thiol-ene addition reaction was discovered as early as 1905 by Posner and 
since then the reaction mechanism, polymerization kinetics and monomers 
reactivity were extensively explored [10]. As explained before, the 
polymerization proceeds by a step-growth mechanism, involving a free radical 
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addition followed by a chain-transfer reaction [11], as illustrated in Figure 3.8.  
 
 
Figure 3.8: Thiol-ene free radical step growth mechanism. 
 
The free radical chain mechanism involves two different steps: an initial 
addition of a thiyl radical to the carbon of an ene functionality and a 
subsequent hydrogen abstraction of a thiol group by a carbon-centered radical 
to form a thiyl radical. Termination occurs through a bimolecular 
recombination of a couple of radicals [11]. The two steps process, as shown in 
Figure 3.9, results in the addition of a thiol group across an ene double bond. 
 
Figure 3.9: Addition of a thiol group across an ene double bond. 
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The step growth nature of the polymerization produces a homogeneous 
uniform crosslinked network with high conversion rates, resulting in reduced 
overall shrinkage and excellent adhesion.  
As any free radical polymerization process, there are a number of ways of 
initiating thiol-ene polymerization, including: the excitation of a diarylketone 
followed by hydrogen transfer, the excitation of an aryl aliphatic ketone 
followed by α-bond cleavage and the direct excitation of the thiol followed by 
a lysis of the sulfur-hydrogen bond. A diarylketone, such as benzophenone 
(BP), can be excited to its singlet state upon irradiation with UV light of 
sufficient energy and this can be followed by an efficient intersystem crossing 
to the triplet state [12][13]. In the presence of thiols, there is an efficient 
hydrogen transfer from the thiol to the excited triplet state of the diarylketone 
resulting in the formation of a thiyl radical and a semipinacol radical. Once 
formed, the thiyl radical initiates the polymerization process by inserting into 
the carbon-carbon double bond of the ene to give a carbon-centered radical, 
thus initiating the two steps chain process, as can be observed in Figure 3.10. 
 
 
Figure 3.10: Photoinitiation of thiol-ene free radical polymerization with a photoinitiator. 
 
This process of initiation, although quite inefficient because of the inability of 
the semipinacol radical either to insert into the carbon-carbon double bond or 
to abstract hydrogen atoms efficiently, does result in reasonable polymerization 
rates because of the rapid propagation rates for thiol-ene photopolymerizations. 
Unfortunately, if BP or some other diarylketone is used to initiate thiol-ene 
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process, most of the diarylketone remains unconsumed at the end of the 
reaction and remains in the final material as a plasticizer and photoreactive 
species [14]. In order to overcome this drawback, it should be possible to 
severely hinder the long term stability of the thiol-ene materials exposed to 
sunlight, or even certain types of room light, using a N-substituted maleimides, 
as excited species, which are able to abstract a hydrogen atom from the labile 
thiol group [15][16][17][18]. Because maleimides are quite reactive in free 
radical processes they are consumed by the radical chain process that they 
initiate and hence do not remain in the final material after exposure. Although 
this eliminates the problem of residual photoinitiator in the thiol-ene material, 
maleimides are toxic and this limits their use. Thiol-ene polymerization can 
also be initiated by the excitation of cleavage photoinitiators, such as a 
dimethoxyphenyl acetophenone (DMPA), which give a benzoyl radical and a 
tertiary carbon radical upon the absorption of a photon of light. A 
rearrangement of the tertiary carbon radical occurs, yielding a methyl radical 
and methyl benzoate. The methyl and benzoyl radicals may insert into a 
carbon-carbon bond directly or abstract a hydrogen from a thiol group. In 
either case, the two-step process characteristic of the thiol-ene free-radical 
chain reaction illustrated in Figure 3.8 is initiated [10]. Although not being as 
efficient as initiation by either hydrogen-abstraction or α-cleavage processes, it 
is still possible to excite directly the thiol and induce the cleavage of the labile 
sulfurhydrogen bond, as shown in the reaction of Figure 3.11. 
 
Figure 3.11: Photoinitiation by direct excitation of a thiol. 
 
One of the most attractive feature of thiol-ene polymerization is that any type 
of ene and thiol molecule can be incorporated into the thiol-ene network. Most 
authors today use the term ―thiol-ene‖ to describe the reaction of thiols with a 
wide variety of unsaturated functional groups such as acrylates, vinyl ethers, 
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allyl ethers, alkenes and norbornenes, in addition to inactivated carbon–carbon 
double bonds [19]. Moreover, different kind of multifunctional thiols can be 
used such as alkyl thiols, thiol glycolate esters and thiol propionate esters. 
Because the choice of enes to copolymerize with different thiols is essentially 
endless, it should be possible to tailor the molecular composition and so the 
final properties of the new materials. The thiol-ene reaction has all the 
desirable features of a ―click‖ reaction being highly efficient, simple to execute 
with no side products and proceeding rapidly to high yield [20]. Furthermore, 
the thiol-ene polymerization is most frequently photoinitiated, particularly for 
polymerizations resulting in highly uniform polymer networks, promoting 
unique capabilities related to spatial and temporal control of the click reaction.  
Photopolymerization is an efficient, environmentally friendly and economically 
favorable method to produce materials, which can display a wide range of 
properties depending on the identity of the reactive species and additives 
employed [21]. Thiol-ene photopolymerizations have an extensive list of 
significant advantages in regards to the other polymerization processes and the 
resulting polymer properties. The thiol-ene crosslinking reactions proceeds 
very rapidly in air but will not reach the gel point until relatively high 
functional group conversions in contrast to the traditional free-radical 
formulations which are normally inhibited by oxygen 
[22][23][24][25][26][27][28][29][30].  
In addition, thiol-ene systems are characterized by low polymerization 
shrinkage, insensitivity of oxygen inhibition effect, relatively high conversion, 
high refractive index, photoinitiator free polymerization and also homogeneous 
polymer structures and, as so, allow to obtain high performance photocured 
polymers. 
As mentioned earlier, in thiol-ene polymerizations a broad spectrum of 
physical properties is achieved because of the great number of monomers that 
can take place in the free radical step grow mechanism. One of the most 
important aspects of the thiol-ene photoinitiated radical polymerization is its 
relative insensitivity to oxygen inhibition, a problem that generally plagues the 
free radical processes [10]. The presence of oxygen in traditional formulations 
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often causes the inhibition effect of polymerization and leads to low curing 
rate, low conversion of monomers and successive flaws of cured products. The 
oxygen in polymerization system will consume the highly reactive free radicals 
and form peroxide radicals that have quite low reactivity toward radical 
polyaddition reaction. However, for thiol-ene photopolymerizations, which 
proceed through a step-growth mechanism, the thiol groups can react with the 
peroxide radicals and generate highly reactive thiyl radicals after hydrogen 
abstraction by the peroxide radicals, as can be observed in Figure 3.12. Thus, 
the thiol-ene photopolymerization can achieve high photopolymerization rate 
and high conversion [14][28][29]. 
 
Figure 3.12: Oxygen scavenging mechanism for thiol-ene free radical polymerization. 
 
Another unique advantage of thiol-ene systems is that the polymerization 
proceeds steadily with the addition of much less amount of photoinitiator than 
traditional photocuring systems. It is even polymerizable in absence of 
photoinitiator. In order to counteract the oxygen inhibition effect and raise the 
curing speed and conversion, the addition of excessive amount of photoinitiator 
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is a routine solution in non-thiol photopolymerization systems. However, the 
relatively high content of photoinitiator with small molecular weight not only 
increases the product cost but also results in some problems of cured materials. 
The presence of non-reacted photoinitiator will lead to yellowing effect of the 
photocured materials under daylight exposure. This problem can be effectively 
solved in thiol-ene photopolymerization systems. Thus, during long-term use 
of the photocured products the migration of fragments of photoinitiators may 
cause some problems such as irritant volatile, contact stimulative and potential 
harm for health. However, in the photocurable thiol-ene systems, whereas 
thiols completely get crosslinked with multifunctional ene monomers, small 
molecule of photoinitiator is fixed in the polymer network without migration 
from the UV-cured products [10]. Furthermore, because of the thioether 
linkage structure formed by thiol-ene free radical addition in polymerization, 
the thiol-ene based cured products show some unique physical, chemical and 
mechanical properties. It was reported that due to the presence of the highly 
flexible thioether linkages, the thiol-ene photocured materials show a 
significant ability to adhere to a variety of surfaces, including metals; for this 
reason they can be largely used in many application fields, including coatings 
for optical fibers, microelectronics, graphic arts and adhesives 
[13][14][15][31]. 
 3.2.3  Huisgen 1,3-dipolar cycloaddition 
Representing a set of Cu-catalyzed azide-alkyne ―click chemistry‖, Huisgen 
1,3-dipolar cycloaddition was developed to make conjugations between 
bioactive surfaces easier and less harsh to biomolecules ligands [32][33]. 
Firstly, azide and alkyne reactive groups are highly specific for one another, 
and unreactive with most functional groups, ensuring specific conjugation at 
the desired location(s) on the reactive moiety. Secondly, the formed bonds are 
highly stable. This is in contrast to amide bonds, which can be cleaved by 
hydrolysis reactions, and disulfide linkages that are susceptible to cleavage 
under reducing environments. Thirdly the formed linkages are extremely rigid, 
which helps to maintain conformation of reacted moieties at the NPs surface 
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and prevents their cross interactions. Combined, these features enable the 
production of highly oriented linkages engineered to ensure optimal reaction 
activity and efficiency. This technique appears to be specially suited for 
attachment of targeting moieties where orientation and stability of linkages are 
particularly important. As such this chemistry has been implemented and 
proved to be effective at binding targeting biomolecules to the NPs surface 
with >90% efficiency under mild reaction conditions and reaction times of 5-8 
hours [34][35][36].    
The basic process of the Huisgen 1,3-dipolar cycloaddition [37][38][39] is 
depicted in Figure 3.13, generating 1,4- and 1,5-triazoles, respectively. 
 
Figure 3.13: Schematic representation of the Huisgen 1,3-dipolar cycloaddition 
 
Nearly all functional groups are compatible with this process, except those that 
are (i) self reactive, or (ii) able to yield stable complexes with the Cu
I
 metal 
under catalyst deactivation.  
Double bonds are tolerated to a certain extent given that they are neither 
electronically activated (i.e., by electron withdrawing substituents) nor 
embedded into substrates of appropriate ring strain [37]. Thus the reactivity of 
phenylacetylene with pheylazide (reaction rate k = 0.29 x 10
7
 dm
3
.M
-1
.s
-1
) is 
comparable to that of hept-1-ene, styrene, and isoprene. Other alkenes display 
faster reactions with phenylazide (e.g., norbornene: k = 188 x 10
7
 dm
3
.M
-1
.s
-1
, 
N-phenyl maleimide: k = 27.60 x 10
7
 dm
3
.M
-1
.s
-1
,  and acetylene carbonic acid 
dimethyl ester: k = 25.4 x 10
7
 dm
3
.M
-1
.s
-1
). Therefore, the reaction with 
strained and electronically activated alkenes represents an important 
competitive reaction partner in the thermal process. Similar reasoning is also 
applicable for the rate-accelerating effect of electron withdrawing substituents 
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on the azido-molecules as determined by Hammett correlations [40]. 
A variety of catalytic systems have been used to effect the 1,3-dipolar 
cycloaddition process. In case of the azide/ acetylene process, mostly Cu
I
 
catalysts have been used and require about 0.25-2 mol.% of the catalysts. Most 
methods use Cu
I
 salts directly, other methods generate the copper(I) species by 
reduction of Cu
II
 salts using sodium ascorbate or metallic copper. Recently, the 
use of copper clusters of Cu/Cu oxide nanoparticles, sized 7-10 nm [41], as 
well as copper clusters of diameter around 2 nm, with a specific surface area of 
168 m
2
.g
-1
 [42] have been described, although with contradicting explanations 
for their catalytic activity. Whereas in the former case the presence of Cu
I
/Cu
II
 
species in a ration of 1:3 was made responsible for the strong catalytic activity 
of the Cu
0
 species. Both publications claim a positive influence of the 
alkylamine ligand present on the nanoparticle surface as an additional factor 
for activity enhancement. Besides the copper catalyst, 1-5 equivalents of base 
are added, mechanistically for promoting the formation of the copper(I)-
acetylide.  
Most of the known solvents can be used for this reaction, in addition, biphasic 
reaction systems (water/ alcohol or water/ toluene) can be applied with 
excellent results. 
The bases used are mostly  triethylamine, 2,6-lutidine, and N,N-
diisopropylethylamine (DIPEA), as well as N,N,N’, N’,N’’-
pentamethylethylenetetramine (PMDETA) or 2,2‘-bipyridine. Besides the 
copper catalyst and the base, triazoles have been shown to accelerate the 
reaction [43]. Some of the ligands are indicative of a complexation of the 
copper(I), which leads to a stabilization of the copper(I) oxidation state, thus 
prevents coupling reactions such as the Ulman [44], and Cadiot-Chodkiewizc 
couplings [45]. Moreover, tris-triazolyl ligands inhibit the Cu
II
-catalyzed 
oxidative coupling reactions of terminal alkynes to diynes under otherwise 
standard conditions [46]. Other systems use tris(carboxyethyl)phosphine 
(TCPE) as a ligand.  
Strong effects of alternative synthetic methodologies have been observed 
within the click reaction. Thus, Fokin and co-workers [47] and others [48] have 
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investigated the reaction under action of microwave irradiation. They used a 
combination of nucleophilic displacements starting from benzylic halides and 
sodium azide directly linking the present phenylacetylene in a single step. The 
reaction was strongly enhanced by the action of microwave irradiation, and 
furnished the corresponding triazoles in yields between 86-93 %. Similar 
observations have been described with click reactions on polymers and 
dendrimers. Another approach [49] starts from the initial observation that 
ammonium salts can act as co-catalysts for the 1,3-dipolar cycloaddition 
process when using solely metallic copper as the catalyst. Thus, ammonium 
salts directly promote the formation of Cu
I
 species, which enable an efficient 
reaction and enhance the cycloaddition products to > 95% yields. 
A mechanistic picture of the copper catalyzed reaction was first proposed by 
Medal and co-workers [50] and Sharpless and co-workers [51] and has later 
been verified by computational methods [52][53]. However, the proposed 
catalytic mechanism (calculated [52] by density functional theory (DTF) 
calculations) that relied on the initial formation of a Cu acetylide between the 
Cu
I
 species and the terminal alkyne which subsequently proceeded by an initial 
π-complex formation between the CuI and the alkyne [54][55], to lead to a 
lowering of the pKa of the terminal acetylene by up to 9.8 units, thus enabling 
the attack onto the C-H bond, especially in aqueous systems, has been recently 
revised [56] in favor of a binuclear mechanism as shown in Figure 3.14. 
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Figure 3.14: schematic representation of the copper catalyzed reaction 
 
Support for this hypothesis, which is similar to the monometallic mechanism 
proposed by Sharpless and co-workers [52][53] by calculation, is based on the 
observation that the rate of catalysis is second order with respect to copper, but 
with increasing concentration of copper, less reactive species are observed 
[57]. Thus, both the high regioselectivity and the rate acceleration are 
accounted for by this mechanism. Similar results are obtained when calculating 
the Cu
I
-catalyzed cycloaddition reaction of azides to nitrile-oxides, for which a 
similar rate enhancement of the copper catalyzed reaction, in confrontation to 
the purely thermal reaction, was observed. 
Since many known polymerization reactions in macro-molecular chemistry 
require the absence of specific functional groups, there is considerable interest 
in the fixation of ligands onto polymers and gels after a successful 
polymerization reaction has been conducted. This is most important when 
living polymerization mechanisms are used, since especially the highly 
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sophisticated chemical mechanisms and equilibria of (quasi-) living 
polymerization reactions are often highly substrate specific and, therefore, 
strongly affected by even small amounts of functional groups, or the respective 
coupling agents required for affixation. Another issue concerns the binding of 
large numbers of ligands onto polymers (i.e., sidechain modified polymers) or 
dendrimers, which require highly efficient coupling reactions to this purpose as 
well. Further interest is directed towards the heterogeneous functionalization of 
polymers in solvent mixtures. Because of the limited solubility of many 
polymers reactants, post-functionalization reactions cannot always be applied 
in homogeneous solution with the derivatized polymer. In these cases, highly 
efficient reactions acting in heterogeneous reaction media are desired. Thus, 
the Huisgen 1,3-dipolar cycloaddition has been brought into the limelight 
recently because of its efficiency, often reaching yields of > 99% irrespective 
of the ligand structure, even in inhomogeneous reaction systems.  
This click reaction is also particularly adapted for the ligation of artificial 
ligands to biomolecules since this reaction work under conditions in which the 
structural integrity of peptides, proteins, carbohydrates, and assemblies derived 
from these is preserved. Thus, besides conventional linking methods (e.g., 
disulfide exchange, amide linkage, reductive aminations, Staudunger-type 
ligation) [58], this method  definitely is an important contribution for biological 
labeling.  
One of the first example to demonstrate the practicability of the azide/alkyne 
click reaction was provided by Meldal and co-workers [60] who used the click 
reaction on peptides during solid-phase synthesis. Based upon this knowledge, 
Ghadiri and co-workers [61] used the click reaction to generate cyclic peptides. 
An impressive example of the completeness and versatility of the azide/alkyne 
click reaction has been presented by Finn and co-workers [62] upon modifying 
all sixty positions of the tobacco mosaic virus. After the generation of a virus-
derivative displaying sixty azido, or acetylenic bonds, the final coupling with a 
rhodamine B dye yields the attachement of sixty moieties onto the surface of 
the labeled virus. The catalyst system used was based on 
Cu
II
SO4/tris(carboxyethyl) phosphine (TCEP)/catalyst/Cu
0
. Both systems 
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yielded an attachment efficiency of 100% in a solvent system based on 
phosphate buffer (plus 5% t-butyl alcohol) at a pH of 8.0. 
The biolabeling in living systems was demonstrated by Tirell and co-workers 
[63] by incorporating the unnatural amino-acids azido-alanine, 
azidohomoalanine, azidovaline, and azidonorleucine into living cells. 
Reporting and quantification of the incorporation was subsequently done by 
―clicking‖ an acetylene-modified biotin ligand onto the surface of E-coli 
bacteria, which displayed the azido moieties. Ultrapure Cu
I
Br (purity 99,999%) 
was found to be superior in catalyzing the click reaction. A related approach to 
the use of activity based protein profiling (ABPP) has been reported by Cravat 
and co-workers [64], which relied on ABPP as a chemical proteomic method, 
which employs active site-directed probes to simultaneously visualize the 
changes in activity of proteins in a cellular environment [65].  
To summarize, the combination of azide/alkyne click chemistry demonstrates a 
new approach to the profiling of enzymatic active sites as well as the search for 
new binding structures onto active protein sites. Clearly, an absolutely  
randomized approach (without knowledge of the enzyme‘s active site) as well 
as an, at least partially directed, approach is viable, to screen dynamic 
combinatorial libraries. Therefore this method points to the future for studying 
associative phenomena, possibly also in supramolecular chemistry and material 
sciences. 
 3.3  Emulsion polymerization 
Emulsion polymerization is a unique chemical process widely used to produce 
waterbone resins with various  colloidal and physicochemical properties. This 
heterogeneous free radical polymerization process involves emulsification of 
the relatively hydrophobic monomer in water by an oil-in-water emulsifier, 
followed by the initiation reaction with either a water-insoluble initiator (e.g., 
sodium persulfate (NaPS)) or an oil-soluble initiator (e.g., 2-2‘-
azobisiobutyronitrile (AIBN)) [66][67][68][69][70][71]. Typical monomers 
used in emulsion polymerization include butadiene, styrene, acrylonitrile, 
acrylate ester monomers, vinyl acetate, and vinyl chloride. An extremely large 
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oil-water interfacial area is generated as the particles nuclei form and grow in 
size with the progress of the polymerization. Thus, an effective stabilizer such 
as ionic and non-ionic surfactants and protective colloid (e.g., hydroxyethyl 
cellulose and polyvinyl alcohol) which can be physically adsorbed or 
chemically incorporated onto the particle surface, is required to prevent the 
interactive latex particles from coagulation. Under the circumstances, 
satisfactory colloidal stability can be achieved  via the electrostatic  
stabilization mechanism [72], the steric stabilization mechanism [73][74], or 
both. The environmentally friendly latex product comprise a large population 
of polymer particles (~101-103 nm in diameter) dispersed  in the continuous 
aqueous phase. These emulsion polymers find a wide range of applications 
such as synthetic rubbers, thermoplastics, coatings, adhesives, binders, 
rheological modifiers, plastic pigments, standards for the calibration of 
instruments, immunodiagnosis tests, polymeric supports for the purification of 
proteins and drug delivery system, etc.  
Emulsion polymerization is a rather complex process because nucleation, 
growth and stabilization of polymer particles are controlled by the free radical 
polymerization mechanisms in combination with various colloidal phenomena. 
Perhaps, the most striking feature of emulsion polymerization is the 
segregation of free radicals among the discrete monomer-swollen polymer 
particles. This will greatly reduce the probability of bimolecular termination of 
free radicals and, thereby, result in a faster polymerization rate and polymer 
with a higher molecular weight. This advantageous characteristic of emulsion 
polymerization cannot be achieved simultaneously in bulk or solution 
polymerization. Although the nucleation period is quite short, generation of 
particle nuclei during the early stage of the polymerization plays a crucial role 
in determining the final latex particle size and particle distribution and it has 
also a significant influence on the quality of latex products. The way to 
effectively control the particle nucleation process represents a very challenging 
task. Transport of monomer, free radicals and surfactant to the growing 
particles and partition of these reagents among the continuous aqueous phase, 
emulsified monomer droplets (monomer reservoir), monomer swollen polymer 
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particles (primary reaction loci) and oil-water interface are the key factors that 
govern the particle growth stage. The colloidal properties of latex products are 
of great importance from both academic and industrial point of view. Some 
representative properties include the particle size and particle size distribution, 
particle surface charge density (or zeta potential), particle surface area covered 
by one stabilizer molecule, conformation of the hydrophilic polymer physically 
adsorbed or chemically coupled onto the particle surface, type  and 
concentration of functional groups on the particle surface, particle morphology, 
optical and rheological properties and colloidal stability. 
A typical emulsion polymerization formulation comprises monomer, water, 
surfactant and a water-soluble initiator. The reaction system is characterized by 
the emulsified monomer droplets (~1-10 µm in diameter, 1012-1014 dm-3) 
dispersed in the continuous aqueous phase with the help of an oil-inwater 
surfactant at the very beginning of polymerization. Monomer-swollen micelles 
(~5-10 nm in diameter, 109-1021 dm-3 in number) may also exist in the reaction 
system, provided that the concentration of surfactant in the aquous phase is 
above its critical micelle concentration (CMC). Only a small fraction of the 
relatively hydrophobic monomer is present in the micelles (if present) or 
dissolved in the aqueous phase. Most of the monomer molecules dwell in the 
giant monomer reservoirs (i.e., monomer droplets). The polymerization is 
initiated by the addition of initiator. According to the micelle nucleation model 
proposed by Harkins [75][76][77] and Smith and Ewart [78][79][80] and 
modified by Gardon [81][82], submicron latex particles (~0.05-1 µm in 
diameter, 10
16
-10
18
 dm
-3 
in number) are generated via the capture of free 
radicals by micelles, which exhibit an extremely large oil-water interfacial 
area. In general, monomer droplets are not effective in competing with micelles 
in capturing free radicals generated in the aqueous phase due to their relatively 
small surface area. However, monomer droplets may become the predominant 
particle nucleation loci if the droplet size is reduced to submicron range. This 
technique is called miniemulsion polymerization [83][84][85][86][87] and 
innovative miniemulsion polymerization technology is still being investigated 
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[86]. 
Waterborne free radicals first polymerize with monomer molecules dissolved in 
the continuous aqueous phase. This would result in the increased 
hydrophobicity of oligomeric radicals. When a critical chain length is achieved, 
these oligomeric radicals become so hydrophobic that they show a strong 
tendency to enter the monomer-swollen micelles and then continue to 
propagate by reacting with those monomer molecules therein, as illustrated in 
Figure 3.15. 
 
Figure 3.15: mechanism for radical entry [88] 
 
As a consequence, monomer-swollen micelles are successfully transformed 
into particle nuclei. These precursor particles continue to grow by acquiring the 
reactant species from monomer droplets and monomer-swollen micelles. In 
order to maintain adequate colloidal stability of the growing particle nuclei, 
micelles that do not contribute to particle nucleation disband to supply the 
increasing demand for surfactant. In addition, the surfactant molecules 
adsorbed on monomer droplets may also desorbs out of the droplet surface, 
diffuse across the continuous aqueous phase and then adsorb on the expanding 
particle surface. The particle nucleation stage ends immediately after the 
exhaustion of micelles. About one of every 10
2
-10
3
 micelles can be 
successfully converted into latex particles.  
The Smith-Ewart theory predicts that the number of latex particles nucleated 
per unit volume of water (Np) is proportional to the surfactant concentration 
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and initiator concentration to the 0.6 and 0.4 powers respectively. This 
relationship shows that the most important parameter that controls the particle 
nucleation process is the surfactant concentration. Although the particle 
nucleation period is relatively short (up to about 10-20% monomer 
conversion), it controls the particle size and particle size distribution of latex 
products. The application properties of emulsion polymers such as rheology 
and film formation are strongly dependent on the particle size and particle size 
distribution. By rule of thumb, latex products with a large particle size can be 
produced by using a relatively low surfactant concentration in the particle 
nucleation stage. In addition, a narrow particle size distribution will be 
achieved. This is simply because the shorter the particle nucleation period (i.e., 
the lower the surfactant concentration), the narrower the resultant particle size 
distribution. It should be noted that flocculation of particle nuclei arising from 
inadequate stabilization of the colloidal system may also take place during 
polymerization. This will make the task of controlling the particle size and 
particle size distribution of latex products more difficult. In addition, it is much 
easier to prepare latex products with high total solid contents when a small 
population of particles with a large particle size is produced at the end of 
polymerization. This is closely related to the relatively mean free path length 
(H/r) between two interactive particles as a function of the total solid content 
[89]. H and r represent the average interparticle distance and particle radius 
respectively. The value of H/r decreases with increasing total solid content. 
Thus, the higher the total solid content, the more crowded the colloidal system 
(i.e. the greater the interaction between two approaching particles). 
Furthermore, larger particles exhibit larger value of H for the stationary particle 
packing. Thus, at constant total solid content, the colloid system comprising 
larger particles should be less crowded. In this manner, high solid latex 
products with satisfactory rheological properties are achieved. This is a very 
important consideration in many industrial applications. 
After the particle nucleation process is completed, the number of latex particles 
(i.e. reaction loci) per unit volume of water remains relatively constant toward 
the end of polymerization. The propagation reaction of free radicals with 
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monomer molecules takes place primarily in monomer-swollen particles. 
Monomer droplets only serve as reservoirs to supply the growing particles with 
monomer and surfactant species. The majority of monomer is consumed in this 
particle growth stage ranging from ~10-20 to 60% monomer conversion. The 
particle growth stage ends when monomer droplets disappear in the 
polymerization system. Smith-Ewart case 2 kinetics has been widely used to 
calculate the rate of polymerization (Rp) 
Rp = kp[M]p(nNp/NA) 
where kp is the propagation constant, [M]p the concentration of monomer in the 
particles, n the average number of free radicals per particle, and NA the 
Avogadro number. This kinetic model was developed based on the following 
assumptions: 
1. Nucleation and coagulation of particles do not occur and the 
number of particle per unit volume of water remains constant during 
polymerization 
2. The particle size distribution is relatively monodisperse. 
3. Desorption of free radicals out of the particles does not take place 
4. Bimolecular termination of the polymeric radical inside the particle 
upon the entry of an oligomeric radical from the aqueous phase is 
instantaneous. 
These assumptions then lead to a scenario that, at any moment, monomer-
swollen particles contain either only one free radical (active) or zero free 
radical (idle). Under the circumstances, a value of n equal to 0.5 is achieved for 
the polymerization systems that follow Smith-Ewart case 2 kinetics. In 
addition, the concentration of monomer in the particles does not vary to any 
extent with the progress of polymerization in the presence of monomer 
droplets. As a result, a steady polymerization rate is attained during the second 
phase. Furthermore, the polymerization kinetics is strictly controlled by the 
population of particles available for consuming monomer. Smith-Ewart case 2 
kinetics has been successfully applied to emulsion polymerizations of 
relatively water-insoluble monomers such as styrene and butadiene. 
Emulsion polymerization proceeds from the second phase to the third phase 
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when all the monomer droplets disappear. In phase III, latex particles become 
monomer starved and the concentration of monomer in the reaction loci 
continues to decrease toward the end of polymerization.  Thus, the steady 
polymerization rate observed in phase II cannot be maintained anymore and the 
polymerization rate decreases during phase III. On the other hand, the 
polymerization rate may increase rapidly with increasing monomer conversion. 
This is attributed to the greatly reduced bimolecular termination reaction 
between two polymeric radicals within the very viscous particle; hence, 
polymerization is carried out at a temperature below the glass transition of the 
monomer-starved polymer solution. This phenomenon is called the gel effect 
[90][91]. To minimize residual monomer in latex products is essential for the 
successful product development because of the potential hazard to end-users. 
The rate of polymerization as a function of monomer conversion and schematic 
representation of the micelle nucleation model are shown in Figure 3.16 and 
Figure 3.17 [92]. 
 
 
Figure 3.16: rate of polymerization as a function of monomer conversion 
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Figure 3.17: schematic representation of the micelle nucleation model 
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4. Materials and Methods 
 4.1  PEG coated magnetite nanoparticles via 
photopolymerization 
In this part we report a new fast and convenient method for preparing magnetic 
nanoparticles with a Fe3O4 core and a Poly(ethylene glycol)-diacrylate shell in 
water. We used a reduction coprecipitation method to obtain Fe3O4 in aqueous 
solution [1][2] whereas the PEGDA coating was obtain via photochemical 
reaction at room temperature in an initiator free aqueous system. The fact that 
this method is solvent free and initiator free makes it ideal for biomedical 
applications. 
 4.1.1  Materials 
FeCl3·6H2O (97%, Sigma-Aldrich), Sodium sulfite (Na2SO3) (≥ 98%, Sigma-
Aldrich), Ammonia (25%, Merck) and Poly(ethylene glycol) diacrylate 
(PEGDA) (Mn = 575, Aldrich) were used as received. 
 4.1.2  Synthesis of Fe3O4 nanoparticles  
Magnetite nanoparticles were synthesized by a chemical co-precipitation of 
Fe
2+
 and Fe
3+
 ions under alkaline conditions, as already reported in literature 
[3]. As a typical procedure 3,25 g of FeCl3·6H2O was dissolved into 100 ml of 
distilled water. The solution was added into a three-necked flask together with 
5 ml of Na2SO3 solution at 5 wt%. Subsequently 25 ml of concentrated 
ammonia were diluted into 40 mL of distilled water and then added into the 
flask under nitrogen inlet; the solution quickly turned black. The solution was 
stirred for 30 minutes at 70 °C and then cooled down to room temperature. The 
black precipitate was separated with a magnet and washed several time with 
distilled water. The Fe3O4 nanoparticles were redispersed in distilled water. The 
concentration of the Fe3O4 nanoparticles was determined by means of TGA to 
be 5,81 mg/ml. The particles diameter was studied via DLS analysis. The water 
dispersion of Fe3O4 nanoparticles showed superparamagnetic property, as 
reported in Figure 4.1.  
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Figure 4.1: Magnetization versus applied magnetic field of synthesized bare  Fe3O4 
particles 
 
 4.1.3  Polymeric coating of Fe3O4 nanoparticles 
The Fe3O4 nanoparticles were coated with PEGDA via UV-curing. In a typical 
procedure 1,72 ml of the aqueous/magnetite dispersion were added to 50 ml of 
deionized water into a three-necked flask under magnetic stirring and nitrogen 
inlet. Subsequently 0.168 ml of PEGDA was added dropwise and then the 
mixture was exposed to UV light for 20 minutes. The polymeric coated 
magnetite nanoparticles were collected with a magnet, washed with distilled 
water and redispersed into distilled water. 
 4.1.4  Characterization techniques 
Particle sizes and size distribution of both bare Fe3O4 and magnetic 
nanoparticles were measured by using Dynamic Light Scattering (DLS). The 
DLS measurements were done on a Zetasizer Nanoseries ZS90 (Malvern). The 
measurement is based on the fact that particles, emulsions and molecules in 
suspension undergo Brownian motion. This is the motion induced by the 
bombardment by solvent molecules that themselves are moving due to their 
thermal energy. If the particles or molecules are illuminated with a laser, the 
intensity of the scattered light fluctuates at a rate that is dependent upon the 
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size of the particles as smaller particles are ―kicked‖ further by the solvent 
molecules and move more rapidly. Analysis of these intensity fluctuations 
yields the velocity of the Brownian motion and hence the particle size using the 
Stokes-Einstein relationship. The morphology and the chemical structure of 
magnetic nanoparticles were further investigated by X-ray Photoelectron 
Spectroscopy (XPS), and transmission electron microscopy (TEM). 
Thermogravimetric analyses (TGA) was performed both on bare and coated 
magnetite nanoparticles.  
The XPS analyses were developed with a XPS VersaProbe5000 instrument 
with a monochromatic X-ray beam (Al source). In order to survive the polymer 
characteristic, during the analyses, a 100 m diameter spot size, an area of 100 
m X 800 m was employed. A Physical Electronics patent neutralization 
system, for reduce charging effect on sample, was also used. This 
neutralization system consists in an electronic ion gun combined with an Argon 
ion gun for positive and negative charge neutralization. 
Thermogravimetric analysis (TGA) was performed with a Mettler TGA/SDTA 
851 instrument between 20 and 700 °C at a heating rate of 10 °C/min in air. 
Samples were observed by TEM by examining in a 300 keV transmission 
electron microscope (TEM) Philips CM30. TEM micrographs were processed 
with a slow scan CCD camera and analyzed with the Digital Micrograph 
program. The TEM observations were always performed using a very low 
electron flux in order to avoid any structural modification of the sample 
induced by the electron beam. 
The magnetic properties of both bare Fe3O4 and magnetic nanoparticles were 
studied by measuring the hysteresis curves at room temperature using a 
Vibrating Sample Magnetometer (VSM).  
Magnetic hysteresis loops were measured at room temperatures on coated 
magnetite water dispersion by using an alternating-gradient field magnetometer 
(AGFM) equipped with a liquid He continuous-flux cryostat and operating in 
the magnetic field range -3 kOe < H < +3 kOe. The diamagnetic contribution 
of sample holder and substrates were carefully subtracted from the measured 
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curves. The magnetic field was applied parallel to the film plane. 
 
 4.2  PEG coated magnetite nanoparticles via UV-thiol-
ene addition reaction 
In this part magnetite nanoparticles were coated following a previous surface 
functionalization. The Fe3O4 nanoparticles were obtained by a reduction 
coprecipitation method and stabilized with citric acid. Afterwards nanoparticles 
surface was modified by a silanization reaction with vinyltrimethoxysilane 
involving magnetite hydroxyl groups. Vinyl functionalized nanoparticles were 
coated with poly (ethylene-glycol) (PEG) using PEG dithiol (PEG-SH) under 
UV irradiation. Thiol-ene is a free-radical reaction that proceeds by a step-
growth mechanism, involving two main steps, a free-radical addition followed 
by a chain transfer reaction; this reaction is well known for occurring in 
absence of any radical photoinitiator which make it particularly appropriate for 
biomedical applications. 
 4.2.1  Materials 
FeCl3·6H2O (97%, Sigma-Aldrich), Sodium sulfite (Na2SO3) (≥ 98%, Sigma-
Aldrich), Ammonia (25%, Merck), Citric acid (≥ 99,5%, Sigma-Aldrich), 
Vinyltrimethoxysilane (VTMS) (98%, Aldrich), Acetic acid concentrated 
solution (0.1 M, Fluka), Polyethylenglycol dithiol (PEG-SH) (Mn ≈ 1500, 
Aldrich) were used as received.  
 4.2.2  Synthesis of Fe3O4 nanoparticles  
Magnetite nanoparticles were synthesized by a chemical co-precipitation of 
Fe
2+
 and Fe
3+
 ions under alkaline conditions, as already reported in literature 
[3]. As a typical procedure 3,25 g of FeCl3·6H2O was dissolved into 100 ml of 
distilled water. The solution was added into a three-necked flask together with 
5 ml of Na2SO3 solution at 5 wt %. Subsequently 20 ml of concentrated 
ammonia were diluted into 40 mL of distilled water and then added into the 
flask under nitrogen inlet; the solution quickly turned black. The solution was 
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stirred for 30 minutes at 70 °C. Successively, the temperature solution was 
raised up to 95 °C and 1 g of citric acid was dissolved into 2 ml of water and 
added to the solution. After 90 minutes the solution was cooled down to room 
temperature. The black precipitate was separated with a magnet and washed 
several time with distilled water. The Fe3O4 nanoparticles were redispersed in 
distilled water. The concentration of the Fe3O4 nanoparticles was determined 
by means of TGA to be 5,81 mg/ml. The particles diameter was studied via 
DLS analysis. The water dispersion of Fe3O4 nanoparticles showed 
superparamagnetic property, as reported in Figure 4.2.  
 
Figure 4.2: Magnetization versus applied magnetic field of synthesized bare Fe3O4 
particles 
 
 4.2.3  Vinyl surface functionalization of magnetite 
nanoparticles 
Vinyl surface functionalization of magnetite nanoparticles was performed by 
reacting VTMS with the hydroxyl groups present on the Fe3O4 surface. Briefly 
a water/ethanol 1:10 vol/vol solution was put in a flask under magnetic stirring 
together with 3 ml of acetic acid and 0.478 ml of VTMS, the solution was 
stirred for 30 minutes at room temperature. The acidic conditions are needed to 
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hydrolyze the alkoxy-silane groups to silanol groups. Afterwards 5 ml of 
synthesized Fe3O4 aqueous dispersion were added and stirred for 24 hours. A 
silanol condensation with hydroxyl groups present on the magnetite 
nanoparticles will allow achieving a vinyl surface functionalization of the 
magnetite nanoparticles. The magnetite concentration was 14.7 mg/ml, as 
determined by TGA analyses. 
 4.2.4  Polyethylenglycol coating of vinyl functionalized Fe3O4 
nanoparticles 
The vinyl functionalized Fe3O4 nanoparticles were coated with PEG-SH via 
UV-curing. In a typical procedure 0,678 ml of the aqueous/vinyl-magnetite 
dispersion (10 mg of vinyl functionalized magnetite nanoparticles) were added 
to 60 ml of deionized water into a three-necked flask under magnetic stirring 
and nitrogen inlet. Subsequently 300 mg of PEG-SH were added dropwise and 
then the mixture was exposed to UV light for 30 minutes. The polymeric 
coated magnetite nanoparticles were collected with a magnet, washed with 
distilled water and redispersed into distilled water. 
 4.2.5  Characterization techniques 
Particle sizes and size distribution of both bare and coated Fe3O4 nanoparticles 
were measured using Dynamic Light Scattering (DLS). The DLS 
measurements were done on a Zetasizer Nanoseries ZS90 (Malvern).The 
morphology and the chemical structure of magnetic nanoparticles were further 
investigated by Transmission Electron Microscopy (TEM) in a 300 keV 
transmission electron microscope (TEM) Philips CM30. TEM micrographs 
were processed with a slow scan CCD camera and analyzed with the Digital 
Micrograph program. The TEM observations were always performed using a 
very low electron flux in order to avoid any structural modification of the 
sample induced by the electron beam. Thermogravimetric analyses (TGA) was 
performed both on bare and coated magnetite nanoparticles with a Mettler 
TGA/SDTA 851 instrument between 20 and 700 °C at a heating rate of 10 
°C/min in air. The magnetic properties of both bare Fe3O4 and magnetic 
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nanoparticles were studied by measuring the hysteresis curves at room 
temperature using a Vibrating Sample Magnetometer (VSM) operating in the 
magnetic field range -10 kOe < H < +10 kOe. The diamagnetic contribution of 
sample holder and solvent were significant. A reference measurement was 
preliminarily done by measuring the magnetic response of the sample holder 
filled with the same amount of pure solvent (i.e., without the magnetic 
nanoparticles). The magnetic contribution ascribed to magnetite NPs (before 
and after functionalization) was obtained from the measured curves by 
subtracting the reference curve. 
 4.3  Polymer grafting onto magnetite nanoparticles 
via click-reaction 
In this work we report the use of ―click‖ reactions for preparing magnetic NPs 
with Fe3O4 core and different biocompatible polymeric shells. We used a 
reduction coprecipitation method to obtain Fe3O4 particles in aqueous solution. 
As a next step, magnetic NPs surface was modified by a silanization reaction 
with (3-bromopropyl) trimethoxysilane in order to introduce bromine groups 
on the particles surface. Afterwards the bromine groups were converted to 
azide groups by the reaction with sodium azide in order to obtain azide groups 
to take part to click reaction with alkyne-functionalized polymers. For this 
reason, acetylene functionalized poly(ethylene glycol) (a-PEG) and poly(ε-
caprolactone) (a-PCL) were synthesized and grafted onto the surface of azide 
functionalized NPs via ―click‖ reaction to obtain monodisperse magnetic NPs. 
The peculiar characteristics of this method make it ideal for biomedical 
applications.  
 4.3.1  Materials 
Ethanol (99,9%, Labochem), Acetic acid (≥ 99,7%, Sigma-Aldrich), (3-
bromopropyl)trimethoxysilane (≥ 97,0%, Aldrich), Tin(II) 2-ethylhexanoate 
(95%, Aldrich), Propargyl alcohol (99%, Aldrich), 4-pentynoic acid (98%, Alfa 
Aesar), N,N'-dicyclohexylcarbodiimide (DCC) (99%, Aldrich), 4-
dimethylaminopyridine (DMAP) (99%, Aldrich), Sodium azide (NaN3) (99%, 
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Acros), Copper bromide (CuBr) (98%, Acros), N,N,N',N'',N''-
pentametyldiethylenetriamine (PMDETA) (99%, Aldrich), poly(ethylene 
glycol)monomethylether (PEG) (Mn= 2000, Fluka), FeCl3·6H2O (97%, Sigma-
Aldrich) were used as received. ε-Caprolatone (ε-CL) was distilled under 
vacuum over CaH2. N,N-Dimethyl formamide (DMF) and dichloromethane 
(99%, CH2Cl2, J. T. Baker) were previously dried and distilled over 
phosphorus pentoxide. 
 4.3.2  Synthesis of Acetylene End-Functionalized PCL 
Poly(ε-caprolactone) with alkyne end-functionality (a-PCL) was prepared by 
Ring Opening Polymerization of ε-CL (5,0 mL; 0,047 mol) in bulk using tin(II) 
2-ethylhexanoate as a catalyst (catalytic amount) and propargyl alcohol (0,102 
mL; 1,175 mmol) as an initiator. The monomer, catalyst and initiator were 
added to a previously flamed Schlenk tube equipped with a magnetic stirring 
bar in the order mentioned. The tube was degassed with 3 freeze-pump-thaw 
cycles, left under nitrogen, and placed in a thermostated oil bath at 110 ˚C for 
18 h. After the polymerization the mixture was diluted with THF and 
precipitated into an excess amount of methanol. Then it was filtrated (filter 
pore n˚4) and dried overnight at room temperature under vacuum. [M]0/[I]0= 
40; conversion= 67%; Mn,theo= 3100; Mn,NMR= 1613; Mn,GPC= 6000 (relative to 
linear polystyrene); Mw/Mn= 1,10. 
1
H NMR (CDCl3,δ): 4,66 (2H, CH≡C-
CH2O), 4,03 (2H, CH2OC=O of PCL), 3,62 (2H, CH2OH, end group of PCL), 
2,28 (2H, C=OCH2 of PCL), 1,20-1,80 (6H, CH2 of PCL). The schematic 
synthesis is depicted in Figure 4.3. 
 
Figure 4.3: synthesis of  a–PCL  
 
 4.3.3  Synthesis of Acetylene End-Functionalized PEG  
Mono hydroxyl functional PEG (Mn: 2000 g/mol, 3,0 g, 1,5 mmol) was 
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dissolved in 25 mL of dry CH2Cl2, and 4-pentynoic acid (0,22 g, 2,25 mmol) 
and DMAP (0,18 g, 1,5 mmol) were successively added to the reaction 
mixture. After stirring 5 min at room temperature, a solution of DCC (0,46 g, 
2,25 mmol) in 15 mL of CH2Cl2 was added to the reaction mixture and stirred 
overnight at room temperature. After filtration of the salt, the solution was 
concentrated and product was purified by column chromatography over silica 
gel eluting with CH2Cl2/ethyl acetate mixture (1:10) and then with 
CH2Cl2/MeOH (10:1). Finally, concentrated solution of acetylene end 
functionalized PEG  (a-PEG) was precipitated in diethyl ether and filtered. 
1
H 
NMR (CDCl3,δ): 4,25 (t, 2H, PEG-OCH2CH2-OC=O), 3,89-3,54 (m, 8H, PEG-
OCH2CH2OC=O, -OCH2CH2- of PEG, and CH2CH2-O), 3,36 (s, 3H, CH3-
OCH2CH2). 2,56-2,48 (m, 4H, CH≡CCH2CH2C=O), 1,97 (t, 1H, CH≡CCH2-
CH2C=O). The schematic synthesis is depicted in Figure 4.4. 
 
Figure 4.4: Synthesis of a-PEG 
 
 4.3.4  Synthesis of Magnetite nanoparticles 
See paragraph  4.2.2  
 4.3.5  Functionalization of Magnetite nanoparticles with (3-
Bromopropyl)trimethoxysilane 
Acetic acid (3 mL), 3-(bromopropyl)trimethoxysilane (0,239 mL) and 
magnetic NPs (74 mg) were added to a solution of water and ethanol (1:10 
vol/vol). The solution was left under magnetic stirring for 24h at room 
temperature. The black precipitate was separated with a magnet and washed 
several time with distilled water. The Fe3O4 NPs were redispersed in distilled 
water. The concentration of bromo functional magnetite NPs (Fe3O4-AC-Br 
NPs) acqueous dispersion was determined by means of TGA to be 6,0 mg/ml  
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 4.3.6  Azidation of Bromine-functionalized Magnetite 
nanoparticles  
Fe3O4-AC-Br NPs in aqueous solution (10 mL) were added to a flask 
containing a large excess  of sodium azide (100 mg, ~13 equiv. Br).  The 
solution was left under stirring at room temperature for 48 h. The azidation 
process was stopped by centrifugation of the solution.  The sample was 
centrifuged 3 times at 5000 rpm for 20 min and washed with water. 
Successively the pellet containing azido functional magnetite (Fe3O4-AC-N3) 
nanoparticles was dried at room temperature for 48 h. 
 4.3.7  Functionalization of Azide-magnetite nanoparticles 
with a-PCL via Click Reaction 
a-PCL ( 55,8 mg, 1 equiv.), CuBr (3,9 mg, 1,5 equiv.), and 2 mL of DMF were 
added in a Schlenk tube. 10 mg of the magnetic NPs (0,9 equiv. N3) were 
dispersed in 3 mL of DMF and added to the tube. Finally, PMDETA (5,8 µL, 
1,5 equiv.) was added to the solution. The tube was degassed with 3 freeze-
pump-thaw cycles, left under vacuum and put in a thermostated bath at 50 ˚C 
for 48 h. In order to stop the reaction, the solution was centrifuged at 5000 rpm 
for 30 min, then the supernatant was removed and the NPs were washed with 
toluene. The solution was centrifuged again at 5000 rpm for 30 min. This 
process was repeated two times with toluene and one time with water in order 
to remove unreacted polymer and copper catalyst. Successively, the NPs 
(Fe3O4-AC-N3 NPs) were dried for 48h at room temperature. 
 4.3.8  Functionalization of the azide-magnetite nanoparticles 
with alkyne-PEG via Click reaction 
Alkyne-PEG (22,5 mg, 1 equiv.) and CuBr (2,6 mg, 1,5 equiv.) were                                                                                                                                                                                                                           
dissolved in 2 mL of DMF in a Schlenck tube. 8,2 mg of Fe3O4-AC-N3 NPs 
(1,2 equiv. N3) and PMDETA (3,7 µL, 1,5 equiv.) were added to the solution. 
The tube was degassed with 3 freeze-pump-thaw cycles, left under vacuum and 
put in a thermostated bath at 50 ˚C for 48 h. In order to stop the reaction, the 
solution was centrifuged at 5000 rpm for 30 min. The pellet dispersed in 0.5 
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mL of THF and precipitated in 5 mL of cold distilled water, then 2 drops of 
hydrochloric acid were added to the solution and the solution was put at 4 ˚C 
for 4 h. The supernatant solution was removed and the NPs were dried under 
vacuum at room temperature overnight. 
 4.3.9  Characterization techniques 
1
H NMR spectra of 5–10% (w/w) solutions in CDCl3 with Si(CH3)4 as an 
internal standard were recorded at room temperature at 250 MHz on a Bruker 
DPX 250 spectrometer. Gel permeation chromatography (GPC) measurements 
were obtained from a Viscotek GPC max Autosampler system consisting of a 
pump, a Viscotek UV detector, and a differential refractive index detector. 
Tetrahydrofuran (THF) was used as an eluent at flow rate of 1,0 mL∙min-1 at 30 
˚C. Molecular weights of the a-PCL and a-PEG were determined with the aid 
of polystyrene standards. Fourier transform infrared (FTIR) spectra were 
recorded on a Perkin-Elmer FTIR Spectrum One B spectrometer. 
Thermogravimetric analysis (TGA) was performed on a Perkin-Elmer 
Diamond TA/TGA instrument at a heating rate of 10 ˚C∙min-1 under nitrogen 
flow. 
Magnetic hysteresis loops were measured at room temperatures on coated 
magnetite water dispersion by using a vibrating sample magnetometer (VSM) 
operating in the magnetic field range  -10 kOe < H < +10 kOe. The 
diamagnetic contribution of sample holder and solvent were significant. A 
reference measurement was preliminarily done by measuring the magnetic 
response of the sample holder filled with the same amount of pure solvent (i.e., 
without the magnetic NPs). The magnetic contribution ascribed to magnetite 
NPs (before and after functionalization) was obtained from the measured 
curves by subtracting the reference curve.  
Samples were observed by TEM by examining in a 300 keV transmission 
electron microscope (TEM) Philips CM30. TEM micrographs were processed 
with a slow scan CCD camera and analyzed with the Digital Micrograph 
program. The TEM observations were always performed using a very low 
electron flux in order to avoid any structural modification of the sample 
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induced by the electron beam. 
 4.4  Photochemical synthesis of gold-PEG core-shell 
nanoparticles 
In this part, we report a new, fast and convenient method for preparing gold 
nanoparticles with a poly(ethylene glycol)-diacrylate (PEGDA) shell in water. 
It is well known that polymer nanospheres can be prepared by conventional 
techniques of water-emulsion polymerization. These environmentally friendly 
products comprise a large population of nanometric size polymer particles 
dispersed in the continuous aqueous phase. Polyethylene glycol (PEG) was 
used as hydrophilic monomer in emulsifier-free emulsion polymerization to 
form polymeric nanoparticles by the UV-induced process. At the same time, 
gold was generated as the core of the PEG nanosphere by the reduction of 
HAuCl4 activated through the radical photogenerated from 2-hydroxy-2-
methyl-1-phenyl-1-propanone. This one-step procedure is very easy to 
implement and fast. Moreover, the fact that this method is performed in water 
makes it ideal for biomedical applications. 
 4.4.1  Materials 
Poly(ethylene glycol) diacrylate (PEGDA) (Mn = 575, Aldrich), hydrogen 
tetrachloroaurate (III) (HauCl4) 30%wt solution in chloridric acid (99,9%, 
Aldrich), 2-hydroxy-2-methyl-1-phenyl-1-propanone (Darocure 1173, CIBA) 
were used as received. 
 4.4.2  Synthesis of gold nanoparticles  
The reduced Au was coated with PEGDA via UV-curing. In a typical procedure 
10 mg of HAuCl4 and 80 mg of radical photoinitiator were added to 60 ml of 
deionized water into a three-necked flask under magnetic stirring and nitrogen 
inlet. Subsequently 2 g of PEGDA were added dropwise and then the mixture 
was exposed to UV light for 30 minutes.  
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 4.4.3  Characterization techniques 
Particle sizes and size distribution of gold nanoparticles were measured by 
using DLS. The DLS measurements were done on a Zetasizer Nanoseries ZS90 
(Malvern). Acrylic double bond conversion, as a function of irradiation time, 
was evaluated by means of real-time FT-IR employing a Thermo-Nicolet 5700. 
The morphology of the water dispersion was evaluated by TEM analysis. 
Samples were observed by TEM by examining in a 300 keV transmission 
electron microscope (TEM) Philips CM30. TEM micrographs were processed 
with a slow scan CCD camera and analyzed with the Digital Micrograph 
program. The TEM observations were always performed using a very low 
electron flux in order to avoid any structural modification of the sample 
induced by the electron beam. Chemical compositions of the dried particles 
were analyzed both with attenuated total reflectance (ATR) and X-ray 
Photoelectron Spectroscopy (XPS). ATR analyses were performed on dried 
samples by using  Thermo-Nicolet 5700. Before the XPS analyses, the PEGDA 
polymer was prepared on a Silicon substrate with a drop, and subsequently put 
for 12 hours in a dryer. The silicon substrate was chosen because the Silicon 
peaks do not overlap with the signal of interest in case the drop is not 
homogeneous. In any case, the drop results very homogeneous because we 
have not detected the presence of the silicon signal from the sample. XPS was 
performed using a VersaProbe5000 Physical Electronics X-ray photoelectron 
spectrometer with a monochromatic Al source and a hemispherical analyzer. 
An electron flood gun combined with Argon ion gun were employed because 
the samples were insulating polymers.  Survey scans as well as narrow scans 
were recorded with a 100 m spot size on an area of 100 m × 800 m spot 
size. Data acquisition and processing were implemented with the instrument 
software Summit and MultiPak 8.2. 
The surface Plasmon resonance of nanoparticles was studied using UV-Vis 
spectra. The UV-Vis spectra were recorded by means of a double beam 
UNICAM UV2 (ATI Unicam, Cambridge, UK) spectrophotometer with 
variable slit width in a spectral range of 190 e 1100 nm, interfaced to a 
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computer via ―Vision 32‖ software for data elaboration. The range between 300 
and 800 nm was monitored with a scan step of 1 nm. 
 
 4.5  Hollow-gold nanoparticles coated with 
Poly(ethylene glycol) methyl ether thiol 
In this part we report the synthesis of hollow gold nanoparticles following a 
method described in literature [5]. In a first time cobalt nanoparticles were 
prepared by reduction of cobalt salts with sodium borohydride under inert 
atmosphere. In a second time, gold salts were added to the colloidal suspension 
of cobalt nanoparticles. These gold salts were reduced to gold atoms as soon as 
they entered in contact with cobalt forming a gold shell while consuming the 
cobalt core. By varying the reaction parameters we were able to find a 
correlation between nanoparticles morphology and the localization of the 
surface plasmon resonance which has, to our knowledge, never been reported 
in literature yet. In a third time one specific sample was coated with 
poly(ethylene glycol) methyl ether thiol exploiting the natural affinity of thiol 
groups for gold. 
 4.5.1  Materials 
Sodium citrate (analytical grade, Sigma), cobalt chloride (analytical grade, R.P 
Normapur
TM
 AR), sodium borohydride (99%, Aldrich), hydrogen 
tetrachloroaurate (III) (HauCl4) 30%wt solution in chloridric acid (99,9%, 
Aldrich), Poly(ethylene glycol) methyl ether thiol (MeO-PEG-SH) (Mn = 
5000, Aldrich). 
 4.5.2  Preparation of hollow gold nanoparticles 
The synthesis process is based on templating using cobalt (Co) nanoparticles as 
initial seeds via a galvanic reaction with Au
3+
 ions as explained previously in 
the literature [5]. This synthesis must be done completely under inert 
environment, to this aim every solution was degassed with N2 before use. 
The solution was prepared in round-bottomed flask, under N2 atmosphere, 
mixing 100 mL of deionized water with sodium citrate aqueous solution (0.1M; 
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42.82 mg in 1 mL of deionized water), fresh sodium borohydride aqueous 
solution (1M; 37.83 mg in 1 mL of deionized water) and cobalt chloride 
aqueous solution (0.5M; 64.92 mg in 1 mL of deionized water). The solution 
was left under N2 atmosphere and magnetic stirring for 1h. Successively a 
certain number of 50 μL injections of hydrogen tetrachloroaurate (III) aqueous 
solution (0.1M; 105 μL in 5 mL of deionized water) were done, waiting 1 min 
between every injection. The solution was left under N2 atmosphere and 
magnetic stirring for one hour, and then for one night without N2. The 
respective volume of every solution was modified in order to obtain different 
morphologies. All the reaction parameters are reported in Table 4.1. 
 
Table 4.1: different sets of reaction parameters for the synthesis of HGNs 
 
  Sod citrate NaBH4 CoCl2 HAuCl4 
Sample Nber µL µL µL µL 
1 400 100 100 250 
2 400 100 100 700 
3 190 180 100 700 
4 330 250 100 700 
5 900 100 100 700 
6 190 180 100 450 
7 330 250 100 450 
8 900 100 100 450 
 
 4.5.3  Coating of hollow gold nanoparticles with Poly(ethylene 
glycol) methyl ether thiol 
Another hollow gold nanoparticles sample was prepared (Sample 9) using 900 
µL of sodium citrate, 250 µL of sodium borohydride, 100 µL of cobalt chloride 
and 700 µL of hydrogen tetrachloroaurate solution, as described previously. 
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These new nanoparticles were coated with Poly(ethylene glycol) methyl ether 
thiol by using the affinity between the thiol groups and gold. In a typical 
procedure 400 mg of polymer were solubilized in 10 mL of deionized water, 
20mL of Sample 9 were added to the solution and it was left at room 
temperature, under magnetic stirring for 6h. The coated nanoparticles were 
purified by dialysis against water (MWCO = 12-14,000 Da) and, then 
concentrated by ultrafiltration (MWCO = 100,0000 Da). 
 4.5.4  Characterization techniques 
The morphology of the water dispersion was evaluated by TEM analysis. 
Samples were observed by TEM by examining in a 300 keV transmission 
electron microscope (TEM) Philips CM30. TEM micrographs were processed 
with a slow scan CCD camera and analyzed with the Digital Micrograph 
program. The TEM observations were always performed using a very low 
electron flux in order to avoid any structural modification of the sample 
induced by the electron beam. 
Particle sizes and size distribution of coated hollow gold nanoparticles were 
measured by using DLS. The DLS measurements were done on a Zetasizer 
Nanoseries ZS90 (Malvern). 
The surface Plasmon resonance of nanoparticles was studied using UV-vis 
spectra. The UV-Vis spectra were recorded by means of a double beam 
UNICAM UV2 (ATI Unicam, Cambridge, UK) spectrophotometer with 
variable slit width in a spectral range of 190 e 1100 nm, interfaced to a 
computer via ―Vision 32‖ software for data elaboration. The range between 400 
and 800 nm was monitored with a scan step of 1 nm. 
 
 4.6  SiO2@Au nanoshell coated with Poly(ethylene 
glycol) methyl ether thiol 
This synthesis is based on different works reported in literature[6][7], however 
each step of the process was adapted in order to obtain the most suitable device 
for our aims. In a first time SiO2 nanoparticles were prepared following the 
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well known Stöber method [8], then the nanoparticles were functionalized with 
(3-Aminopropyl) triethoxysilane and gold seeds were grafted onto the surface. 
Eventually these gold seeds were grown by reduction of gold salts with 
hydroxylamine hydrochloride to form a uniform gold shell. The amount of gold 
salts used on the last step was varied in order to study the correlation between 
shell thickness and the surface plasmon resonance localization. On a second 
time, the Stöber method was slightly modified to obtain smaller nanoparticles 
and form smaller nanoshells, never reported in literature to our knowledge. In a 
third time these nanoshell were coated with poly(ethylene glycol) methyl ether 
thiol exploiting the natural affinity between thiol groups and gold. 
 4.6.1  Materials 
Ethanol (≥99,8%, Fluka), Tetraethyl orthosilicate (TEOS) (≥99,0%, Aldrich), 
NH4OH (28-30% in H2O, Sigma-Aldrich), Chloridric acid (37% in H2O, 
Sigma-Aldrich), (3-Aminopropyl)triethoxysilane (APTES) (≥ 98%, Sigma-
Adrich), Sodium hydroxide (NaOH) (≥ 98%, Sigma-Adrich), Tetrakis 
(hydroxymethyl) phosphonium chloride (THPC) (80% in H2O, Aldrich), 
Hydrogen tetrachloroaurate (III) (HauCl4) (99,999%, Aldrich), Sodium 
chloride (NaCl) (≥99,5%, Sigma), Potassium carbonate (99,995%, Aldrich), 
Hydroxylamine hydrochloride (NH2OH•HCl) (99,0%, Sigma-Aldrich), 
Poly(ethylene glycol) methyl ether thiol (MeO-PEG-SH) (Mn = 5000, 
Aldrich). 
 4.6.2  Preparation of SiO2 nanoparticles (Stöber method – 110 
nm) 
The formation of 110 nm SiO2 nanoparticles is based on the famous work of 
Stöber et al. [8]. In a typical procedure, 34 mL of ethanol, 2,8mL of TEOS and 
2,8 mL of NH4OH were added to a round bottom flask. The solution was left 
under magnetic stirring, at room temperature for 8 h. 
The solution was centrifuged for 10‘ at 10000 rpm and the pellet was washed 
with ethanol. The process was repeated twice and the nanoparticles were 
dispersed in ethanol. 
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 4.6.3  Functionalization of SiO2 nanoparticles with (3-
aminopropyl) triethoxysilane (APTES) 
This step was based on the work of Wu et al. [9], 2mL of deionized water, 13 
mL of ethanol, 20 µL of chloridric acid and 500 µL of APTES were added to a 
round bottom flask. The solution was left under magnetic stirring at room 
temperature for 30 min.  
5 mL of SiO2 nanoparticles colloidal suspension were added to the solution and 
the flask was put into a thermostatic bath at 60°C. The solution was left under 
magnetic stirring, at 60°C for 6h. 
The solution was centrifuged for 10‘ at 10000 rpm and the pellet was washed 
with ethanol. The process was repeated twice and the nanoparticles were 
dispersed in ethanol. 
 4.6.4  Synthesis of gold nanoparticles (GNPs)  
Following the method reported in literature [10], 45 mL of deionized water, 3 
mL of NaOH aqueous solution (0.1 M) and 1 mL of THPC aqueous solution 
(1.2 mL diluted to 100 mL with water) were added to a round bottom flask in a 
sonicating bath. The solution was left sonicating at room temperature for 2 
min. 2 mL of an aqueous solution of HAuCl4 (25 mM) were added to the 
solution. After a few minutes under sonication the color of the solution goes 
from yellow to orange-brown. The solution was kept at 4°C in a dark glass 
bottle for 15 days before use. 
 4.6.5  Functionalization of SiO2-APTES nanoparticles with 
GNPs 
40 mL of GNPs colloidal suspension, 2,5 mL of NaCl aqueous solution (1M) 
and 100 µL of SiO2-APTES colloidal suspension were added to a test tube. The 
tube was sonicated for 1‘ and the solution was left still for a night at room 
temperature. 
The solution was centrifuged for 10 min at 10000 rpm and the pellet was 
washed with deionized water. The process was repeated twice and the 
nanoparticles were dispersed in water. 
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 4.6.6  GNPs reduction on SiO2-APTES nanoparticles surface 
The Kcarb solution was prepared, putting in a flask 24,9 mg of potassium 
carbonate and 1,74 mL of HAuCl4 aqueous solution (25 mM) diluted to 100 
mL with deionized water. 
Each sample was prepared by putting in a flask 0,5 mL of SiO2-GNPs colloidal 
suspension, the volume indicated in Table 4.2 of Kcarb solution and 25 mL of 
an NH2OH•HCl aqueous solution (130 mg/L) dropwise under vigorous 
magnetic stirring. 
The solutions were left under magnetic stirring overnight at room temperature. 
 
Table 4.2: Experimental conditions 
 
SiO2_GNPs Kcarb NH2OH-HCl
mL mL mL
Nanoshell 8 0.5 50 25
Nanoshell 9 0.5 40 25
Nanoshell 10 0.5 30 25
Nanoshell 11 0.5 20 25
Nanoshell 12 0.5 10 25
Nanoshell 13 0.5 5 25
 
 4.6.7  Preparation of SiO2 nanoparticles (Stöber method – 25-
65 nm) 
Successively the method was slightly modified in order to obtain smaller SiO2 
nanoparticles, 34 mL of ethanol, 2,8mL of tetraethyl orthosilicate (TEOS) and 
NH4OH (see Table 4.3) were added to a round bottom flask in a sonicating 
bath. The solution was left sonicating at room temperature for 6 h.  
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Table 4.3: Experimental conditions for SiO2 nanoparticles preparation 
 
 
Ethanol TEOS NH4OH 
 
mL mL mL 
SiO2 NPs 5 
34 2.8 
1.7 
SiO2 NPs 6 2.0 
SiO2 NPs 7 2.3 
SiO2 NPs 8 2.6 
 
The solution was centrifuged for 10 min at 10000 rpm and the pellet was 
washed with ethanol. The process was repeated twice and the nanoparticles 
were dispersed in ethanol. 
The functionalization of SiO2 nanoparticles with APTES was realized as 
described before so as the synthesis of gold nanoparticles.  
The functionalization with GNPs was slightly different though: 10 mL of GNPs 
colloidal suspension, 625 µL of NaCl aqueous solution (1M) and 50 µL of 
SiO2-APTES colloidal suspension were added to a test tube. The tube was 
sonicated for 1min and the solution was left still for a night at room 
temperature. 
The solution was centrifuged for 10 min at 10000 rpm and the pellet was 
washed with deionized water. The process was repeated twice and the 
nanoparticles were dispersed in water. 
Successively, for GNPs reduction on SiO2-APTES nanoparticles surface, the 
Kcarb solution was prepared, putting in a flask 24,9 mg of potassium carbonate 
and 1.74 mL of HAuCl4 aqueous solution (25 mM) diluted to 100 mL with 
deionized water. Each sample was prepared by putting in a flask 0,5 mL of 
SiO2-GNPs colloidal suspension, the volume indicated in Table 4.4 of Kcarb 
solution and 25 mL of an NH2OH•HCl aqueous solution (130 mg/L) dropwise 
under vigorous magnetic stirring. 
The solutions were left under magnetic stirring overnight at room temperature. 
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Table 4.4: Kcarb solution volume for each sample preparation 
 
 
Kcarb 
 
mL 
1 2.5 
2 3.75 
3 5 
 4.6.8  Coating of Sample with Poly(ethylene glycol) methyl 
ether thiol 
Sample 3 was coated with poly(ethylene glycol) methyl ether thiol by using the 
affinity between the thiol groups and gold. In a typical procedure 400 mg of 
polymer were solubilized in 10 mL of deionized water, 20mL of Sample 3 were 
added to the solution and it was left at room temperature, under magnetic 
stirring for 6h. The coated nanoparticles were purified by centrifugation (3800 
rpm for 2h) and redispersed in water. 
 4.6.9  Characterization techniques 
Gold nanoparticles sizes and size distribution were measured using Dynamic 
Light Scattering (DLS). The DLS measurements were done on a Zetasizer 
Nanoseries ZS90 (Malvern).The morphology of the water dispersion was 
evaluated by TEM analysis. Samples were observed by TEM by examining in a 
300 keV transmission electron microscope (TEM) Philips CM30. TEM 
micrographs were processed with a slow scan CCD camera and analyzed with 
the Digital Micrograph program. The TEM observations were always 
performed using a very low electron flux in order to avoid any structural 
modification of the sample induced by the electron beam. 
The surface Plasmon resonance of nanoparticles was studied using UV-vis 
spectra. The surface Plasmon resonance of nanoparticles was studied using 
UV-Vis spectra. The UV-Vis spectra were recorded by means of a double beam 
UNICAM UV2 (ATI Unicam, Cambridge, UK) spectrophotometer with 
variable slit width in a spectral range of 190 e 1100 nm, interfaced to a 
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computer via ―Vision 32‖ software for data elaboration. The range between 400 
and 1100 nm was monitored with a scan step of 1 nm. 
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5. Hyperthermia 
 5.1  PEG coated magnetite nanoparticles via 
photopolymerization 
Magnetite nanoparticles were synthesized by a chemical co-precipitation of 
Fe
2+
 and Fe
3+
 ions under alkaline conditions, following a previous method 
reported in literature [1]. The concentration of Fe
2+
/Fe
3+
 was 1:2 and the 
synthesis was carried out under inert atmosphere to prevent Fe
2+
 oxidation to 
Fe
3+
. DLS measurements showed an average size of Fe3O4 particles of about 
400 nm (see Figure 5.2). The magnetization curves showed superparamagnetic 
property (i.e. no remanence effect) of the bare particles and relatively high 
magnetization values (see Figure 5.1).  
 
Figure 5.1: Magnetization versus applied magnetic field of synthesized bare  Fe3O4 
particles 
 
The achieved magnetite nanoparticles were coated with PEGDA by UV-
activation in water under nitrogen inlet. The Fe3O4 particles show 
photoinitiator activity, as already reported in literature [2] and recently 
investigated by our group [3]: semiconductor nanoparticles upon 
photoexcitation can generate radicals which in turn start polymerization chains. 
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Under UV-light, valence band holes and conduction band electrons can be 
generated on Fe3O4 surface; valence band holes have intense liability to capture 
electrons and acrylic monomer can be initiated by valence band holes to 
produce cured polymeric coating on the particles surface.  Therefore, PEGDA 
coating on Fe3O4 particles was performed by UV irradiation of water 
dispersion containing the magnetite previously synthesized. The 
magnetite/PEGDA ratio was modified in the range between 1.25 up to 15 phr. 
The size distribution curves for the bare Fe3O4 and for the coated particles with 
increasing Fe3O4/PEGDA ratio are reported in Figure 5.2.  
 
Figure 5.2: Size distribution curves for the bared Fe3O4 and for the PEGDA coated 
particles 
 
From the distribution curves it can be seen that the size of magnetite particles 
has increased because of organic coating and also because of their possible 
aggregation. The increase of the average size and size distribution by 
increasing the magnetite content could be due to formation of smaller 
nanoparticles aggregates. This was further confirmed by TEM analysis. 
Coating the Fe3O4 particles with PEGDA endowed the particles with excellent 
— bare Fe3O4 
--- 1.25 phr 
… 2.5 phr 
–·– 5.0 phr 
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biocompatibility and hydrophilicity, which is a mandatory request for medical 
applications.  
In order to confirm the PEGDA shell formation around magnetite 
nanoparticles, the XPS analyses were performed on the core-shell 
nanoparticles. The high resolution XPS spectra of survey and C 1s of 
functionalized nanoparticles are reported in Figure 5.3 and Figure 5.4 
respectively.  
 
Figure 5.3: High resolution XPS spectra of survey spectra of functionalized Fe3O4 
particles 
 
In survey scan (Figure 5.3) we used 187.85 eV pass energy and 2 kV argon ion 
gun. In the survey spectra it is possible to observe typical spectrum of 
polymeric material (PEGDA), with evidence of Oxygen and Carbon signal. A 
mapping procedure on the investigated sample did not show any Iron signal 
form the nanoparticles. This is clear evidence that the PEGDA shell around the 
magnetite nanoparticles is at least 5 nm thick (which is the maximal depth 
resolution of XPS analysis). 
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Figure 5.4: High resolution XPS spectra of C 1s of functionalized Fe3O4 particles 
 
The high resolution spectra were carried on C1s with a pass energy of 23.5 eV. 
In Figure 5.4 it is reported the C1s signal with related deconvolution; the C1s 
signal were fitted with four components [4]. The 284.66 eV signal (A) 
corresponds to C-C bond, the 285.99 eV (B) correspond to C-C(=O)OR, the 
286.87 eV (C) correspond COC, and 288.49 eV (D) is related to C(O)OR, as 
schematized in the Table 5.1.  
 
Table 5.1: XPS C1s signal were fitted with four components 
 
Attribution B.E. eV 
(PEGDA) 
Atomic Percentage  
(%) 
A      C-C  284.66 34.50 
B      C-C(=O)OR 285.99 54.06 
C      COC 286.87 8.58 
D      C(O)OR 288.49 2.85 
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From these analyses PEGDA seems uniformly distributed on magnetite. 
The degree of functionalization of the magnetite particles was evaluated 
through TGA analysis. The TGA curves for the bare Fe3O4 particles and for the 
PEGDA functionalized particles (samples achieved with a Fe3O4 content of 5 
phr, as an example) are reported in Figure 5.5, depicting the variation of 
residual masses of the samples with temperature.  
 
Figure 5.5: TGA curves of the bare Fe3O4 particles and of the PEGDA UV-coated 
particles 
 
The absolute weight loss of the uncoated Fe3O4 is about 3,1% for the whole 
temperature range, due to the removal of adsorbed physical and chemical 
water. For PEGDA-coated particles, the main weight loss stage occurred at 
around 225 °C and can be attributed to the PEGDA decomposition.  This 
curves indicated that the magnetite content was about 64%, with a PEGDA 
shell content which was calculated to be around 36% of the total weight.  
The morphology of the coated magnetite particles was investigated by TEM 
analysis. The TEM micrographs of coated Fe3O4 particles achieved for the 
formulations containing 5 phr Fe3O4 are reported in Figure 5.6.  
— Bare Fe3o4 particles 
--- PEGDA UV-coated particles 
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A B 
C D 
 
 
Figure 5.6: TEM micrograph for the coated Fe3O4 particles  
(A 2.5 phr 52000x, B 5.0 phr 110000x, C 1.25 phr 61000x, D  5 phr 89000x) 
 
It can be seen that the particles have a strong tendency to aggregate as a result 
of the interaction of the polymer coated on the nanoparticles. While the 
average size of the particles are in the nanometre range, within 3 to 10 nm, the 
large aggregates of the particles are around 1-2  µm   in good agreement with 
the DLS analyses. 
The magnetization curves for coated Fe3O4 nanoparticles are shown in Figure 
5.7.   
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Figure 5.7: Magnetization versus applied magnetic field at room temperature 
 
When the amount of magnetite is low with respect to the PEGDA (with a ratio 
within 1,5 to 2,5 phr) the hysteresis loop shows a non negligible coercivity and 
a remanence different from 0. This behaviour is not acceptable for biomedical 
applications, especially for in-vivo utilization. Nevertheless, it can be seen that 
by increasing the Fe3O4/PEGDA ratio in the system up to 10-15 phr both 
remanence and coercivity values tend to zero: these samples show a 
superparamagnetic like behaviour, and therefore they are suitable for 
biomedical applications.   
Conclusions 
Magnetite nanoparticles were synthesized by a chemical co-precipitation of 
Fe
2+
 and Fe
3+
 ions under alkaline conditions the magnetization curves showed 
superparamagnetic property (i.e. no remanence effect) and relatively high 
magnetization values. The achieved magnetite nanoparticles were coated with 
PEGDA by UV-activation in water adapting a known methodology to 
nanoparticles coating for the very first time. After polymeric functionalization 
— 1.25 phr 
– – 2.5 phr 
… 5.0 phr 
–·– 10 phr 
--- 15 phr 
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DLS showed that size of magnetite particles has increased because of organic 
coating and also because of their possible aggregation. XPS analyses showed 
that the PEGDA shell around the magnetite nanoparticles is at least 5 nm thick 
and uniformly distributed on magnetite surface. From TEM morphological 
investigations, it is possible to observe that while the average size of the 
particles are in the nanometre range, within 3 to 10 nm, the large aggregates of 
the particles are around 1-2  µm   in good agreement with the DLS analyses. 
The magnetization curves for coated Fe3O4 nanoparticles showed that only  by 
increasing the Fe3O4/PEGDA ratio in the system up to a value of 10-15 phr 
both remanence and coercivity tend to zero and makes the particles suitable for 
bio-medical applications. In conclusion, we have developed a novel and 
successful in-situ photochemical coating of magnetite nanoparticles which 
showed superparamagnetic-like behaviour.  
 5.2  PEG coated magnetite nanoparticles via UV-thiol-
ene addition reaction 
Magnetite nanoparticles were synthesized by a chemical co-precipitation of 
Fe
2+
 and Fe
3+
 ions under alkaline conditions, following  previous method 
reported in literature[5][6][7][8][9][10]. The concentration of Fe
2+
/Fe
3+
 was 1:2 
and the synthesis was carried out under inert atmosphere to prevent Fe
2+
 
oxidation to Fe
3+
. Citric acid was added during the synthesis in order to protect 
the nanoparticles avoiding macroscopic aggregations. The magnetization 
curves showed superparamagnetic property (i.e. no remanence effect) of the 
bare particles and relatively high magnetization values (see Figure 5.8).  
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Figure 5.8: Magnetization versus applied magnetic field of synthesized bare Fe3O4 
particles 
 
DLS measurements showed an average size of Fe3O4 particles of about 30 nm 
(see DLS curve in Figure 5.9).  
 
Figure 5.9: Size distribution curves for the bare Fe3O4 (curve a) and for the PEG-coated 
particles (curve b) 
 
 a 
a 
 a 
b 
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The achieved magnetite nanoparticles were functionalized with vinyl groups by 
using VTMS. The schematized reaction is represented in Figure 5.10.  
 
Figure 5.10: Schematic representation of the vinyl functionalization of magnetite surface 
and subsequent PEG-coating via thiol-ene reaction. 
 
Modified magnetite nanoparticles were characterized by ATR spectroscopy as 
can be seen in Figure 5.11. The ATR-FTIR spectra are reported for respectively 
the bare Fe3O4 nanoparticles (spectra a) and for vinyl functionalized Fe3O4 
nanoparticles (spectra b).  
 
Figure 5.11: ATR-FTIR spectra of bared Fe3O4 (spectra a) and vinyl modified Fe3O4 
(spectra b) nanoparticles. 
 
 a 
b 
 a 
a 
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In spectra b it can be seen that the strong and broad peak centered at around 
3100 cm
-1
 disappeared, while a double peak centered at around 1600 cm
-1
 
appeared after reactive functionalization of the nanoparticles. The 
disappearance of the peak centered at 3100 cm
-1
 can be attributed to the 
consumption of the hydroxyl groups present on the surface of Fe3O4 
nanoparticles, during the silanization reaction, while the appearance of the 
double peak centered at 1600 cm
-1
 can be attributed to the vinyl groups present 
on the nanoparticles surfaces after reaction with VTMS (see the reaction 
scheme of Figure 5.10).  
The achieved vinyl functionalized magnetite nanoparticles were coated with 
PEG-SH by UV-activation in water under nitrogen inlet. It is well known that 
under UV-light thiol groups can generate thyil radicals which are highly 
reactive towards C=C double bonds. The thiol-ene reaction is particularly 
interesting because it has all the desirable features of a ―click‖ reaction, being 
highly efficient, simple to execute with no side products and proceeding 
rapidly to high yield. The UV-induced thiol-ene reaction is a free-radical 
process that proceeds by a step-growth mechanism, involving two main steps, a 
free-radical addition followed by a chain transfer reaction [11][12]. The UV 
activation of PEG-dithiol will allow to coat the vinyl functionalized Fe3O4 
nanoparticles with a PEG shell.  
The DLS measurements after coating the vinyl-Fe3O4 nanoparticles with PEG-
SH showed an average size of nanoparticles of about 60 nm (see DLS curves b 
Figure 5.9). The increased size is due to the formation of the polymeric shell 
around the particles.  
In order to confirm the polymer coating onto the surface of Fe3O4 particles via 
thiol-ene photochemical reaction, FT-IR spectra were recorded on dried 
samples. In Figure 5.12 the FT-IR spectra of coated magnetite nanoparticles is 
reported.  
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Figure 5.12: FT-IR of dried PEG-coated magnetite nanoparticles. 
 
It can be assigned a strong absorption peak of stretching vibrations of ether 
bonds at 1100 cm
-1
. Absorbent peaks were also evident at 2900 cm
-1
 belonging 
to asymmetric stretching vibration and scissoring bending vibration of CH2 
aliphatic groups. All these peaks are in accordance with the presence of a PEG 
shell around the magnetite particles. Furthermore the typical double peak 
centered at around 1600 cm
-1
, which was previously observed on vinyl 
functionalized nanoparticles (Figure 5.11, spectra b), disappeared indicating the 
complete conversion of double bonds, due to the thiol addition. The broad peak 
centered at around 3500 cm
-1
 is due to the presence of water trace in the dried 
sample.  
The TEM micrographs for magnetite coated particles are reported in Figure 
5.13.  
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Figure 5.13:  TEM micrograph for aqueous dispersion of the PEG-coated Fe3O4 
nanoparticles 
 
It is possible to observe that the single particles are in the nanometric size 
range with an average size of about 20-50 nm, they are well dispersed and they 
do not show strong tendency of microscopic aggregation. The TEM 
investigation is quite in a good agreement with DLS analyses which shows that 
by vinyl functionalization and following PEG coating it was possible to 
achieve nanometric size particles well distributed and not-aggregated.  
Coating the Fe3O4 particles with PEG endowed the particles with excellent 
biocompatibility and hydrophilicity, which is a mandatory request for medical 
applications. 
The degree of functionalization of the magnetite particles was evaluated 
through TGA analysis. The TGA curves for the PEG-coated Fe3O4 particles are 
reported in Figure 5.14, depicting the variation of residual masses of the 
samples with temperature.  
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Figure 5.14: TGA curves of the PEG-coated Fe3O4 nanoparticles 
 
The main weight loss stage occurred at around 225 °C and can be attributed to 
the PEG decomposition. This curve indicated that the magnetite content was 
about 40%, with a PEG-shell content which was calculated to be around 60% 
of the total weight. 
The magnetization curve of the ferrofluid containing bare magnetite 
nanoparticles is shown in Figure 5.15.  
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Figure 5.15: Room-temperature magnetization curve of the ferrofluid containing bare 
Fe3O4 nanoparticles 
 
The curve exhibits superparamagnetic-like features (slow approach to 
saturation, absence of hysteresis) in spite of the rather large NP size.  In fact, a 
simple calculation shows that almost spherical magnetite NPs of average size 
30 nm (and volume V  1.4 x 10
-17
 cm
3
 ) are in the blocked state at room 
temperature, the blocking temperature being TB  410 K, as is obtained from 
the usual expression TB= KAV/25kB when the value of the magnetic anisotropy 
constant KA is taken equal to that of bulk magnetite, |KA| = 1 x 10
5
 erg/cm
3
,  as 
appropriate to these nanoparticles [13][14]. Therefore, the superparamagnetic-
like behavior is to be attributed to the fact that magnetic moments are affected 
by Brownian motion of the nanoparticles in a ferrofluid. A simple calculation 
shows that for a spherical nanoparticle of volume V the Debye relaxation time 
for rotation of NPs dissolved in water,  = 3 V/kBT [15], is of the order of 10 
s at room temperature, i.e. much shorter than the measurement time. As a 
consequence these NPs appear to be in a superparamagnetic state although 
their magnetization is blocked along an easy direction, because they are 
submitted to fast, random rotations of their crystallographic axes.  
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The magnetization curves of the ferrofluid containing coated Fe3O4 
nanoparticles are shown in Figure 5.16a, b before and after subtraction of a 
strong diamagnetic signal which survives after subtraction of diamagnetic 
contributions from sample holder and solvent.  Such a signal is ascribed to the 
polymeric shell surrounding the NPs.  
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Figure 5.16: (■): room-temperature magnetization curves of the ferrofluid containing 
coated Fe3O4 nanoparticles; (a): before subtraction of diamagnetic from polymer coating; 
(b): after subtraction. (○) in (b): ferrofluid containing bare nanoparticles. 
 
Again, the curve exhibits no detectable hysteresis in spite of the rather large NP 
size, for the reasons discussed above (although the larger volume of coated 
NPs entails a larger Debye relaxation time, this remains well below the 
measurement time). The symbols (○) in Figure 5.16b, which are exactly 
superimposed to the curve for coated NPs, refer to the bare nanoparticles, 
showing that their magnetic response is definitely not modified by polymeric 
coating. 
Conclusions 
Magnetite nanoparticles were synthesized by a chemical co-precipitation of 
Fe
2+
 and Fe
3+
 ions under alkaline conditions. The magnetization curves showed 
superparamagnetic property (i.e. no remanence effect) of the bare particles and 
relatively high magnetization values. DLS measurements showed an average 
size of Fe3O4 particles of about 30 nm. The achieved magnetite nanoparticles 
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were functionalized with vinyl groups by using VTMS, and they were further 
functionalized via thiol-ene reaction with PEG-SH under UV-activation. The 
DLS measurements after coating the vinyl-Fe3O4 nanoparticles with PEG-SH 
showed an average size of nanoparticles of about 60 nm. FT-IR analyses of the 
particles confirmed the presence of a PEG shell around the magnetite particles. 
The TEM micrographs for magnetite coated particles show that the single 
particles are nanometric size range with an average size of about 20-50 nm, 
they are well dispersed and they do not show strong tendency of microscopic 
aggregation. The degree of functionalization of the magnetite particles was 
evaluated through TGA analysis showing a PEG-shell content which was 
calculated to be around 60%. 
Superparamagnetic-like behavior of coated Fe3O4 nanoparticles, which is 
typically looked after in biomedical applications, is ensured by the Brownian 
motion of magnetic NPs in the ferrofluid.  Polymeric coating does not modify 
the magnetic response of the magnetite nanoparticles. 
 5.3  Polymer grafting onto magnetite nanoparticles 
via click-reaction 
In this work, we aim to show the use of ―click chemistry‖ for the preparation of 
magnetite-core/polymer-shell NPs. The overall strategy, as presented in Figure 
5.17, is based firstly on the preparation of bromine-functionalized magnetite 
NPs, and then after azidation, the NPs are functionalized via click-reaction 
either with PCL or PEG polymeric shells. 
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Figure 5.17: overall strategy of magnetite functionalization via „click“ reaction 
 
Magnetite NPs were synthesized by a chemical co-precipitation of Fe
2+
 and 
Fe
3+
 ions under alkaline conditions, following previous method reported in 
literature [16][17][18][19][20][21]. Citric acid was added during the synthesis 
in order to protect the NPs avoiding macroscopic aggregations. 
The magnetite NPs, prepared with the co-precipitation method, were 
functionalized with bromine groups by using 3-(bromopropyl)trimethoxysilane 
(see Figure 5.17). Modified magnetite NPs were characterized by FTIR 
spectroscopy. In Figure 5.18, the FTIR spectra are reported for respectively 
bare Fe3O4 NPs and bromine functionalized Fe3O4 NPs.  
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Figure 5.18: IR spectra of bare magnetite nanoparticles (A) and bromine functionalized 
nanoparticles (B). 
 
In spectrum B, it can be seen that the strong and broad peak centered at around 
3100 cm
-1
 disappeared, while a peak centered at around 1112 cm
-1
 appeared 
after reactive functionalization of the NPs. The disappearance of the peak 
centered at 3100 cm
-1
 can be attributed to the consumption of the hydroxyl 
groups present on the surface of Fe3O4 NPs, during the silanization reaction, 
while the appearance of the peak centered at 1112 cm
-1
 can be attributed to the 
C-O-Si stretching band.  
The bromine-functionalized magnetite NPs were used as the starting point for 
‗‗click‘‘ modification by conversion to an azide-functional surface through 
nucleophilic substitution. As a matter of fact the nanoparticles were azidated by 
reaction of the bromine groups with sodium azide. The successful azidation 
was confirmed by ATR spectrum. In Figure 5.19 the IR spectra of both bromine 
functionalized NPs and azide functionalized NPs are reported (A) with a zoom 
on the azide peak region (B). 
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Figure 5.19: Confrontation of the magnetic nanoparticles IR spectra before and after 
azidation (A), zoom on the azide peak region (B). 
 
The azidation of the NPs was confirmed by the appearance of the peak 
centered at 2100 cm
-1
 characteristic of the azide group.  
For the subsequent click modification, alkyne-PCL and alkyne-PEG was 
synthesized as described in the experimental part. 
In particular the alkyne-PCL (a-PCL) was prepared by Ring Opening 
Polymerization of ε-CL in bulk using tin(II) 2-ethylhexanoate as a catalyst and 
4-pentyn-1-ol as an initiator, illustrated in Figure 4.3. The alkyne PCL was 
further characterized by ATR spectroscopy.  
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Figure 5.20: spectrum of the a-PCL. 
 
As can be seen in Figure 5.20, the successful synthesis of alkyne PCL was 
confirmed by the alkyne stretching band around 2150 cm
-1
 and the typical 
bands of PCL such as C=O stretching at 1730 cm
-1
, asymmetric C-O-C 
stretching at 1241 cm
-1
 or C-C stretching at 1047 cm
-1
. 
 
Regarding the alkyne-PEG (a-PEG), it was synthesized by the etherification 
reaction between 4-pentynoic acid and monohydroxyl functional PEG in 
CH2Cl2 (reaction scheme illustrated in Figure 4.4). The a-PEG was further 
characterized by ATR spectroscopy. 
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Figure 5.21: spectrum of a-PEG. 
 
As can be seen in Figure 5.21, the successful synthesis of a-PEG was 
confirmed by the alkyne stretching band around 2150 cm
-1
 and the typical 
bands of PEG such as –COC vibration  around 1010 cm-1 and out-of-plane 
bending of the –CH of the chain at 960 cm-1. 
The polymer functionalized NPs were characterized by ATR spectroscopy. In 
Figure 5.22 are reported the spectra of a-PCL and a-PCL functionalized 
magnetic NPs.  
 
Figure 5.22: spectrum of the a-PCL (A) and of the PCL functionalized nanoparticles (B). 
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As can be seen from the spectrum, the alkyne peak around 2150 cm
-1
 
respectively disapeared confirming the reaction between the azide group and 
the alkyne goup. The functionalization is further confirmed by the presence of 
the typical peaks of PCL such as C=O stretching at 1730 cm
-1
, asymmetric C-
O-C stretching at 1241 cm
-1
 or C-C stretching at 1047 cm
-1
 and the 
disappearance of the alkyne stretching band at 2100 cm
-1
.  
The degree of functionalization of the magnetite particles was evaluated 
through TGA analysis. The TGA curve for the PCL-coated Fe3O4 particles is 
reported in Figure 5.23, depicting the variation of residual masses of the 
samples with temperature.  
 
Figure 5.23: TGA of PCL functionalized magnetic nanoparticles. 
 
The main weight loss stage occurred at around 200 °C  can be attributed to the 
PCL decomposition. This curve indicated that the magnetite content was about 
40%, with a PCL-shell content which was calculated to be around 60% of the 
total weight.  
In Figure 5.24 is reported the ATR spectrum of a-PEG functionalized NPs.  
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Figure 5.24: spectrum of PEG functionalized magnetite nanoparticles. 
 
 
As can be seen on the spectrum the alkyne peak around 2150 cm
-1
 disapeared 
confirming the reaction between the azide group and the alkyne goup. The 
functionalization is further confirmed by the presence of the typical peaks of 
PEG such as –COC vibration around 1010 cm-1 and out-of-plane bending of the 
–CH of the chain at 960 cm-1.  
The degree of functionalization of the magnetite particles was evaluated 
through TGA analysis. The TGA curve for the PEG-coated Fe3O4 particles is 
reported in Figure 5.25, illustrating the variation of residual masses of the 
samples with temperature.  
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Figure 5.25: of PEG functionalized magnetite nanoparticles 
 
 
The main weight loss stage occurred at around 225 °C and can be attributed to 
the PEG decomposition. This curve indicated that the magnetite content was 
about 20%, with a PEG-shell content which was calculated to be around 80% 
of the total weight. 
Magnetization curves of PCL functionalized NPs and PEG functionalized NPs 
are reported respectively in Figure 5.26 and Figure 5.27.  
 
Figure 5.26: Magnetization curve of PCL coated magnetite nanoparticles 
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Figure 5.27: Magnetization curve of PEG coated magnetite nanoparticles 
 
In both cases the hysteresis loop shows neither remanence nor coercivity, this 
confirms the fact that the polymer coated NPs have a superparamagnetic 
behavior  and are, for this reason, suitable for biomedical applications. 
The morphology of the coated NPs in aqueous solution has been investigated 
with TEM after transferring the aqueous solution to carbon coated copper 
grids. Figure 5.28 shows TEM micrograph of PCL coated NPs.  
200 nm
 
Figure 5.28: TEM micrograph for aqueous dispersion of the PCL-coated Fe3O4 
nanoparticles 
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Figure 5.29 shows TEM micrograph of PEG coated NPs .  
50 nm
 
Figure 5.29: TEM micrograph for aqueous dispersion of the PEG-coated Fe3O4 
nanoparticles. 
 
The presence of aggregates may be due to the water droplet evaporation during 
TEM analysis. However, it is possible to observe that for both samples the 
single particles are in the nanometric size range with an average size of ranging 
between 20 and 50 nm. The TEM investigation shows that by functionalization 
via click reaction it was possible to achieve nanometric size particles which can 
be suitable for their magnetic properties to biomedical applications.  
Conclusions 
Magnetite nanoparticles (NPs) were functionalized with bromine groups using 
(3-Bromopropyl)trimethoxysilane, bromine groups were then substituted with 
azide groups using sodium azide. Successively the NPs were coated with a-
PEG and a-PCL via click reaction, reacting alkyne groups of the polymers with 
azide groups on the surface of NPs. ATR analysis confirmed the presence of a 
polymeric shell in both cases. The degree of functionalization of the magnetite 
particles was evaluated through TGA analysis showing a PCL-shell content 
which was calculated to be around 60% and a PEG-shell content which was 
calculated to be around 80%.  The analysis of the magnetization curves show 
that the NPs have a superparamagnetic behavior which is one of the most 
important requirements for intravenous administration in bio-medical 
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application. TEM analysis confirmed the nanometric size the narrow size 
distribution of the coated NPs. Moreover, coating the Fe3O4 particles with PEG 
and PCL endowed the particles with excellent biocompatibility and 
hydrophilicity, which is a mandatory request for medical applications. 
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6. Photothermal therapy 
 6.1  Photochemical synthesis of gold-PEG core-shell 
nanoparticles 
Gold-PEGDA core shell particles were prepared in water by adapting the 
method developed by our groups [1][2] in which gold nanoparticles were in 
situ generated from HAuCl4 as precursor in the presence of a radical 
photoinitiator. It is well known that microcapsule formation can be achieved by 
photochemical means in water-acrylic emulsion [3]. In our work, free-
emulsifier emulsion polymerization is performed by using PEGDA as 
hydrophilic monomer. It is expected that PEG nanospheres would be formed by 
UV-induced polymerization after adding the acrylic resin into water in 
dropwise manner. The nanospheres formed this way could integrate the gold 
precursor and generate gold nanoparticles by a reduction process occurring 
within the PEGDA droplets. The overall process is schematically represented 
in Figure 6.1.  
 
Figure 6.1: Photochemical synthesis of gold-PEG core-shell nanoparticles 
 
Accordingly, the synthesis was conducted in a three-necked flask in which gold 
precursor and radical photoinitiator were previously added to a large amount of 
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water. While the acrylic resin was added dropwise, the UV irradiation was 
turned on. Different formulations were investigated using different 
photoinitiator content in the range between 2 to 6 wt% with respect to the 
amount of acrylic resin added to the water dispersion. During UV irradiation 
the solution turns from yellow to purple, indicating successful gold reduction.  
The photopolymerization process was investigated by real-time FT-IR analysis 
by plotting conversion curves as a function of irradiation time. In this analysis, 
while the plateau value gives the final acrylic double bond conversion, the 
slope of the curve corresponds to the polymerization rate. In Figure 6.2, the 
real time FT-IR kinetic curves for the different formulations containing 
increasing amount of radical photoinitiator are reported.  
 
Figure 6.2: Conversion curves as a function of irradiation time for PEGDA/HAuCl4 water 
dispersion containing the radical photoinitiator at 2 (-) 4 (- -) or 6 (
…
) wt% with respect to 
the PEGDA resin. 
 
By increasing the photoinitiator concentration, an increase in the 
photopolymerization rate was observed. It should be noted that regardless of 
the photoinitiator concentration, an almost complete acrylic double bond 
conversion is achieved after few minutes of irradiation in all cases. In the batch 
system, where curing occurred in a very dilute PEGDA in water dispersion, the 
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curing time was prolonged for 30 minutes in order to assure complete acrylic 
double bond conversion in the shells around the gold particles.  
Dynamic light scattering curves are reported in Figure 6.3 for the different 
water dispersion.  
 
Figure 6.3: Size distribution obtained by DLS measurements of the water gold-PEGDA 
core-shell nanoparticles obtained from water formulations containing the radical 
photoinitiator at 2 (-) 4 (- -) or 6 (
…
) wt% with respect to the PEGDA resin 
 
It is noted that the particles size increases by increasing the photoinitiator 
content. When 2 wt% radical photoinitiator is employed, rather homogenously 
distributed nanometric size particles are obtained. However, by increasing the 
photoinitiator content to 4 wt%, the average size is still nanometric but with 
larger dimension. Finally, when the photoinitiator content is increased up to 6 
wt%, the particles formed are not in the nanometric size range anymore. The 
observed increase on particle dimension could be attributed to an increase of 
the acrylic thickness shell around the gold nanoparticles due to the larger 
concentration of active radicals available for PEGDA polymerization. 
The morphology of the coated gold particles in aqueous solution has been 
investigated with TEM after transferring the aqueous solution to carbon coated 
copper grids. Figure 6.4 shows TEM micrograph for the formulations 
containing 2 wt% of radical photoinitiator.  
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Figure 6.4: TEM micrograph of the gold/PEGDA core-shell nanoparticles obtained from 
the water formulations containing 2 wt% of radical photoinitiator. The aqueous solution 
was transferred to carbon coated copper grids 
 
The presence of large aggregates formed by single particles of the average size 
within 10 to 50 nm is in a good agreement with the DLS analyses. The large 
aggregate may be due to the water droplet evaporation during TEM analysis: 
evaporation results in the increase in the concentration. As a consequence the 
number density and distance of the particles increase leading to the formation 
of large clusters.   
In order to confirm the coating of PEGDA on the surface of gold particles by 
the described photochemical route, ATR spectra were recorded on dried 
samples. The ATR spectra of the gold-PEGDA core-shell nanoparticles 
obtained from the solution containing 2 wt% of radical photoinitiator is 
reported in Figure 6.5.  
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Figure 6.5: ATR spectrum of the of the dried gold/PEGDA core-shell nanoparticles 
obtained from the water formulations containing 2 wt% of radical photoinitiator. 
 
The strong peak centred at 1700 cm
-1
 was attributed to the stretching vibration 
of the ester groups. Absorption bonds of stretching vibrations of ether bond 
appeared at 1100 cm
-1
. Absorbent peaks were also evident at 2900 cm
-1
 
belonging to asymmetric stretching vibration and scissoring bending vibration 
of CH2 aliphatic groups. All these peaks revealed the existence of PEGDA 
coating on the gold particles. 
The gold nanoparticles functionalization was further confirmed by XPS 
analysis. XPS measurements allow determining the surface composition of 
functionalized gold particles. The XPS measurements were performed on gold-
PEGDA core-shell nanoparticles obtained from the solution containing 2 wt % 
of radical photoinitiator.  
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Figure 6.6: High resolution XPS spectra of survey spectra performed on gold-PEGDA 
core-shell nanoparticles obtained from the solution containing 2 wt% of radical 
photoinitiator. 
 
 
Figure 6.7: High resolution XPS spectra of C 1s of gold-PEGDA core-shell nanoparticles 
obtained from the solution containing 2 wt% of radical photoinitiator 
 
In the survey scan (Figure 6.6), O1s signal in the 523-543 eV region, C1s 
signal in the 228-298 eV region was evidenced. , However, Au 4f, in the ( 80-
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98 eV) region was not detected. This finding is a clear evidence of the fact that 
the PEGDA shell around the gold nanoparticles is at least 5 nm thick (as 
discussed in paragraph  5.1 ). In the high resolution spectra of C1s region 
(Figure 6.7), fitted with four components and related atomic percentage, were 
reported. The same information with relative atomic percentage was depicted 
in Table 6.1.  
 
Table 6.1: XPS attribution of the different signals recorded on dried gold-PEGDA core-
shell structure. The reference shift was performed on C1s peak at 284.8 eV correspond to 
C-C signal. 
 
Attribution B.E. eV  
(PEGDA) 
Atomic Percentage   
(%) 
A      C-C  284,79 41,24 
B      C-C(=O)OR 286,26 43,43 
C      COC 287,02 13,25 
D       C(=O)OR 288,98 2,08 
 
The reference shift was performed on C1s peak at 284,8 eV corresponds to C-C 
signal [4]. The observed second peak at 286,26 eV is related to C-C(=O)OR 
labelled with B according to reference. The third shoulder, (labelled with C) 
corresponds to COC signal, and finally, the last component D could be related 
to C(=O)OR bound. 
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Figure 6.8: UV-vis spectra of the water gold-PEGDA core-shell nanoparticles obtained 
from water formulations containing the radical photoinitiator at 2 (-) 4 (- -) or 6 (
…
) wt% 
with respect to the PEGDA resin 
 
In Figure 6.8 the UV-Vis spectrum of the water dispersions show the presence 
of a strong absorption peak centred at around 550 nm, which is close to the 
reported surface plasmon resonance for gold nanoparticles in solution [5]. The 
size and shape of metal nanoparticles determine the spectral position of 
plasmon band absorption. It is evident from the spectra reported in Figure 6.8, 
a slight shift of the maximum peak of the plasmon resonance toward infrared 
wavelength by increasing the amount of radical photoinitiator. This can be 
attributed to the increased thickness of the polymeric shell around the gold 
nanoparticles, as already evidenced by DLS analyses. 
Conclusions 
Gold-PEGDA core shell particles were prepared in water via a photoinduced 
electron transfer and free-radical polymerization of an acrylic formulation. 
DLS measurements reveal the achievement of nanometric size distribution of 
— 2 wt% 
--- 4 wt% 
… 6 wt% 
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the synthesized particles. The TEM micrographs showed that the particles are 
in the nanometre range, within 10 to 50 nm, which is in good agreement with 
the DLS analyses.  ATR and XPS analyses confirmed the formation of PEGDA 
shell around the gold particles. All the identified IR peaks revealed the 
existence of PEGDA coating on the gold particles. The C1s peaks 
deconvolutions further evidence XPS signals from PEGDA, which overlap 
homogeneously Au nanoparticles. UV-vis spectra showed the presence of a 
surface plasmon resonance, which is a size-related electronic feature. 
Homogenous core-shell structured nanoparticles obtained this way are 
expected to find important applications in bio-medical fields. 
 6.2  Hollow-gold nanoparticles 
The HGNs were prepared by adapting the method found in literature [6] in 
which the synthesis is based on templating using cobalt (Co) nanoparticles as 
initial seeds via a galvanic reaction with Au
3+
 ions. It is essential that the 
oxidation state of the seed metal ion (Co
2+
 in this case) be lower than that of 
the metal ion to be reduced (Au
3+
 here) [6]. Since the reduction potential of the 
AuCl
4-
/Au redox couple (0,935 V vs SHE) is indeed much higher than that of 
the Co
2+
/Co redox couple (- 0,377 V vs. SHE), AuCl
4-
 will be reduced to Au 
atoms as soon as Co nanoparticles are added into the solution due to the big 
gap between the potential of these two redox couples. In addition, because the 
reduced gold atoms are largely confined to the vicinity of sacrificial template 
outer surface, the diameter of Co nanoparticles determines that of the resulting 
gold hollow nanostructures. Therefore, the fabrication of Co nanoparticles is a 
critical foundation in the whole preparation procedure [7]. The gold shell at its 
formation stage should have an incomplete porous structure so that Co
2+
 and 
HAuCl
4-
 can continuously diffuse into the shell. The porous structure allows 
the remaining active Co ―core‖ to be continuously oxidized to Co2+ by H+ 
when there is not sufficient supply of HAuCl4[7]. The overall process is 
represented in Figure 6.9 
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Figure 6.9: schematic representation of HGNs formation 
 
The combination of shell diameter and thickness determines the peak position 
of the SPR absorption. Moreover, on the basis of theoretical calculation, the 
SPR bandwidth depends sensitively in the uniformity of the shell diameter and 
thickness, and poorer uniformity results in broader spectral width [6]. For these 
reasons we decided to realize different formulations to assess the relation 
between the surface plasmon resonance position and the morphology of the 
device. The results obtained are reported in Table 6.2 hereafter. The mean 
external and internal diameters have been measured on at least 100 TEM 
pictures. 
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Table 6.2: Effect of the variation of the reaction parameter on shell thickness and SPR 
localization 
  Sod citrate NaBH4 CoCl2 HAuCl4 Ext diam   Int diam Max SPR 
Sample Nber  µL µL µL µL nm nm nm 
1 400 100 100 250 32,86 21,48 600 
2 400 100 100 700 68,46 44,07 606 
3 190 180 100 700 63,93 49,24 677 
4 330 250 100 700 53,26 40,16 639 
5 900 100 100 700 63,97 46,76 619 
6 190 180 100 450 59,41 48,4 683 
7 330 250 100 450 34,65 22,1 586 
8 900 100 100 450 55,59 37,64 611 
 
As can be seen from Table 6.2 varying the reaction parameters it is possible to 
obtain a wide range of internal and external diameters, hence a wide range of 
shell thicknesses. Namely, we obtained external diameters going from 32,86 
nm to 68,46 nm and internal diameters going from 21,48 nm to 49,24 nm as 
can be seen in Figure 6.10.  
 
 
Figure 6.10: TEM images of HGNs samples  
 
In this way we obtained SPR localized between 586 nm and 683 nm, into the 
near infrared region. However, looking at the absorbance spectra reported in 
Figure 6.11 it is possible to see that the shift of the absorbance peak, compared 
to the one of gold, is not directly correlated to the external diameter. 
1 7 3 5 2 4 8 6 
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Figure 6.11: absorbance spectra of HGNs samples and 15 nm gold nanoparticles (Au) 
 
Plotting the different data in our possession we eventually found the correlation 
between the localization of the SPR and the ratio between the external diameter 
and the internal diameter as can be seen on Figure 6.12. 
Au             1     2   8   5       4         3  6 
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Figure 6.12: correlation between the SPR localization and the ratio external diameter on 
internal diameter 
 
The relation between these 2 parameters is exponential, and the typical 
equation would be: 
f(x)=y+ae
-bx 
 
to our knowledge, it is the first time that such a correlation is found. 
From an experimental point of view this means that there are 2 regimes: in the 
first one, when the ratio is superior to 1,2, little variation of this ratio leads to 
important shift of the SPR while, when the ratio is inferior to 1,2, the SPR shift 
is a lot more difficult to control by varying the ratio. Moreover, we can see that 
smaller is the ratio value more significant is the SPR shift toward NIR region.  
In a second time, another sample was prepared, sample 9. The size and the 
morphology of the new nanoparticles were studied by TEM, the pictures are 
reported in Figure 6.13. 
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Figure 6.13: TEM pictures of Sample 9 
 
The nanoparticles are nearly spherical and monodisperse. The external mean 
diameter is 51.1 ± 9.7 nm and the internal mean diameter is 30.2 ± 7.2 nm 
(mean diameters measured on 100 HGNs). 
These nanoparticles were then coated with poly(ethylene glycol) methyl ether 
thiol using the affinity between thiol groups and gold. The nanoparticles size 
and granulometric distribution were studied by DLS analysis, the results are 
reported on Table 6.3. 
 
Table 6.3: DLS analysis of bare and coated hollow gold nanoparticles 
Sample Name 
Z average 
(nm) 
PDI 
Bare nanoparticles 60.22 0.114 
Coated nanoparticles 78.00 0.140 
 
The DLS analysis demonstrates a mean diameter increase of about 18 nm while 
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the polydispersity index is not significatively changed, this confirm the 
successful coating of the nanoparticles. Moreover the absorbance of the 2 
colloidal suspension was measured and the confronted in Figure 6.14. 
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Figure 6.14: Uv-Vis spectra of bare nanoparticles (black) and coated nanoparticles (red) 
The absorbance spectra of bare nanoparticles and coated nanoparticles are 
slightly shifted, the first one is at 623 nm and the second one at 614 nm. 
Conclusions 
Hollow gold nanoparticles were synthesized by reduction of gold salts on the 
surface of cobalt nanoparticles. By varying the reaction parameters we were 
able to obtain a wide range of diameters and shell thicknesses. In this way it 
was possible to study the shift of the surface plasmon resonance in function of 
the variation of these parameters. We found an exponential correlation between 
the ratio of the external diameter and the internal diameter and the surface 
plasmon resonance localization, to our knowledge this correlation has never 
been reported in literature. Moreover, we were able to coat hollow gold 
nanoparticles with a biocompatible polymer (PEG) in order to make them 
suitable for biomedical applications. This polymeric coating did not 
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significatively shift the SPR peak, leaving it in the NIR region which is 
compulsory for photothermal therapy. 
 6.3  SiO2@Au nanoshell 
Metal nanoshells are a class of interesting subwavelength photonic particles 
with highly tunable plasmonic properties. A perfect nanoshell is composed of a 
spherical dielectric core homogeneously coated with a concentric nanoscale 
metallic shell. The nanoshell plasmon resonance frequencies and lineshapes are 
strongly dependent on the relative ratio between core and shell dimensions, the 
overall size of nanoshells, and the dielectric properties of surrounding medium. 
Recent advances in the chemistry of molecular self assembly and surface 
modification of both dielectric and metal colloids have provided the essentials 
elements that enables the immobilization of metal nanoparticles onto the 
surface of larger dielectric cores as described on Figure 6.15 
[8][9][10][11][12]. 
 
 
Figure 6.15: schematic representation of nanoshell formation 
 
Spherical silica nanoparticles were grown following the well known method 
described by Stöber et al. [13]. Their size and morphology were studied by 
TEM and the pictures are reported on Figure 6.16. 
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Figure 6.16: TEM pictures of SiO2 nanoparticles 
 
The nanoparticles obtained are spherical with a diameter of 110 nm and are 
fairly well dispersed.  
Successively, the small gold nanoparticles (GNPs) were prepared by reduction 
of chloroauric acid with THPC as described by Duff et al. [15]. The mean 
diameter of GNPs nanoparticles was studied via DLS analysis the 
granulometric distribution can be seen on Figure 6.17. 
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Figure 6.17: DLS analysis of GNPs 
 
We can see that the mean diameter of the nanoparticles is around 4 nm and the 
size distribution is fairly narrow. The morphology of the nanoparticles was 
further studied by TEM (see Figure 6.18). 
 
 
Figure 6.18: TEM picture of GNPs 
 
 
6. Photothermal therapy 
________________________________________________________ 
161 
 
The nanoparticles seem fairly dispersed and their diameter is in agreement with 
DLS analysis. 
The attachment of the small GNPs on the surface of silica nanoparticles was 
carried out by functionalizing the silica nanoparticles with APTES and having 
these groups react with the surface of GNPs. The morphology of the 
nanoparticles was studied by TEM, the pictures can be seen on Figure 6.19. 
 
  
  
 
Figure 6.19: TEM pictures of SiO2_APTES nanoparticles functionalized with GNPs 
 
The size distribution of the nanoparticles is a little bit wider, between 110 and 
170 nm. Moreover, the GNPs seem rather well dispersed on the nanoparticles 
surfaces. For the formation of the gold shell in the next reaction step, it is 
important that all non-attached GNPs are removed from the dispersion of the 
gold-functionalized silica nanoparticles. 
The principal idea for the formation of the gold-shell is to grow the small 
GNPs attached to the silica nanoparticles surface larger by soft reduction of 
gold onto them. After some initial growth these gold particles begin to 
coalesce, and finally a continuous gold shell is formed. This shell may then be 
grown further to a thicker shell. To get well defined, uniform, and closed shells, 
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it is important that all small nanoclusters are growing simultaneously (not only 
the larger seeds) so that, after the clusters have grown a few nanometers, all 
clusters have coalesced and the resulting gold shell acquires a uniform 
thickness. On the other hand, it is important that the newly added gold ions are 
only reduced on the small gold nanoclusters attached on the gold shells. 
Besides growth on gold clusters in the solution, the new nucleation of gold 
nuclei should also be prevented. 
The nanoshell diameter was studied by TEM analysis on an average of 100 
nanoparticles for each sample and the surface plasmon resonance was obtained 
on a spectrophotometer. 
The results obtained are reported in Table 6.4.  
 
Table 6.4: Mean external diameter, mean internal diameter and SPR localization of 
samples Nanoshell 8 to Nanoshell 13 
 
Diam Ext Diam Int SPR
nm nm nm
Nanoshell 8 176.2±14.4 115.3±5.9 552
Nanoshell 9 174.8±11.7 115.6±2.4 556
Nanoshell 10 159.1±14.5 114.9±3.9 554
Nanoshell 11 146.0±13.9 113.7±3.1 615
Nanoshell 12 161.2±13.5 113.6±3.5 556
Nanoshell 13 137.4±12.8 113.8±6.3 755
 
 
The TEM pictures of the different samples are reported hereafter in Figure 
6.20, Figure 6.21, Figure 6.22, Figure 6.23, Figure 6.24 and Figure 6.25: 
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Figure 6.20: Nanoshell 8 
 
  
  
Figure 6.21: Nanoshell 9 
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Figure 6.22: Nanoshell 10 
 
 
  
  
Figure 6.23: Nanoshell 11 
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Figure 6.24: Nanoshell 12 
 
 
  
  
Figure 6.25: Nanoshell 13 
 
We can clearly see that the internal diameter remains constant in all samples 
and consistent with the initial diameter of SiO2 nanoparticles while the external 
diameter is varying with the volume of Kcarb solution added. This variation of 
the shell thickness leads to a shift of the surface plasmon resonance localization 
6. Photothermal therapy 
________________________________________________________ 
166 
 
as can be seen in Table 6.4. We plotted Figure 6.26 to understand the 
correlation between these 2 parameters. 
Regime 2
The SPR does not depend on 
the thickness of the Au shell.
The SPR value is of about 
550nm
Regime 1
The SPR strongly depends on the 
thickness of the Au shell.
Its value ranges from 750 to about 
550nm
Transition
The transition between the 
regimes 1 and 2 takes place 
at a Au shell thickness of 
about 20 nm
 
Figure 6.26: Surface Plasmon resonance localization in function of the gold shell 
thickness 
 
On this figure we can see that the surface plasmon resonance localization 
depends strongly on the shell thickness, indeed there is an exponential 
correlation between these 2 parameters. Moreover, as reported on the graph, 
this correlation is composed by 2 different regimes. In the first one, for a shell 
thickness inferior to 20 nm, the SPR localization undergoes significant 
variation (from 550 nm to 750 nm), varying the shell thickness. In the second 
regime, for a shell thickness superior to 20 nm the SPR localization does not 
depend on the shell thickness anymore and is situated around 550 nm. To 
conclude, it was possible to shift the surface plasmon resonance of the 
nanoparticles to 750 nm, deep into the near infra-red, which is good for our 
application; however the external diameter of the nanoparticles is going from 
136 nm to 177 nm hence too large for intravenous administration. 
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For this reason we decided trying to adapt the Stöber method to obtain smaller 
SiO2 nanoparticles. More precisely, in this particular reaction ammonia is used 
as a catalyst, for this reason we decided to modify its concentration and check 
the effect on nanoparticles diameter.  
The SiO2 nanoparticles obtained this way were characterized by TEM (at least 
100 nanoparticles were measured for each sample to determine the mean 
diameter), the results obtained are reported in Table 6.5 and in Figure 6.27: 
 
Table 6.5: Diameter of the SiO2 nanoparticles varying the NH4OH concentration 
 
 
NH4OH Diam 
 
mL nm 
SiO2 NPs 5 1.7 27.64 ± 3.04 
SiO2 NPs 6 2.0 36.94 ± 4.61 
SiO2 NPs 7 2.3 51.33 ± 5.49 
SiO2 NPs 8 2.6 65.36 ± 6.88 
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Figure 6.27: Variation of the SiO2 nanoparticles diameter varying the NH4OH 
concentration 
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We note that, as expected, the diameter of the SiO2 nanoparticles increases, 
increasing the NH4OH concentration. The TEM pictures of the samples are 
reported in Figure 6.28, Figure 6.29, Figure 6.30 and Figure 6.31. 
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Figure 6.28: SiO2 NPs 5 
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Figure 6.29: SiO2 NPs 6 
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Figure 6.30: SiO2 NPs 7 
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Figure 6.31: SiO2 NPs 8 
 
We observe that increasing the NH4OH concentration the regularity of the 
nanoparticles increases as well as the mean diameter.  
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For the following part we decided to use the sample SiO2 NPs 6 as it represents 
a good compromise between mean diameter (small enough) and regularity of 
the morphology. These SiO2 nanoparticles were functionalized with gold seeds 
as described before and the gold seeds were grown until forming a gold shell 
using the Kcarb solution. The volume of Kcarb solution added to the reaction 
was increased progressively until obtaining a complete an homogeneous gold 
shell (checked by TEM observations), this was obtained for Sample 3 (by 
adding 5 mL of Kcarb solution), while on Sample 1 and 2 the gold shell was 
incomplete. The morphology of these nanoshells is reported on Figure 6.32. 
 
  
  
Figure 6.32: TEM pictures of Sample 3 Nanoshells  
 
These Nanoshells have a mean diameter of 45.3 nm (see Figure 6.34), they 
have a nearly spherical shape and are fairly well dispersed. Moreover the 
colloidal suspension of Nanoshells in water shows a very strong absorbance 
peak at 979nm as can be seen on Figure 6.33. 
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Figure 6.33: UV-Vis spectrum of colloidal suspension of Nanoshells in water 
 
Eventually, the Nanoshells were coated with poly(ethylene glycol) methyl ether 
thiol (MeO-PEG-SH), using the natural affinity between thiol groups and gold, 
in order to have a biocompatible device suitable for intravenous administration. 
The success of the coating was checked using DLS analysis, the size 
distribution curves of nanoshells before and after coating are reported in Figure 
6.34. 
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Figure 6.34: DLS analysis of Nanoshells before and after coating with MeO-PEG-SH 
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The increase in the nanoparticles mean diameter (from 45.3 nm before coating 
to 74.6 nm afterward) demonstrate the success of the polymeric coating. 
Moreover the size distribution curve stays fairly narrows which confirms  the 
absence of aggregation. The UV-Vis spectrum of the coated Nanoshells in 
colloidal suspension shows a shift of the SPR from 979 nm to 972 nm, this 
variation is not significant for the application we are interested in, staying 
always in the range of interest. 
Conclusions 
In a first part, nanoshells were prepared following methods described in 
literature. SiO2 nanoparticles of 110 nm diameter were obtained and 
functionalized with APTES, successively GNPs were grafted on their surface 
and these GNPs were grown until forming an uniform gold shell. By varying 
the amount of gold salts added in the last step of the synthesis it was possible 
to obtain a wide range of shell thicknesses and to study the shift or surface 
plasmon resonance in function of this parameter. Therefore, we were able to 
find the correlation between shell thickness and SPR localization. In a second 
part, the Stöber process was slightly modified in order to obtain smaller 
nanoparticles, with diameters between 25 nm and 65 nm. In this way it was 
possible to obtain nanoshells smaller than those reported in literature. In a third 
part one sample was coated with poly(ethylene glycol) methyl ether thiol, using 
the natural affinity between thiol groups and gold, in order to have a device 
suitable for biomedical applications. 
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Conclusions 
As explained in the introduction, the preparation of nanodevices for biomedical 
application, and more specifically to be at direct contact with blood, imply a 
certain number of rules and requirements. Particularly, all the materials 
employed and their method of preparation have to meet precise specifications 
and characteristics while bringing the innovation needed and potential 
improvements in the applications of interest. 
The first application is hyperthermia for which magnetite nanoparticles were 
synthesized by a chemical co-precipitation of Fe
2+
 and Fe
3+
 ions under alkaline 
conditions; magnetization curves showed superparamagnetic property (i.e. no 
remanence effect) and relatively high magnetization values. The achieved 
magnetite nanoparticles were coated with PEGDA by UV-activation in water 
adapting a known methodology to nanoparticles coating for the very first time. 
It was possible to observe that while the average size of the particles are in the 
nanometre range, within 3 to 10 nm, the large aggregates of the particles were 
around 1-2  µm   in good agreement with the DLS analyses. The magnetization 
curves for coated Fe3O4 nanoparticles showed that only  by increasing the 
Fe3O4/PEGDA ratio in the system up to a value of 10-15 phr both remanence 
and coercivity tend to zero and makes the particles suitable for bio-medical 
applications. This first type of nanoparticles was suitable for hyperthermia but 
slightly too large for intravenous administration, for this reason and other 
preparation method was implemented. 
Firstly, in order to reduce the aggregation tendency of magnetite it was 
stabilized with citric acid, which didn‘t modify the magnetic behaviour. Then, 
the achieved magnetite nanoparticles were functionalized with vinyl groups by 
using VTMS, and they were further functionalized via thiol-ene reaction with 
PEG-SH under UV-activation. The DLS measurements after coating the vinyl-
Fe3O4 nanoparticles with PEG-SH showed an average size of nanoparticles of 
about 60 nm, and TEM observations demonstrated that they were well 
dispersed and did not show strong tendency of microscopic aggregation. The 
degree of functionalization of the magnetite particles was evaluated through 
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TGA analysis showing a PEG-shell content which was calculated to be around 
60%. Superparamagnetic-like behavior of coated Fe3O4 nanoparticles, was 
ensured by the Brownian motion of magnetic NPs in the ferrofluid and  
polymeric coating dids not modify the magnetic response of the magnetite 
nanoparticles. These nanoparticles seem to meet all the requirement described 
before. 
Another method was studied which consisted in coating magnetite 
nanoparticles with a-PEG and a-PCL via click reaction, reacting alkyne groups 
of the polymers with azide groups on the surface of magnetic NPs. ATR 
analysis confirmed the presence of a polymeric shell in both cases. The degree 
of functionalization of the magnetite particles was evaluated through TGA 
analysis showing a PCL-shell content which was calculated to be around 60% 
and a PEG-shell content which was calculated to be around 80%.  The analysis 
of the magnetization curves show that the NPs had a superparamagnetic 
behavior. TEM analysis confirmed the nanometric size the narrow size 
distribution of the coated NPs.  
The second application considered in this work is photothermal-therapy: Gold-
PEGDA core shell particles were prepared in water via a photoinduced electron 
transfer and free-radical polymerization of an acrylic formulation. DLS 
measurements reveal the achievement of nanometric size distribution of the 
synthesized particles. The TEM micrographs showed that the particles are in 
the nanometre range, within 10 to 50 nm. However the SPR of these NPs was 
not shifted enough into the NIR to be efficient in this kind of application, for 
this reason other gold core morphologies were studied. 
Hollow gold nanoparticles were synthesized by reduction of gold salts on the 
surface of cobalt nanoparticles. By varying the reaction parameters we were 
able to obtain a wide range of diameters and shell thicknesses. In this way it 
was possible to study the shift of the surface plasmon resonance in function of 
the variation of these parameters. We found an exponential correlation between 
the ratio of the external diameter and the internal diameter and the surface 
plasmon resonance localization, to our knowledge this correlation has never 
been reported in literature. Moreover, we were able to coat hollow gold NPs 
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with a biocompatible polymer (PEG). This polymeric coating didn‘t 
significatively shift the SPR peak, leaving it in the NIR region which is 
compulsory for photothermal therapy. 
Last but not least, nanoshells were prepared following methods described in 
literature. SiO2 nanoparticles of 110 nm diameter were obtained and 
functionalized with APTES, successively GNPs were grafted on their surface 
and these GNPs were grown until forming an uniform gold shell. By varying 
the amount of gold salts added in the last step of the synthesis it was possible 
to obtain a wide range of shell thicknesses and to study the shift or surface 
plasmon resonance in function of this parameter. Therefore, we were able to 
find the correlation between shell thickness and SPR localization. In a second 
part, the Stöber process was slightly modified in order to obtain smaller 
nanoparticles, with diameters between 25 nm and 65 nm. In this way it was 
possible to obtain nanoshells smaller than those reported in literature. In a third 
part one sample was coated with poly(ethylene glycol) methyl ether thiol, using 
the natural affinity between thiol groups and gold, in order to have a 
biocompatible device without significantly shifting the SPR. 
The role of the material sciences engineer is to propose new material and 
devices to biologists and medical researchers following precise specifications, 
in this perspective I prepared different devices complying with the 
requirements for biomedical applications; the next step would be now to test 
these devices in vitro and in vivo to check if they indeed can bring 
improvement in cancer therapies.  
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